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ABSTRACT 
 
The cohesin complex has a conserved and fundamental role in chromosome biology 
as it is involved in sister chromatid cohesion, DNA repair and gene regulation. 
Mutations in cohesin and its regulators lead to human developmental disorders and 
cancer, and it is hypothesised that this is due to cohesin’s roles in gene regulation.  
Cohesin mediates gene regulation primarily through the formation or stabilisation of 
long-range chromatin loops from CTCF, a conserved transcriptional regulator, binding 
sites. Cohesin-anchored chromatin loops were first described at specific loci to 
physically tether distal regulatory elements to gene promoters. This thesis investigated 
whether the roles of cohesin in mediating chromatin loops at individual loci in the 
genome could apply genome wide, and if so, whether such global cohesin-anchored 
chromatin loops could contribute to chromosomal organisation. To test this, I 
established a post-mitotic cell system from mouse so that cohesin proteins could be 
genetically deleted in a manner that did not interfere with their roles in mitosis. Using 
this system, cohesin was shown to be an anchor point for chromatin loops of all scales 
throughout the genome which included both gene loops and loops required for 
chromosome architecture. Cohesin-deficient post-mitotic cells exhibited global 
chromosomal decompaction and widespread transcriptional deregulation. While the 
majority of cohesin chromatin pools were depleted, chromatin domain borders were not 
abolished and residual cohesin complexes were still bound to chromatin in cohesin-
deficient cells. To test whether such residual cohesin complexes may still be mediating 
long-range chromatin loops and thus maintaining chromosome structures, I used RNAi 
to knock-down cohesin regulators, such as CTCF and Stag proteins, in cohesin-
deficient post-mitotic astrocytes. My results highlight a role for CTCF and Stag proteins 
in the regulation of cohesin-mediated genome organisation in mouse. Thus, it was 
shown that cohesin proteins have key roles in genome organisation and functions.  
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CHAPTER 1. INTRODUCTION 
 
1.1. BACKGROUND  
The Structural Maintenance of Chromosome (SMC) protein family consists of 
condensin and cohesin complexes which act as fundamental regulators of 
chromosome structure and are conserved from bacteria to humans (Wood et al., 
2010). Genetic and biochemical studies have demonstrated that SMC proteins have 
critical roles in DNA replication, chromosome segregation and chromatin condensation 
during mitosis and meiosis (Wood et al., 2010). Over the last decade, cohesin 
complexes have been shown to have functions in addition to their roles in chromosome 
segregation, and include gene regulation and DNA repair (Merkenschlager and Odom, 
2013; Nasmyth and Haering, 2009). 
 
STRUCTURE OF THE COHESIN COMPLEX 
MOLECULAR ARCHITECTURE OF THE COHESIN COMPLEX 
The core cohesin complex consists of four subunits; two SMC proteins, Smc1 and 
Smc3, an α-kleisin protein, Scc1 (also known as Mcd1/Rad21), (herein referred as 
Rad21), and a stromalin protein, Scc3 (also known as Psc3/SA/Stag) (herein referred 
as Stag) (Anderson et al., 2002; Haering et al., 2002; Haering et al., 2004; Losada et 
al., 1998; Losada and Hirano, 2001; Melby et al., 1998). In vertebrate somatic cells, 
immunoprecipitation studies have shown that the cohesin complex can contain either 
Stag1 or Stag2, but not both (Losada et al., 2000; Sumara et al., 2000). These 
observations imply that multiple versions of the complex can exist in vivo.  
The structure of these subunits has been best characterised in S. cerevisiae, however 
the deep sequence conservation of these proteins and similar biochemical results 
imply that cohesin complexes have similar structures in other species (Anderson et al., 
2002; Haering et al., 2002; Hirano et al., 2001). Each SMC subunit folds on itself so 
that an SMC intra-molecular (Haering et al., 2002) anti-parallel (Melby et al., 1998) 
coiled coil monomer is formed. Haering et al. removed the hinge domains of Smc3 and 
Smc1 to show that the heterotypic interactions between hinges are both necessary and 
sufficient for the interaction between the two SMC proteins. More electron microscopy 
20 
 
and biochemical experiments on the bacterial, yeast and vertebrate cohesin show that, 
at one end, each SMC monomer has a globular hinge domain where the SMC proteins 
heterodimerise and due to the angle of dimerisation, the two arms create a V-shaped 
molecule (Anderson et al., 2002; Haering et al., 2002; Hirano et al., 2001). On the other 
end, each SMC homodimer creates a functional adenosine triphosphate (ATP) 
nucleotide-binding domain (NBD), when the N-terminus of the Walker A motif (i.e. the 
phosphate-binding loop motif) dimerises with the C-terminus of the Walker B motif 
(Haering et al., 2002; Haering et al., 2004; Löwe et al., 2001) (Figure 1a, b, Interface 
‘A’). When ATP is bound to Walker A and B motifs within the Smc1 head, it also binds 
to a ATP-Binding Cassette (ABC) signature motif (i.e. LSGGQ or C-motif) within the 
Smc3 head and vice versa, creating a transient bipartite ring that can bind and 
hydrolyse ATP, a function required for cohesin chromosome binding (Arumugam et al., 
2003; Weitzer et al., 2003) (Figure 1a, b, Interface ‘A’).  
The cohesin ring closes when the Smc3 coiled coil region near the NBD and the Smc1 
NBD bind to the N- and C-terminal domains of Rad21, respectively (Arumugam et al., 
2003; Gruber et al., 2003; Haering et al., 2002; Gligoris et al., 2014; Huis in ’t Veld et 
al., 2014) (Figure 1a). Haering et al. used purified yeast Smc3/1 and Rad21 to show 
that they co-immunoprecipitate and that the removal of both heads of Smc3/1 but not 
the replacement of the Smc hinge abolished Rad21 binding to the complex. Also a 
small linker between Smc3 N- and C-terminus co-purified with Rad21 which supports 
the arguments that cohesin is a ring (Haering et al., 2002). Another part of the cohesin 
complex is Stag subunit (Haering et al., 2002; Toth et al., 1999) and it interacts with 
two regions at the C-terminus of Rad21 (Roig et al., 2014). Crystal structure studies 
have shown that Stag is a crescent-shaped protein composed of tandem α-helices 
(Roig et al., 2014) (Figure 1a). The C-terminus of Stag, which binds to Rad21, is the 
region that differs between Stag1 and Stag2 paralogues. The N-terminus is highly 
conserved and present in organisms lacking other regulators (i.e. Pds5, Wapl, and 
Scc2/4) (Roig et al., 2014), highlighting its evolutionary conserved roles in cohesin 
biology. Through mutations or depletion experiments, it was shown to be essential to 
cohesin loading and release from chromosomes and therefore, to its functions in Sister 
Chromatid Cohesion (SCC) (discussed below) (Hauf et al., 2005; Hu et al., 2011a; 
Remeseiro et al., 2012a; Rowland et al., 2009; Toth et al., 1999). This has been further 
validated when the yeast cohesin complex and the loading of cohesin to chromatin 
reaction were recapitulated in vitro, revealing that Stag is essential for cohesin loading 
and it stimulates cohesin ATPase activity (Murayama and Uhlmann, 2014).  
21 
 
 
Figure 1. The architecture of the cohesin complex. a) Graphical representation of the core cohesin 
complex (Smc1 and Smc3, Rad21 and Stag). The hinge region where Smc3 and Smc1 dimerise, the Smc 
coiled coil region and the ATPase domains (or head domains) are indicated (grey lines). b) Interface A 
depicts the structure of the Smc ATPase domains (i.e Walker A/B and ABC signature motifs) and their 
association with ATP. Interface B depicts the hinge region where Smc1 and Smc3 dimerise. Interface C 
presents the amino acid sequence of Rad21 (red), which associates with Stag and vice versa (orange). 
Adapted from Nasmyth et al. (2011), Arumugam et al. (2003), Zhang et al. (2013) and Roig et al. (2014). 
 
Protein-protein interactions between the core cohesin subunits, specifically the Smc3-
Smc1 hinge domains (Haering et al., 2002; Hirano and Hirano, 2002), and SMC 
ATPase domains-Rad21 interfaces (Arumugam et al., 2003; Haering et al., 2004; 
Weitzer et al., 2003) are required for cell viability, implying that only intact cohesin 
complexes are essential for its functions.  
Specifically, the disruption of SMC head-Rad21 interface (Figure 1b, Interface ‘A’) 
leads to decreased viability due to the inability to form cohesin complexes or to 
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associate stably with chromatin. Initial experiments in yeast showed that mutations at 
either Rad21 or Smc1 head disrupt their association and result in lower viability 
(Haering et al., 2004). The chemical fusion of Rad21 to either Smc1 or Smc3 (through 
its N- or C-terminus) rescues lethality from mutation in the N- or C-terminus of Rad21, 
supporting the argument that the interactions forming the cohesin ring are essential for 
cohesin functions (Gruber et al., 2006) (Figure 1b). Specifically, mutations at the SMC 
Walker A/B motifs inhibit cohesin’s ability to bind ATP, while mutations at the SMC C-
motif prevent ATP hydrolysis and both mutations compromise viability (Arumugam et 
al., 2003; Weitzer et al., 2003). These studies show that Smc1 but not Smc3 ATP-
binding mutants fail to form complexes while both Smc1 and Smc3 ATP-hydrolysis 
mutants are loaded onto chromatin but accumulate at centromeres. Recent evidence 
sheds light on why Smc3-Rad21 interaction doesn’t require ATP binding. The Rad21 
N-terminal region associates with the coiled coil region of Smc3, an interaction 
fundamental for cohesin association with chromatin and cell viability (Gligoris et al., 
2014; Huis in ’t Veld et al., 2014). These studies provided evidence for an additional 
functionally essential interaction within the Smc3-Rad21 interface, implying an 
additional mechanism that ensures the ring structure of cohesin. 
Specific residues at the Smc1/3 hinge region (Figure 1b, Interface ‘B’) are shown to be 
important for its dimerisation (Haering et al., 2002). This event is essential for the de 
novo association of cohesin with chromatin and cell viability as shown by experiments 
in yeast using a system where the Smc1/3 hinge regions are linked in a rapamycin-
dependent manner (Gruber et al., 2006). In vitro DNA binding assays show that SMC 
mutants that fail to dimerise via the hinge, have decreased ability to associate with 
DNA (Hirano and Hirano, 2002). Mutations that specifically neutralised a positive 
charged channel in this interface (i.e. Smc hinge region) led to loss of SCC without 
affecting Smc dimerisation or cohesin association with chromosomes (Kurze et al., 
2011). Interstingly, the above mutations led to a decrease in the acetylation of Smc3, 
which is an important step during S-phase (discussed below). Thus, it was proposed 
that this interphase is implicated in conformational changes in the cohesin complex 
during S-phase and establishment of SCC. 
The interface between Rad21-Stag (Figure 1b, Interface ‘C’) is also essential to 
cohesin functions. Mutations in yeast Stag led to decreased SMC and Rad21 levels on 
chromatin and vice versa (Toth et al., 1999) and premature sister chromatid separation 
(Rowland et al., 2009). The yeast Stag is essential for cohesin loading onto chromatin 
by stimulating cohesin’s ATPase activity (Hu et al., 2011b; Murayama and Uhlmann, 
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2014). It is also important for its release since its phosphorylation during the ‘prophase’ 
pathway in vertebrates promotes cohesin removal off chromosomes (Hauf et al., 2005). 
While the Stag paralogs are 85% similar in sequence, it has been shown both by RNAi-
depletion and conditional alleles in mice, that lacking one or both alleles of the Stag 
genes leads to different functions in cohesion and in DNA repair (Canudas and Smith, 
2009; Kong et al., 2014; Remeseiro et al., 2012a). Since cohesin association with DNA 
is regulated by the cohesin interfaces to which Stag proteins are bound, the different 
cohesin-Stag complexes may influence differently the way cohesin binds DNA. 
 
COHESIN FORMS A RING-LIKE STRUCTURE WHICH ENTRAPS DNA  
The protein-protein interactions described above assemble the core subunits into a 
tripartite ring-like structure with a diameter of ~ 40 nm (Haering et al., 2002), a structure 
also visualised by microscopy studies (Anderson et al., 2002). Due to the nature of the 
cohesin structure and the fact that release of cohesin from yeast chromosomes 
requires opening of the cohesin ring via cleavage (Uhlmann et al., 1999), it was 
hypothesised that the complex may entrap DNA inside its ring (Haering et al., 2004). 
Direct evidence to support this idea came from experiments in yeast, where cohesin 
subunits remain associated with each other, but not with circular mini-chromosomes, 
after Tobacco Etch Virus (TEV)-mediated cleavage within the coiled-coil domain of 
Smc3 or in Rad21 (Gruber et al., 2003). Subsequently, it was shown that when cohesin 
was bound to circular minichromosomes in yeast, the way to disrupt this association 
was either by opening the cohesin ring or by restriction enzyme-mediated digestion of 
the circular DNA (Ivanov and Nasmyth, 2005). Finally, when all of cohesin interfaces 
were chemically fused or cross-linked together and a protein denaturation step was 
added to the method, cohesin remained associated with circular, but not linear DNA 
(Haering et al., 2008). All of these studies supported the argument that cohesin forms a 
tripartite ring which topologically embraces DNA. These observations led to the 
question of how cohesin actually associates with DNA. Several subsequent studies 
explored where the cohesin ring physically opens to accommodate DNA ‘entry’ and 
‘exit’ and whether one or more cohesin rings are needed to mediate SCC.  
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THE COHESIN ‘ENTRY’ AND ‘EXIT’ GATES 
At one end, the cohesin ring is closed by the interactions between the Smc1 and Smc3 
hinge regions (Figure 1b, Interface ‘B’). The nature of the hinge interactions prompted 
the idea that this interface may function as the DNA ‘entry gate’ (Haering et al., 2002). 
Further studies in yeast showed that ATP binding brings Smc1/3 NBD together and 
therefore, it was suggested that its subsequent hydrolysis enables their topological 
separation from the hinge (Weitzer et al., 2003). This view was corroborated from 
studies where fusion of SMC NBDs with N- and C- terminus of Rad21 permitted SCC 
but prevented cohesion establishment and not its maintenance (Gruber et al., 2006). 
Mutations in the cohesin hinge domains that don’t interfere with SMC dimerisation 
compromise the acetylation of Smc3 (Kurze et al., 2011), supporting a role for the SMC 
hinge in cohesion establishment and therefore, an entry of the DNA from this interface.  
From the other end, Rad21 functionally brings together Smc1 and Smc3 NBDs (Figure 
1b, Interface ‘A’) (Haering et al., 2004), which are shown to act as the ‘exit gate’ of 
DNA molecules from the cohesin ring. In mammalian cells, it has been shown that 
cohesin is removed from chromosomes in a two-step process during mitosis (Losada 
et al., 1998; Sumara et al., 2002; Waizenegger et al., 2000). During prophase, cohesin 
removal takes place by the opening of the ring through Rad21-Smc3 interphase and is 
mediated by Wapl (discussed below). During anaphase, both in yeast and mammalian 
cells, cohesin removal requires Rad21 proteolytic cleavage at two sites from a cysteine 
protease, namely separase, in both human and yeast cells (Hauf et al., 2001; Uhlmann 
et al., 1999). The expression of non-cleavable forms of Rad21 leads to anaphase-
arrested cells. Mutations that prevent the phosphorylation of Rad21 during mitosis, 
enhance the cleavability of Rad21 by separase (Hauf et al., 2005), implying this post-
translational modification on Rad21 acts as a protective mechanism from separase-
cleavage. In studies investigating cohesin association with chromatin, these cleavage 
sites were targeted and used as a useful experimental tool that results in the opening 
of the cohesin rings (Gruber et al., 2003). 
 
COHESIN ASSOCIATES WITH DNA AS ONE OR TWO RINGS 
One of the proposed models of cohesin association with chromatin, namely the 
‘embrace model’, predicts that both sister chromatids are entrapped inside the same 
cohesin ring. Initial immunoprecipitation experiments in yeast showed that the cohesin 
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complex contains 1:1:1 ratio of the core components (Haering et al., 2002). Ivanov et 
al. developed a method where complexes of circular ‘cohesed’ mini-chromosomes and 
cohesin were visualised to show that cohesin was released from circular ‘cohesed’ 
mini-chromosomes by either DNA digestion or cohesin cleavage via the SMC coiled 
coils or Rad21 (Ivanov and Nasmyth, 2005). Then, Haering et al. introduced cysteine 
pairs that could be chemically fused at different cohesin interfaces. When they fused all 
cohesin interfaces, cohesin remained associated with circular ‘cohesed’ mini-
chromosomes even after a denaturation step (Haering et al., 2008). Later, by using the 
same methodology, it was established in vivo that cohesin is topologically embracing 
yeast ‘cohesed’ cohesin (i.e. Smc3 acetylated) (Gligoris et al., 2014).  
Other models, the so-called ‘handcuff model’ propose that a single chromatid is 
entrapped by a single cohesin ring, and that the two cohesin rings then interact with 
one another to connect the two sister chromatids (Huang et al. 2005; Zhang et al. 
2008b). By biochemical experiments in mammalian cells, chromatin-bound Flag-tagged 
Rad21 (or Smc1/3) could be immunoprecipitated with Stag 6xHis-tagged Rad21, 
implying that there could be interactions between cohesin complexes. However, Stag 
subunits couldn’t immunoprecipitate with themselves and their depletion disrupted 
Rad21-Rad21 interaction. Therefore, it was suggested that two cohesin rings interact 
with each other via Stag subunit. Later, it was shown that the disruption of the 
interaction between Rad21 and Stag1 didn’t interfere with Stag-Pds5 interactions 
(Zhang et al., 2013). Since Stag proteins interact with only one region in Rad21, it was 
proposed that the cohesin ‘handcuffs’ are stabilised by factors such as Pds5. A study in 
yeast shows that the depletion of Stag or Pds5 compromised cohesion without 
interfering with cohesin levels on chromatin (Kulemzina et al., 2012). Thus, Pds5 and 
Stag depletion is sufficient to destabilise the handcuff while not causing the unloading 
of the rings (Kulemzina et al., 2012). However, there is not sufficient in vivo evidence to 
conclude whether the topological entrapment of sister chromatids uses embrace, 
handcuff or a combination of the two models.  
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THE ROLE OF COHESIN IN SISTER CHROMATID COHESION 
SISTER CHROMATID COHESION  
Three decades ago, two models for the mechanism by which sister chromatids were 
‘cohesed’ were proposed. One suggested that a physical intertwining of DNA after 
replication could lead to cohesion of sister chromatids and the second introduced the 
idea that there are proteins involved in creating SCC (Koshland and Hartwell, 1987; 
Murray and Szostak, 1985). Koshland et al. showed that in yeast chromomosomes 
DNA catenation is unlikely the main player. By using cell cycle mutants in budding 
yeast, the authors showed that the majority of cells released from anaphase didn’t 
show detectable DNA catenation on the yeast minichromosomes and the 
chromosomes segregated properly after mitosis (Koshland and Hartwell, 1987). Initial 
evidence for a protein involved in SCC during mitosis came from genetic screens in 
yeast designed to identify factors which failed to maintain SCC after mitotic arrest, 
identifying several cohesin proteins, such as Rad21 and Stag yeast homologues, Scc2, 
Eco1, Smc1 and Smc3 (Guacci et al., 1997; Michaelis et al., 1997; Toth et al., 1999). It 
was also shown that these proteins, which some of them comprise the cohesin 
complex, function to tether sister chromatids together from DNA replication during S-
phase until the end of mitosis when sister chromatids segregate into daughter nuclei 
(Gruber et al., 2003; Guacci et al., 1997; Losada et al., 1998; Michaelis et al., 1997; 
Uhlmann et al., 1999). This function for cohesin in SCC is evolutionarily conserved, 
and found to be essential in yeast, flies and vertebrates (Guacci et al., 1997; Losada et 
al., 1998; Losada et al., 2000; Michaelis et al., 1997; Vass et al., 2003). Thus, cohesin 
has an essential role during the cell cycle in maintaining the structure of sister 
chromatids and forming the bridges that holds them together up to the moment that 
they are due to be separated to the daughter nuclei.  
 
COHESIN LOADING ON DNA  
The loading of cohesin onto chromatin takes place after mitosis and depends on ATP 
hydrolysis and the cohesin loading complex (Figure 2) (Hauf et al. 2005; Nishiyama et 
al. 2010; Losada et al. 2014; Peters et al. 2009). Although the act of cohesin loading 
onto chromatin and the players involved are conserved throughout evolution, the timing 
of cohesin loading differs from yeast to mammals (Ciosk et al., 2000; Hu et al., 2011; 
Murayama and Uhlmann, 2014, Gillespie and Hirano, 2004; Watrin et al., 2006). In 
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budding yeast, cohesin is loaded onto the DNA at the end of G1 phase (Guacci et al., 
1997; Michaelis et al., 1997), whereas in mammalian cells this process is initiated 
already in telophase following reformation of the nuclear envelope (Gerlich et al., 2006; 
Losada et al., 1998; Sumara et al., 2000). This difference is proposed to be due to 
differences in mitotic removal pathways of cohesin in these organisms. In budding 
yeast, most Rad21 is cleaved by separase in metaphase (Uhlmann et al., 1999). In 
vertebrates, most of the cohesin is removed from chromosomes during the prophase 
pathway without Rad21 cleavage (Waizenegger et al., 2000), implying that a soluble 
pool of cohesin is available for immediate re-loading onto the DNA at the end of 
mitosis.  
 
Figure 2. The regulation of the cohesin complex during cell cycle. In G1-phase, cohesin is loaded on 
chromosomes, a reaction mediated by the loading complex. In S-phase, Esco proteins acetylate Smc3 and 
sister chromatid cohesion is established. In mammalian cells, the maintenance of cohesion is regulated by 
sororin, which is recruited by Smc3 acetylation on Pds5, and by Wapl which antagonises sororin and 
mediates cohesin removal off chromatin. In mammalian cells cohesin is removed off chromosomes in a 
two-step process during mitosis. In prophase, Wapl mediates cohesin removal from chromosome arms 
and the phosphorylation of Stag proteins by Polo-like kinase 1 (Plk1) promotes it. Centromeric cohesion is 
protected by Shugosin and protein phosphatase 2 (PP2A). At the onset of anaphase, cohesin Rad21 
subunit is cleaved by the protease separase so that sister chromatids can segregate to the daughter 
nuclei. Adapted from Hauf et al. (2005), Nishiyama et al. (2010), Losada et al. (2014) and Peters et al. 
(2009). 
One of the key events required for cohesin loading is the ATPase activity of the SMC 
NBDs, which was initially shown in yeast (Arumugam et al., 2003; Arumugam et al., 
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2006; Ladurner et al., 2014; Weitzer et al., 2003) and suspected to involve the opening 
of the hinge interface (Gruber et al., 2006) (Figure 1b, Interface ‘B’). Both Smc3 and 
Smc1 hydrolysis mutants failed to associate with chromosomes, proposing that ATP 
hydrolysis is essential for the association of cohesin with chromatin shown in 
metaphase spreads (Arumugam et al., 2003; Weitzer et al., 2003). In vivo studies using 
ATP hydrolysis mutants showed that they didn’t prevent cohesin association with 
chromatin at core centromeres, where Scc2 (i.e the loading factor) is also enriched, but 
that these mutants reduced the residence time of cohesin on chromatin (Hu et al., 
2011). Corroborative evidence in mammalian cells show that Smc3 ATPase mutants 
fail to associate stably with chromatin shown by inverse fluorescence recovery after 
photo-bleaching (iFRAP) (Ladurner et al., 2014). FRAP is used to measure the ability 
of a molecule to move over time. For this purpose, a fluorophore is covalently attached 
to the molecule of interest (e.g. protein) and a fluorescence microscope is used to 
visualise the fluorescently tagged molecule. While standard FRAP follows the recovery 
of fluorescently tagged proteins into the photobleached region of interest, iFRAP 
involves the entire fluorescently labelled area being bleached apart from a small region 
where the loss of fluorescence from this point is monitored over time. In vitro 
reconstitution experiments in yeast show that cohesin does associate with chromatin 
transiently but the reaction requires ATP (Murayama and Uhlmann, 2014). Thus, ATP 
hydrolysis is not required for the ring formation but is fundamental for the stable binding 
of cohesin on chromosomes.  
Several studies underline the conserved functional importance of the Scc2/Nipbl and 
Scc4/Mau2 complex in the loading of cohesin on chromatin via direct protein-protein 
interactions in yeast (Ciosk et al., 2000; Hu et al., 2011; Murayama and Uhlmann, 
2014), in Xenopus extracts (Gillespie and Hirano, 2004), and in mammals (Watrin et 
al., 2006). Mutations in Scc2 (Michaelis et al., 1997) or Scc4 (Ciosk et al., 2000) lead to 
impaired cohesin association with chromatin and defects in SCC, while they don’t 
interfere with cohesin complex assembly. In HeLa cells expressing cohesin ATPase 
mutants, cohesin levels on chromatin were decreased shown by biochemical and 
immunofluorescence experiments (Ladurner et al., 2014). This was proposed to be due 
to their decreased time of residence on chromatin, which was even further reduced 
after the depletion of the loading factor as shown by iFRAP (Ladurner et al., 2014). In 
vitro reconstitution experiments in yeast show that cohesin does associate with 
chromatin in the absence of Scc2/4, however the addition of the loading factor makes 
the reaction more efficient and stable (Murayama and Uhlmann, 2014). Once loading 
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has taken place it doesn’t interfere with SCC establishment or maintenance 
(Lengronne et al., 2006). Thus, it is proposed that the cohesin loading reaction involves 
two steps; a) the initial dynamic association of cohesin with chromatin mediated by 
Scc2/4 loading factor and then, b) ATP hydrolysis of the SMC NBDs, producing a more 
stably bound cohesin. The molecular details of how exactly the loading reaction 
happens remains poorly understood. Some of the outstanding questions in this context 
include, whether the entrapment of DNA by cohesin involves transient hinge 
dissociation as well as whether and how the Scc2/4 complex participates in this 
process. 
 
SISTER CHROMATID COHESION ‘ESTABLISHMENT’ DURING S-PHASE 
After cohesin complexes are loaded on chromatin, either by the end of G1 in yeast or in 
early G1 in vertebrates, there is an important event that needs to take place, namely 
the establishment of SCC, which transforms cohesin into its “cohesed” state. The 
‘establishment of cohesion’ reaction requires chromatin-bound cohesin, the activity of 
specific acetyl transferases (CoATs) and must occur specifically in S-phase (Figure 2).  
Early results showed that while the presence of cohesin on DNA is necessary for SCC 
(Lengronne et al., 2006), it is not sufficient (Skibbens et al., 1999; Toth et al., 1999; 
Uhlmann and Nasmyth, 1998). But what is the timing for SCC establishment during cell 
cycle? SCC can only be established during S-phase, since in yeast when components 
of the cohesin complex are expressed in G2 or M phase, they are able to associate with 
chromosomes but they fail to establish SCC (Haering et al., 2004; Lengronne et al., 
2006; Strom et al., 2004).  
SCC establishment results in more stable cohesin complexes on chromatin. Evidence 
for this comes from FRAP experiments performed in yeast (Kurze et al., 2011), in fly 
(Gause et al., 2010) and in vertebrate (Gerlich et al., 2006; Kueng et al., 2006) cells, 
that have shown two distinct pools of cohesin after S-phase; one pool with a short and 
another pool with a long-half-life of cohesin on chromatin. In mammalian cells, Stag2, 
one of the core cohesin subunits, was tagged with a green fluorescent protein (GFP) 
and its residence time on chromatin was measured by FRAP (Gerlich et al., 2006). 
Gerlich et al. used Stag2 instead of another cohesin component to infer the time of 
residence of the cohesin complex on chromatin because GFP-Stag2 was shown to co-
immunoprecipite and co-localise with the endogenous Stag1, Smc1, and Rad21 on 
30 
 
5%–20% sucrose-density gradient. This study revealed that cohesin has a mean 
residence time of 16-25 minutes in both G1 and G2 synchronised cells (30-40% of 
nuclear cohesin) and only G2 cells possess an additional cohesin pool (30% and 50% 
of nuclear and chromatin-bound cohesin, respectively) with residence time of ~6 hours. 
The latter is proposed to be the ‘cohesed’ cohesin pool. Recently, these observations 
were further expanded upon studies in G1 and G2 sorted HeLa, where cohesin binding 
sites remained unchanged (Wendt and Peters, 2009), suggesting that the increase in 
stability in G2 might not affect the positions where cohesin is enriched across the 
genome. Interestingly, an additional cohesin ‘transient binding’ pool in G1 with a 
residence time of one minute was observed. This pool was not dependent on the 
loading factor (Ladurner et al., 2014), raising the question of whether this new transient 
pool could be similar to the transient cohesin-DNA association that was reported in 
vitro in yeast (Murayama and Uhlmann, 2014). Thus, it is suggested that cohesin is 
loaded onto the DNA in G1 and a proportion of it is ‘cohesed’ in S-phase with a much 
higher time of residence and is maintained through G2. 
SCC establishment also requires the activity of specific acetyltransferases, called Eco1 
(also known as Eso1/Esco) (Figure 2). This function is conserved from yeast to 
humans (Hou and Zou, 2005; Skibbens et al., 1999; Tanaka et al., 2000; Toth et al., 
1999). It was initially shown that an Eco1 loss-of-function mutation leads to premature 
separation of sister chromatids and lethality (Skibbens et al., 1999; Toth et al., 1999). 
The specific substrates of Eco1 activity are a pair of highly conserved lysines (K112 
and K113 in yeast; K105 and K106 in humans) within the NBD of Smc3, close to but 
not at, its ATP binding pocket (Ben-Shahar et al., 2008; Nishiyama et al., 2010; 
Rowland et al., 2009; Unal et al., 2008; Zhang et al., 2008) (Figure 2). In budding 
yeast, replacement of both residues to non-acetylatable forms, causes lethality due to 
cohesion defects, while loss-of-function mutations of Eco1 are suppressed after the 
replacement of one lysine on Smc3 to an acetylation mimic residue and cells escape 
cell death (Ben-Shahar et al., 2008; Rowland et al., 2009; Unal et al., 2008). These 
results confirm that the two Smc3 lysines are the relevant targets of Eco1 for SCC 
establishment. In mammals, there are two enzymes, Esco1 and Esco2, which both led 
to cohesion defects upon depletion (Hou and Zou, 2005; Nishiyama et al., 2010), but 
only Esco1 was reported to cause acetylation defects (Zhang et al., 2008), implying 
additional functions for Esco2. During the cell cycle, the acetylation of Smc3 increases 
during S-phase and is at least partly dependent on DNA replication (Ben-Shahar et al., 
2008), which again strengthens the argument about cohesion being established during 
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S-phase. Therefore, Eco1-mediated acetylation of Smc3 is essential to cohesion 
establishment and SCC.  
 
SISTER CHROMATID COHESION ‘ANTI-ESTABLISHMENT’ AND ‘ESTABLISHMENT’ FACTORS 
The role of Smc3 acetylation was unclear until evidence from studies in yeast and 
mammalian cells showed it counteracts the ‘anti-establishment’ activity of other 
cohesin regulators and thus allows sisters to stay ‘cohesed’ (Figure 2) (Ben-Shahar et 
al., 2008; Chan et al., 2012; Rowland et al., 2009; Sutani et al., 2009; Unal et al., 
2008). These regulators are discussed below.  
Precocious dissociation of sisters protein 5 (Pds5) is an important regulator of cohesin 
association with chromatin and its ability to regulate SCC (Figure 2). Its essential roles 
in cohesion are conserved from yeast and flies to vertebrates (Carretero et al., 2013; 
Chan et al., 2013; Dorsett et al., 2005; Panizza et al., 2000). Psd5 essential roles in 
SCC were shown by loss-of-function mutations, which suppress the lethality caused by 
Eco1/Eso1 in yeast (Rowland et al., 2009; Tanaka et al., 2001), even in fission yeast 
where the gene is not essential for SCC. This predicted a SCC anti-establishment role 
for Pds5 in yeast. Vertebrate cells contain two Pds5 paralogs, Pds5A and Pds5B. By 
Pds5A/B depletion it was shown that they are important for SCC in human cells and 
Xenopus egg extracts (Losada et al., 2005) and that both contribute to telomere and 
arm cohesion but only Pds5B is required for centromeric cohesion (Carretero et al., 
2013). More recent evidence has suggested a two-part mechanism for Pds5’s roles in 
cohesion establishment. The authors showed that Pds5 promotes Smc3 acetylation via 
its interaction with Rad21 N-terminus during S-phase and protects Smc3 from de-
acetylation during G2/M phases (Chan et al., 2013). In mammals, Pds5 was also 
proposed to act as ‘docking platform’ for other cohesin regulatory proteins, sororin or 
Wapl (discussed below) that contribute to the maintenance or removal of cohesin on or 
off chromatin, respectively (Nishiyama et al., 2010).  
Cohesin complexes are also regulated by wings apart-like protein (Wapl), which was 
initially discovered for its roles in heterochromatin organisation in Drosophila (Verni et 
al., 2000) (Figure 2). Wapl is involved in cohesin regulation on chromatin during the 
cell cycle by regulating its removal from chromosomes (Gandhi et al., 2006; Kueng et 
al., 2006). Indeed, its depletion leads to a delayed prometaphase, increased levels of 
cohesin and poorly resolved SCC but doesn’t prevent the cells from exiting mitosis 
32 
 
(Gandhi et al., 2006). Indeed, Wapl-null cells exit mitosis but they have less cohesin 
available to load in the next cycle (Tedeschi et al., 2013). It also reverses the 
phenotype of precocious sister chromatid separation caused from Rad21 and Esco2-
mutations in mammalian cells (Gandhi et al., 2006).  Similarly, the depletion of the 
yeast ortholog, Rad61, suppresses lethality from Eco1 depletion (Rowland et al., 
2009). These results support its roles in SCC ‘anti-maintenance’ activity. During 
interphase, Wapl was also shown to be important for maintaining the dynamic nature of 
cohesin on chromatin. In mammalian cells during G1 (Tedeschi et al., 2013) and G2 
(Kueng et al., 2006), its depletion by RNAi or genetically increases the amount of 
cohesin on chromatin and increases the time of residence of the ‘dynamic’ cohesin 
pools shown by immunofluorescence and FRAP experiments, respectively. This 
function is also corroborated in yeast cells in G2 (Chan et al., 2012).  Wapl mediates 
cohesin functions by directly interacting with the cohesin complex and other cohesin 
regulator proteins. Specifically, in yeast, Wapl interacts with Stag and the loading factor 
(Rowland et al., 2009). In mammals, Wapl interacts with core cohesin components and 
Pds5A/B, as shown by immunoprecipitation experiments and mass spectrometry 
analysis, and its binding to cohesin depends on the presence of Rad21 and 
Stag1/Stag2 (Gandhi et al., 2006; Kueng et al., 2006). The functional significance of 
the above interactions was shown by a series of mutations on Wapl (Ouyang et al., 
2013). Thus, Wapl is involved in cohesin removal off chromatin during the cell cycle. It 
is proposed to promote cohesin removal by transiently opening the cohesin ring via its 
Smc3-Rad21 interface (Buheitel and Stemmann, 2013; Chan et al., 2012; Eichinger et 
al., 2013). In flies, Smc3's NBD was linked by a short polypeptide to the N-terminal 
domain of kleisin and so, cohesin could associate with chromosomes but couldn’t be 
removed shown by FRAP (Eichinger et al., 2013), similar results were obtained in 
human cells (Buheitel and Stemmann, 2013). Its Wapl-dependant removal during 
prophase became possible when the linker was cleaved (Eichinger et al., 2013). 
Altogether, these studies propose that Wapl is a conserved cohesion ‘anti-
establishment’ player.  
Sororin, a protein conserved in Drosophila (Nishiyama et al., 2010), was initially 
identified as a substrate of the Anaphase Promoting Complex (APC)/Cdh1 and shown 
to be fundamental for SCC (Rankin et al., 2005) (Figure 2). Its roles in cohesin 
functions were shown when depletion of sororin led to decreased stable cohesin 
binding without reducing cohesin amounts on chromatin in G2-phase (Schmitz et al., 
2007). In HeLa cells, RNAi-mediated depletion, co-immunoprecipitation and 
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immunofluorescence experiments showed that sororin was recruited to chromatin-
bound, acetylated Smc3 cohesin during S-phase (Nishiyama et al., 2010). In mitotic 
chromosome spreads, simultaneous Wapl and sororin depletion leads to a phenotype, 
which is similar to Wapl depletion alone, proposing a role for sororin in SCC which 
depends on Wapl (Nishiyama et al., 2010). The authors in this study propose a 
mechanism whereby sororin’s association with Pds5 would prevent Wapl’s association 
with Pds5. Thus, sororin is an additional player in protecting Smc3 acetylated ‘cohesed’ 
cohesin by not allowing Wapl to associate with Pds5 and therefore, protecting SCC.  
Several lines of evidence support a role for Pds5-Wapl in counteracting the cohesion 
establishment factor Eco1. Yeast genetics have shown that Eco1 loss-of-function 
mutants can be suppressed by mutations in Smc3, Pds5, Stag and depletion of Wapl 
(Ben-Shahar et al., 2008; Chan et al., 2012; Rowland et al., 2009; Sutani et al., 2009; 
Unal et al., 2008). In budding yeast, recent studies shed light on the role of Pds5 
whereby Pds5 promotes Smc3 acetylation during S-phase and Wpl1 removes cohesin 
(Chan et al., 2012) while during G2, Pds5 protects it via preventing the de-acetylation of 
Smc3 (Chan et al., 2013). In flies and mammals, a new player sororin is recruited by 
Smc3 acetylation counteracting the ‘anti-establishment’ activity of Wapl (Nishiyama et 
al., 2010; Tedeschi et al., 2013). Therefore, there is an interplay between 
establishment and anti-establishment mechanisms so that both SCC and the dynamic 
nature of cohesin on chromatin are maintained.  
 
SISTER CHROMATID RESOLUTION DURING MITOSIS 
In eukaryotic cells, the dissociation of cohesin complexes takes place during two 
phases of mitosis (Losada et al., 1998; Sumara et al., 2002; Waizenegger et al., 2000) 
in contrast to yeast where all cohesin is removed during the transition to anaphase 
(Uhlmann et al., 1999; Uhlmann et al., 2000). In eukaryotes, the first wave of cohesin is 
removed from chromatin during the ‘prophase pathway’ when the majority of cohesin 
dissociates from chromosome arms, but not from centromeres (Figure 2) 
(Waizenegger et al., 2000). This process is regulated by Aurora B and Polo-like kinase 
1 (PLK1) (Losada et al., 2002; Sumara et al., 2002). PLK1-mediated phosphorylation of 
the C-terminal domain of Stag1/2 (Hauf et al., 2005) and Rad21 are shown to decrease 
cohesin association with DNA (Sumara et al., 2002). By expressing ‘non-
phosphorylatable’ mutants of Stag2 and Rad21, it was shown that Rad21 
phosphorylation is dispensable for cohesin dissociation from chromosomes in early 
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mitosis but enhances the cleavability of Rad21 by separase (described below). 
Meanwhile, Stag2 phosphorylation is essential for the prophase pathway and is not 
required for separase cleavage (Hauf et al., 2005). Furthermore, Wapl has an 
important role in cohesin removal during the prophase pathway. FRAP analysis of 
Wapl-depleted cells uncovered a reduction in cohesin disassociation from 
chromosomes during prophase whereas Wapl overexpression leads to precocious loss 
of SCC (Gandhi et al., 2006; Kueng et al., 2006; Tedeschi et al., 2013). The Scc2/4 
complex also dissociates from chromosomes during prophase, which may also 
contribute to the removal of arm cohesin by Wapl (Watrin et al., 2006). Altogether 
these results suggest that ‘prophase pathway’-dependent phosphorylation events are 
promoting the removal of cohesin which requires Wapl. 
The prophase pathway does not remove all cohesin from chromosomes, as doing so 
would compromise their bi-orientation on mitotic spindles. How does a population of 
cohesin ‘escape’ removal during the prophase pathway? Centromeric cohesin is 
protected from the prophase pathway due to a centromere-specific protein called 
Shugoshin1 (Sgo1). Shugoshins bind the PP2A holoenzyme, which is also localised to 
centromeres in mitotic cells (Riedel et al., 2006; Tang et al., 2006). Depletion of Sgo1 
leads to cohesin resolution as early as pro-metaphase without activating the separase 
pathway (Figure 2) (Kitajima et al., 2006; McGuinness et al., 2005; Salic et al., 2004). 
Thus, Sgo1 is predicted to be the ‘protector’ of centromeric cohesion during anaphase. 
The mechanism by which Sgo1-PP2A protect centromeric cohesin was unclear until 
recently. Liu et al. showed that the phosphorylation of Sgo1 recruits Sgo1-PP2A to 
chromatin-bound cohesin while it promotes the de-phosphorylation of sororin (Liu et al., 
2013). Thus, the authors propose that the de-phosphorylation of sororin protects 
centromeric cohesin from Wapl removal of cohesin.  
An additional event, which takes place during mitosis, is the de-acetylation of Smc3. In 
yeast, this is mediated by the histone de-acetyltransferase Hos1 during anaphase 
(Beckouet et al., 2010) and in mammalian cells by HDAC8 (Deardorff et al., 2012). In 
cells lacking HDAC8, Smc3 acetylated cohesin was accumulated at the end of mitosis 
and in the next cohesin loading cycle, cohesin chromatin occupancy was decreased 
due to accumulation of acetylated cohesin (Deardorff et al., 2012). The authors found 
that cleaved fragments of Rad21 associated with Smc1/3 in G1 in HDAC8-depleted 
cells and proposed that the loading reaction is inefficient with ‘cohesed’ cohesin 
complexes. In this study, the phenotype resembled the one caused by Nipbl depletion. 
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Thus, de-acetylation is a critical part of the cohesin cycle on chromatin and its 
deactivation leads to cohesin that can’t be loaded de novo in G1.  
The majority of soluble cohesin is removed during the ‘prophase pathway’ and 
therefore is not cleaved by separase at the metaphase-to-anaphase transition (Sun et 
al., 2009; Waizenegger et al., 2000). This process does not exist in yeast.  It is thus 
proposed that the purpose of the prophase removal pathway is to generate a large 
fraction of intact (non-cleaved) cohesin complexes which can then be loaded onto 
chromosomes during telophase rapidly. It has been suggested that this readily 
available intact cohesin pool is important for other cohesin functions such as in 
regulating transcription. A clue to support this is that HDAC8 depletion leads to a non-
dissolution and accumulation of acetylated complexes which can’t be functionally 
loaded onto chromosomes and causes de-regulation of transcription similar to that 
caused by Nipbl depletion (Deardorff et al., 2012).  
The second ‘wave’ of cohesin removal from chromatin takes place shortly before the 
onset of anaphase, when residual cohesin dissociates due to cleavage of Rad21 by 
separase (Figure 2) (Hauf et al., 2005; Kumada et al., 2006; Nakajima et al., 2007; 
Uhlmann et al., 1999; Uhlmann et al., 2000). Once chromosomes are bi-oriented on 
the mitotic spindle, the spindle checkpoint is inactivated and APC/C becomes active. 
This leads to the ubiquitination and degradation of its substrates, which include the 
separase inhibitor, securin and cyclin B1, the activating subunit of Cyclin-Dependant 
Kinase 1 (Cdk1) and thus, activating separase (Waizenegger et al., 2000). Next, as 
soon as separase is active, it was shown that separase cleaves Rad21 at two sites, 
which is both required and sufficient for sister chromatid separation (Uhlmann et al., 
1999; Uhlmann et al., 2000). The cleavage of centromeric cohesin by separase is a 
very important event to ensure proper chromosome segregation since either the 
ectopic expression of non-cleavable Rad21 mutants or the de-activation of separase 
cleavage led to defects in chromosome segregation (Hauf et al., 2001; Kumada et al., 
2006).  
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A ROLE FOR COHESIN IN GENE REGULATION AND GENOME ORGANISATION 
GENE REGULATION IN CIS AND METHODS TO UNDERSTAND GENE REGULATION AND GENOME 
ORGANISATION 
Gene regulation has critical roles during development, evolution and disease (Bulger 
and Groudine, 2011; Kang et al., 2011). Many genes are regulated in a very precise 
spatio-temporal manner by cis-regulatory elements (CREs), namely enhancers, and 
insulators, which can be located at a considerable distance away from their target 
genes (Segal et al., 2008; Spitz et al., 2003). Enhancers can increase transcriptional 
output from their target-promoters and are bound by trans-acting proteins. On the other 
hand, insulators oppose either the positive effects of enhancers. A classic example of 
gene regulation in cis is the developmental gene Sonic Hedgehog (Shh), whose 
expression is modulated throughout development by a set of enhancers located up to 1 
Mb away in linear distance (Lettice et al., 2002). Another very well characterised 
example of in cis gene regulation comes from the β-globin locus where DNAse I 
hypersensitive sites (HS) were found to be located tens of kilobases away from the five 
β-globin genes and were shown to be part of a Locus Control Region (LCR). LCRs 
differ from the classic definition of enhancers in that they activate expression of genes 
in transgene assays independent of where they integrate in the genome (i.e position-
independent) and in a tissue-specific manner (i.e. in erythroid cells) (Fraser et al., 
1993; Grosveld et al., 1987). So it was hypothesised that in erythroid cells, the HS sites 
control the expression of the β-globin genes by making the chromatin accessible to 
trans-acting factors responsible for bridging the genes with their cis-regulatory 
elements. At the same time, the mechanism by which the ‘bridging’ of these elements 
(i.e. enhancers and promoters) takes places remained unclear. That was when the 
idea of ‘DNA looping’ became popular predicting that the target gene promoter and the 
regulatory element are in close physical proximity, thus creating an environment 
appropriate for gene regulation (Griffith et al., 1986).  
A direct relationship between gene regulation and spatial organisation in the nucleus 
was supported by microscopy studies (Fraser and Bickmore, 2007). One microscopy 
method widely used is Fluorescence in situ hybridisation (FISH), which utilises DNA or 
RNA fluorescently labeled probes to detect specific DNA or RNA sequences in the 
nucleus (Bickmore, 1999). Using combinations of fluorescently labeled probes, FISH 
methods allowed for the visualisation of entire chromosomes (i.e chromosome paints) 
to individual genes within an individual cell. Such microscopy studies showed the 
existence of chromosome territories (CT) with preferential positions in the nucleus 
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(Bolzer et al., 2005), whereby gene-dense chromosomes are localised more to the 
interior of the nucleus and gene poor at the periphery of the CT (Croft et al., 1999). 
This evidence suggests that chromatin organisation within the nucleus is not random. 
Studies looking deeper into sub-chromosome structures showed the re-localisation of 
genes outside their CT in domains of constitutively high gene expression (Mahy et al., 
2002) or the close proximity of co-regulated genes (Brown et al., 2006) to suggest a 
relationship between transcriptional output and proximity. In this context, co-regulated 
genes such as the β-globin genes, were found to be close in space frequently by FISH 
(e.g. at nuclear speckles) and, their close proximity was correlated with transcriptional 
status (Brown et al., 2006). Recently, using the 3D-FISH method and high-resolution 
microscopy, the HoxD13 was found to frequenty co-localise with a tissue-specific 
enhancer in cells expressing the gene during limb development (Williamson et al., 
2012). These observations suggested that the topology of the chromatin fibre was not 
random and could be functionally significant. While microscopy provided key insights at 
the level of individual cells, its resolution is restricted to the number of sites one can 
investigate and its sensitivity to the light-capturing capability of the particular 
microscope used in the respective study.  
Higher resolution methods were required to gain further insights into chromosomes 
organisation and how this is linked to chromatin functions (e.g. gene expression). In 
2002, the Chromosome Conformation Capture (3C) method (Figure 3) was developed 
to study genome organisation in higher resolution and output than that by microscopy 
methods. The premise behind 3C is that when chromatin fragments are ‘proximal’ in 
the nuclear space, they will be more likely to be ligated together and could represent 
interactions between chromatin fragments (Dekker et al., 2002). The integration of 3C 
with next-generation sequencing (ie. Hi-C, 4C) has made possible the view of 
chromatin topology at a resolution and throughput difficult to obtain by microscopy. It is 
worth noting that the chromatin interaction datasets are based on probabilistic models 
and thus, provide the ‘likely conformation’ of chromatin in the given cell type. Another 
consideration of 3C methods is that they are population-based assays and so they 
don’t allow us to distinguish between a chromatin loop occurring in very few cells or 
one which occurs in the majority of the cells within the population. Taken together with 
the dynamic nature of chromatin, this is one of the disadvantages of this approach that 
one should consider when interpreting 3C data.  
Importantly, 3C methods allow the detection of the association/proximity of genomic 
loci across the genome, such as enhancer-promoter interactions, which are important 
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for gene expression [reviewed in (Sexton and Cavalli, 2013)]. An example of the above 
is the identification of the globin promoters interacting with the LCR which correlated 
with the tissue-specific transcriptional output and thus, creating a ‘hub’ of active 
transcription (Tolhuis et al., 2002). Later, these methods proposed that the frequent 
association of cis-regulatory elements with target gene promoters may be an important 
requirement of gene regulation and not just a byproduct of gene expression changes. 
For example, changes in the interactome landscape were observed by using 3C 
methods before any transcriptional or phenotypic changes occured in a timecourse 
study during differentiation (Apostolou et al., 2013).  
In an effort to understand whether such cis-regulatory chromatin loops exist genome-
wide, several derivatives of the 3C method were developed [reviewed in (de Wit and de 
Laat, 2012; Sofueva and Hadjur, 2012)]. For example, Chromosome Conformation 
Capture on Chip or Circular (4C) (Schoenfelder et al., 2010) or with sequencing (4C-
Seq) method (van de Werken et al., 2012), which detects interactions between one 
known loci in the genome (i.e. bait) and all possible interactor loci, have been used to 
generate information about spatial networks of co-regulated genes (i.e. globin genes). 
Chromosome Conformation Capture Carbon Copy (5C) (Dostie et al., 2006), which 
detects interactions between several known and several known loci, has been used to 
underline the physical separation of regulatory units by topologically associated domain 
borders at the organisation of the X-chromosome inactivation centre (Nora et al., 
2012). Finally, two global derivatives of 3C include: a) Hi-C which uses a biotin tag to 
enrich for all chromatin fragments, which were thought to be proximal in nuclear space, 
and high-throughput sequencing to globally map chromatin contacts (Lieberman-Aiden 
et al., 2009) and b) ChIA-PET which includes a chromatin immunoprecipitation step for 
a protein of interest and only detects a subsets of genomic interactions between 
regions bound by the protein of interest (Fullwood et al., 2009b). The 3C methods 
revolutionised the way genome organisation was understood and provided an 
additional, high-throughput toolbox of methods to understand how the genome folds.  
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Figure 3. Chromosome conformation capture (3C) method. The principle that the 3C method is based 
on is that when chromatin fragments are ‘proximal’ in nuclear space, they will be more likely to be ligated 
together and could represent interactions between chromatin fragments. 3C techniques include the 
following main steps: a) crosslinking proteins with DNA using folmaldehyde so that DNA fragments are 
crosslinked together when they are in close proximity to each other in three-dimensional space within 
intact nuclei; b) DNA fragments are digested with a restriction endonucleae and ligated so that the closer 
the fragments are, the more often they will ligate to each other. The 3C approach detects interactions 
between two known sequences by using primers for both of these sequences. 4C-seq, a candidate 
approach, uses primers against a known ‘bait’ sequence to detect interactions with all possible interactor 
sequences. Hi-C, a genome-wide approach, uses a biotin tag to select all possible chromatin fragments 
which are found in close proximity in the nuclear space and next generation sequencing to map chromatin 
interactions genome-wide. Adapted from Sofueva et al. (2012). 
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COHESIN REGULATES GENE EXPRESSION DURING DEVELOPMENT AND DISEASE 
In 1999, a seminal paper in Drosophila showed that Nipped-B/delangin, a homolog of 
the cohesin loading factor, was required for the activation of the Cut and Ultrabithorax 
homeobox genes, as well as of genes in the Notch pathway (Rollins et al., 1999). The 
authors were searching for factors that could facilitate the communication between 
distal enhancers and promoters. Using a screen designed to identify such elements of 
cut expression in Drosophila, they showed that the cohesin loading factor, Nipped 
binds the gypsy insulator element, which is located between the cut gene and its 
enhancer located 85 kb upstream, enabling its activation (Rollins et al., 1999). Later it 
was shown that cohesin acts as a boundary element separating the cut gene and 
enhancer while Nipped displaces cohesin to activate the cut gene (Rollins et al., 2004). 
Additional evidence to support a role for cohesin in gene expression during 
development came from studies in zebrafish. It was shown that the reduction in 
expression of Rad21 or Smc3 impaired Runx gene expression and development of the 
hematopoietic and nervous systems (Horsfield et al., 2007). These studies provided 
strong evidence that affecting the dosage of cohesin proteins could result in gene 
expression defects.  
A strong connection between cohesin proteins and developmental gene regulation 
came from humans. Heterozygous mutations in NIPBL and deletions or missense 
mutations in SMC1a, SMC3, RAD21, and HDAC8 were reported to be causal for the 
human developmental disorders Cornelia de Lange (CdLS) and Roberts syndromes 
(Deardorff et al., 2007; Deardorff et al., 2012; Krantz et al., 2004; Musio et al., 2006; 
Tonkin et al., 2004). A 30% decrease in Nipbl protein (caused by in-frame mutations) 
was sufficient to cause severe phenotypes seen in CdLS (Kawauchi et al., 2009). 
Importantly, cells from patients with CdLS did not exhibit obvious defects in SCC 
(Vrouwe et al., 2007), raising the question of whether cohesin proteins could have 
secondary functions in cells. These results also support the notion that cohesin dosage 
may be important for different functions of cohesin. Indeed, a study in yeast, where the 
authors achieved titrated cohesin levels, showed that 30% of initial cohesin protein are 
not sufficient to maintain cohesin function in DNA repair whereas, its reduction to 13% 
was sufficient to compromise cohesin function in SCC (Heidinger-Pauli et al., 2010). 
Thus, cohesin dosage is an important factor in an understanding of its different 
functions. 
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Evidence for cohesin’s gene regulatory role in the pathology of CdLS came when 
human cell lines were derived from CdLS patients carrying the above mutations 
exhibited wide-spread transcriptional de-regulation without indications of cohesion 
defects (Liu et al., 2009), linking cohesin to gene regulation important during human 
development. Liu et al. further supported the direct role of cohesin in gene regulation in 
the context of CdLS by showing an enrichement of cohesin binding at the 
transcriptional start sites (TSS) of the de-regulated genes by analysing 15,162 unique 
transcripts. More recently, in CdLS cell lines carrying loss-of-function mutations in 
HDAC8, cohesin complexes were released from chromatin retaining Smc3 acetylation. 
These were re-loaded onto chromatin but with decreased occupancy resulting in 
altered transcription similar to that seen in CdLS cell lines with NIPBL mutations 
(Deardorff et al., 2012). Additionally, mutations in ESCO2 were reported in the CdLS-
related syndromes, namely, Roberts syndrome (Schule et al., 2005; Vega et al., 2005). 
Interestingly, the depletion of other cohesin regulator proteins was also linked to severe 
developmental defects due to widespread transcriptional de-regulation. Examples 
include, deletion of Pds5b in mice also results in severe developmental abnormalities 
in the absence of defects in cohesion (Zhang et al., 2007) and Stag1-null mouse 
embryonic fibroblasts (MEFs) exhibit transcriptional de-regulation resembling the de-
regulation signature of CdLs cell lines (Remeseiro et al., 2012b).  
More recently, it has been shown that mutations in cohesin subunits and its regulators 
are prevalent in several cancers (Leiserson et al., 2015), including glioblastoma 
(Solomon et al., 2011), myeloproliferative neoplasms (Kon et al., 2013) and bladder 
cancers (Balbas-Martinez et al., 2013). Supporting the studies in developmental 
disorders, studies in patients with bladder cancer have shown that STAG2 mutations 
are correlated with good prognosis and normal karyotypes (Balbas-Martinez et al., 
2013), implying that roles other than those associated with SCC may be defective in 
this cancer. Similarly, in myeloproliferative neoplasms, STAG2-mutated cells were also 
shown to have normal karyotypes but mutations were correlated with poor prognosis in 
myeloid neoplasms (Kon et al., 2013). While the impact of cohesin mutations on cancer 
prognosis and progression are not yet well understood, its roles in gene regulation 
during development (i.e. Runx) (Horsfield et al., 2007), in pluripotency (i.e. Nanog) 
(Nitzsche et al., 2011), and at known oncogenes (i.e. MYC) (Rhodes et al., 2010), point 
to a gene-regulatory function of cohesin in cancer. 
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COHESIN REGULATES GENE EXPRESSION THROUGH CTCF 
Although strong evidence existed for cohesin’s role in gene regulation as discussed in 
the previous paragraph, the mechanism(s) by which cohesin could perform this novel 
non-mitotic function was unclear. A key clue came with the advent of chromatin-
immunoprecipitation (ChIP)-technology, allowing researchers to identify in high 
resolution, the exact sites on chromatin to which cohesin was bound. The integration of 
ChIP with genome-wide scale gene expression analyses, led to a deeper insights into 
cohesin’s roles in gene expression. 
ChIP studies provided the initial evidence that cohesin may regulate gene expression. 
ChIP of Scc1 and Smc3 subunits in the yeast genome showed their enrichment both at 
core centromeres, where it co-localised with the loading factor Scc2, and at distinct 
sites of active convergent gene transcription along chromosome arms (Lengronne et 
al., 2004). The authors also showed that the induction of transcription leads to the 
relocalisation of the cohesin subunits at sites of convergent transcription. Based on 
these results, it was proposed that RNA polymerase ‘pushes’ cohesin to relocate from 
its loading sites to the ones between actively transcribed genes. In Drosophila cell 
lines, ChIP-chip experiments revealed that the binding sites of Smc1, SA and the 
cohesin loader were detected at actively transcribed genes with RNA polymerase II 
(Misulovin et al., 2008). In mammalian cells, ChIP-chip and ChIP-Seq experiments also 
revealed that cohesin was enriched at active transcription start sites across the 
genome (Parelho et al., 2008; Wendt et al., 2008). Thus, evidence from Drosophila and 
mammalian cells reveals an enrichment of cohesin at actively transcribed genes. 
Taken together with the fact that cohesin was expressed in post-mitotic cells and 
tissues (Wendt et al., 2008) strengthened the argument that it could have additional 
roles apart from SCC.  
A key molecular clue about the mechanism by which cohesin regulates gene 
expression came when cohesin was shown to co-localise on chromatin with CCCTC-
binding factor (CTCF), an evolutionarily conserved protein with established roles in 
transcriptional regulation (Parelho et al., 2008; Rubio et al., 2008; Stedman et al., 
2008; Wendt et al., 2008). ChIP studies of CTCF and Scc1 in mammalian cells showed 
that the binding profiles for these two proteins were very similar, with ~80% of CTCF 
sites overlapping with Rad21 and ~60% of Rad21 sites overlapping with CTCF 
(Parelho et al., 2008; Rubio et al., 2008; Wendt et al., 2008). Co-occupied sites were 
enriched for transcriptional start sites and sites within gene bodies. Then, it was shown 
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that cohesin recruitment depends on CTCF. This was revealed by base-substitutions 
that eliminate CTCF-binding on a known insulator element of the human myotonic 
dystrophy gene integrated in mouse cells (Rubio et al., 2008), as well as by CTCF 
protein depletion and ChIP-qPCR studies (Hadjur et al., 2009; Parelho et al., 2008b; 
Wendt et al., 2008). These observations were confirmed globally using ChIP-Seq 
(Schmidt et al., 2010) and in other species. In Drosophila, ChIP analysis of cohesin 
binding sites found cohesin co-localised with insulator proteins including with dCTCF, 
the fly homologue, and the depletion of the latter led to loss of hundreds of cohesin 
sites (Van Bortle et al., 2014). Biochemical evidence for a direct protein interaction 
between CTCF and cohesin was provided using Glutathione-S-Transferase (GST)-
fusion proteins where the C-terminal region of CTCF was shown to directly interact with 
both the Stag1 and Stag2 cohesin subunit (Xiao et al., 2011). CTCF mutants at the C-
terminal region failed to recruit Stag proteins on chromatin and compromised CTCF 
insulator function shown in vitro by transgene assays and in vivo by the transient 
expression of the mutants in mouse fibroblasts. These observations have led to a 
model whereby CTCF is recruited to specific sites across the genome and cohesin is 
localised to CTCF-bound sites through its direct interaction with CTCF.  
 
CTCF, THE VERTEBRATE INSULATOR, AND GENE REGULATION 
What underlies the sites to which CTCF is recruited and what mechanisms modulate 
its occupancy there? CTCF is an 11 zinc finger DNA-binding protein which recognises 
a 20 bp asymmetric consensus motif and two additional smaller motifs, upstream and 
downstream of the core 20bp consensus motif. This was shown in vitro at selected 
sites (Filippova et al., 1996) and by genome-wide ChIP-Seq studies at tens of 
thousands of sites (Cuddapah et al., 2009; Kim et al., 2007; Nakahashi et al., 2013; 
Parelho et al., 2008b; Wendt et al., 2008). The CTCF motif is highly conserved 
between species (Schmidt et al., 2012) and across cell types (Wang et al., 2012). 
CTCF binds to its consensus motif by the combinatorial use of its 11 zinc fingers 
(Filippova et al., 1996; Nakahashi et al., 2013). In vitro studies using gel shift assays 
showed that deletions or mutations targeting individual or a group of zinc fingers 
abolish CTCF occupancy at a number of sites (Filippova et al., 1996). Similarly, 
mutations targeting different groups of zinc fingers followed by ChIP-Seq show that the 
core zinc-fingers (i.e. 4–7) are responsible for CTCF binding at ~80% of the core motifs 
(Nakahashi et al., 2013).  
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CTCF occupancy is regulated at multiple levels with implications for its functions. The 
CTCF core motif is flanked by an upstream and a downstream motif that increases 
CTCF occupancy or decreases it, respectively (Nakahashi et al., 2013; Schmidt et al., 
2012), implying that flanking motifs are involved in regulation of CTCF occupancy 
across the genome. However, CTCF occupancy is regulated at additional levels than 
that of the actual DNA sequence of its motifs. Since the motif is GC rich, CTCF binding 
is also regulated by DNA methylation, such that methylation of the motif abolishes 
CTCF binding at several sites (Bell and Felsenfeld, 2000; Wang et al., 2012) 
(discussed below). In addition, post-translational modifications of CTCF itself, such as 
phosphorylation of the C-terminal region, which is at the site where it interacts with the 
cohesin complex through Stag proteins, can modulate its functions without interfering 
with its occupancy on DNA (El-Kady and Klenova, 2005; Klenova et al., 2001; Xiao et 
al., 2011). Thus, DNA sequence and modifications modulate CTCF affinity on DNA and 
therefore, its functions.  
CTCF was originally identified as a repressor of myc transcription (Lobanenkov et al., 
1990). Several studies then revealed that CTCF can act as an insulator by blocking 
promoters from regulatory elements in cis [reviewed in (Herold et al., 2012)]. A region 
widely used in transgenic reporter in vitro assays, which assess whether an element 
can block the communication between an enhancer and a promoter of a reporter gene, 
is derived from the chicken β-globin locus. This sequence carries a DNase I 
hypersensitive site (5’-HS4), which in vivo separates the β-globin locus from 
neighboring heterochromatin (Chung et al., 1993). First, Bell et al. inserted this region 
between an enhancer and a neomycin-reporter to identify potential proteins (i.e. CTCF) 
bound to the specific regions of strong insulation (Bell et al., 1999) (Figure 4). Since 
then, CTCF binding sites have been identified across the LCR, which regulates the β-
globin genes (Farrell et al., 2002). Another well-characterised region where the 
insulator function of CTCF is important for gene imprinting, is the Insulin-Like Growth 
Factor 2 (IGF2)/H19 region (Figure 5). The two genes share an enhancer but H19 is 
expressed only from the maternal allele and IGF2 only from the paternal allele. In this, 
a region called Imprinting Control Region (ICR) of upstream of H19 and down-stream 
of IGF2, is methylated in the paternal allele and is required for the imprinting of both 
genes. CTCF was shown to bind across the ICR region and that its binding to this 
region was responsible for blocking the communication between the IGF2 promoter 
and its enhancer in an in vitro transgene assay (Bell and Felsenfeld, 2000). The 
authors also found that the methylation of CTCF binding sites at the ICR region 
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eliminates the binding of CTCF. This evidence pointed to methylation-dependant CTCF 
binding and in turn, CTCF mediated regulation of gene imprinting at IGF2/H19 locus. 
Thus, these initial studies described CTCF’s role in insulation with implications in gene 
imprinting.  
At the same time, additional roles of CTCF were shown in gene activation. An example 
of this is the Protocadherin (Pcdh) cluster of genes, which contains promoter-enhancer 
contacts essential for the development and function of the nervous system. Each Pcdh 
cluster consists of a number of constant exons located downstream of its alternative 
exons and downstream of the enhancer regions. The conditional deletion of CTCF from 
neurons resulted in the de-regulation of the Pcdh cluster and in functional defects 
(Hirayama et al., 2012). The depletion of the Pcdhα enhancer bound by CTCF resulted 
in reduced Pcdhac1 expression in brain and increased expression in tissues that 
normally exhibit very low levels of Pcdhac1 (Kehayova et al., 2011). CTCF was also 
shown to function as a barrier between active and inactive regions, which are marked 
as such by histones modifications (Cuddapah et al., 2009). Thus, CTCF is an essential 
regulator of genome functions with diverse roles.  
 
Figure 4. CTCF regulates the conformation of the β-globin locus. Schematic representation of the 
linear (upper) and 3D conformation (lower) of the mouse β-globin locus. The four b-globin genes (orange 
arrows) are flanked by the ofractory receptor (OR) genes (grey arrows). The expression of the β-globin 
genes is regulated by a series of cis-acting regulatory elements at the 5’ and 3’ end of the locus (e.g. ɛy 
and βh1 in primitive erythroid cells; β-major and β-minor in definitive erythroid cells). There are six DNase I 
hypersensitive (HS) sites (black arrows) upstream of the β-globin genes at the Locus Control Region 
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(LCR) which is required for the high-levels of transcription. There are three CTCF binding sites identified 
both upstream (i.e. 5′ HS85, 5′ HS62/60, and 5′ HS5) and downstream downstream (i.e. 3′ HS1) of the 
genes. The lineage-specific CTCF-binding patterns and the 3C-based intrachromosomal interactions are 
represented as well as the globin gene expression activity (expressed in green and non-expressed in 
orange arrows) in both erythroid progenitors and erythroid cells. Adapted from Phillips et al. (2009), 
Tolhuis et al. (2002), Splinter et al. (2006). 
 
 
Figure 5. CTCF regulates the conformation and in turn gene expression at the imprinted H19/Igf2 
locus. Schematic representation of the linear (upper) and 3D conformation (lower) of the mouse imprinted 
Igf2/H19 locus. The maternally expressed H19 gene is located downstream from the Insulin-like growth-
factor 2 (Igf2) gene that is expressed exclusively from the paternal allele. The imprinting control region 
(ICR) upstream of H19 contains four CTCF-binding sites and is essential for regulation of the locus. 
Differentially methylated regions (DMRs), such as upstream of Igf2 promoters and within Igf2 exon 6, act in 
concert to regulate reciprocal, allele-specific expression patterns from a set of downstream enhancers, the 
endodermal tissue enhancer (Ee) and mesodermal tissue enhancer (Em) (yellow ovals) downstream of 
the H19 gene. −CH3, DNA methylation. The methylation-dependant CTCF-binding and the 3C-based 
intrachromosomal interactions are represented as well as the gene expression profiles in both the 
maternal and paternal alleles. Adapted from Phillips et al. (2009), Kurukuti et al. (2006), Nativio et al. 
(2009). 
 
COHESIN FACILITATES THE INSULATOR FUNCTIONS OF CTCF 
Functional studies show that cohesin contributes to CTCF functions. Wendt et al. 
showed that cohesin is required for CTCF’s insulator function at the IGF2/H19 locus 
and that this role is independent of its cohesion functions in HeLa cells (Wendt and 
Peters, 2009). Depletion of either CTCF or cohesin in 293T cells expressing a reporter 
plasmid carrying the HS4 insulator, revealed a loss of insulation and concomitant 
47 
 
expression of the gene reporter, indicating a role for cohesin in CTCF-mediated 
insulation (Parelho et al., 2008). Evidence for cohesin and CTCF mediated insulation in 
viral genomes came from depleting CTCF-binding sites from the Kaposis Sarcoma 
Herpes Virus (KSHV) genome or cohesin via RNAi in latently infected cells. They 
showed that cohesin binding is disrupted leading to the non-canonical expression of 
the lytic cycle gene pointing to a CTCF/cohesin-mediated repression of the lytic cycle 
(Stedman et al., 2008). Cohesin and CTCF also collaborate to activate transcription. 
They were shown to mediate alternative promoter usage at the Pcdh family cluster and 
functional output in neurons (Guo et al., 2012; Monahan et al., 2012). Supporting 
evidence comes from Stag1-null mouse brains which exhibited de-regulation of the 
Pcdh cluster suggested to be from loss of Stag1 binding across the cluster shown by 
ChIP-qPCR (Remeseiro et al., 2012b). Thus, these studies first described cohesin 
facilitating CTCF insulator and gene regulatory functions.  
Cohesin was also shown to regulate gene expression in a CTCF-independent context. 
While studies looking at co-localisation of cohesin and CTCF by ChIP-chip and ChIP-
seq in vertebrates showed that CTCF and cohesin co-localised at the majority of sites 
across the genome, there was also a number of cohesin sites that were bound to 
chromatin without CTCF (Rubio et al., 2008; Wendt et al., 2008). New insight as to the 
functional significance of this group of cohesin sites came from ChIP-seq studies for 
cohesin and either tissue-specific (Faure et al., 2012; Schmidt et al., 2010) or 
pluripotency (Kagey et al., 2010; Nitzsche et al., 2011) transcription factors in 
mammalian cells. Cohesin was shown to be important at these non-CTCF bound sites, 
since cohesin depletion compromised cell cycle re-entry of breast cancer cell lines as a 
response to Estrogen Receptor (ER) (Schmidt et al., 2010). The cell cycle re-entry of 
these cells as a response to ER treatment is thought to arise from transcriptional 
changes and thus, implying a role for cohesin/ER in transcriptional regulation. 
Supporting evidence for a functional role for cohesin-no-CTCF sites came from ChIP-
Seq studies in primary liver cells, where this group of cohesin sites were co-localising 
with essential tissue-specifc transcription factors at enhancer regions and thereby, 
activating tissue-specific transcription (Faure et al., 2012). Another study also shows 
cohesin-non-CTCF sites at sites of tissue-specific expression in pluripotent ESCs 
(Nitzsche et al., 2011). These studies suggest a functional role of cohesin in the 
regulation of tissue-specific gene expression where cohesin-CTCF-independent sites 
are co-occupied by tissue-specific transcription factors and in turn regulate tissue-
specific expression. 
48 
 
COHESIN AND CTCF ANCHOR LONG-RANGE CHROMATIN LOOPS 
The fact that cohesin has a conserved role in linking sister chromatids in trans during 
SCC led to the hypothesis that this could apply for cohesin-mediated gene regulation in 
cis. At the same time, cohesin was shown to co-localise across the genome with 
CTCF, a known chromatin architectural protein. Indeed, CTCF proteins had been 
shown to be important for mediating chromatin loops in cis.  The formation of chromatin 
loops arising from CTCF sites was first shown by (Splinter et al., 2006). Initially, 
chromatin contacts between the DNase I HS sites at the LCR and promoters of the β-
globin were detected in tissues where the genes were active (Tolhuis et al., 2002) 
(Figure 4). Later studies targeting specifically CTCF insulator HS sites at the β-globin 
locus, via either the conditional deletion of CTCF or targeted disruption of its binding 
site, destabilised the long-range chromatin interactions that flank the locus and its LCR 
(Splinter et al., 2006). However there were no changes observed in the transcription of 
the genes in the locus and a higher-order role in chromatin structure in this region was 
proposed for CTCF (Splinter et al., 2006). An important study was at the IGF2/H19 
locus where the gene promoters were shown to interact in the paternal allele and 
chromatin contacts arising from CTCF binding at the H19 ICR are restricting these 
interactions in the maternal allele (Kurukuti et al., 2006) (Figure 5). So CTCF mediates 
chromatin loops, which may serve gene regulatory roles, but how CTCF could mediate 
these chromatin loops was unclear at the time. 
Given CTCF’s roles in chromatin looping and the colocalisation of CTCF with cohesin 
all along mammalian chromosome arms, including sites which were known to engage 
in CTCF-anchored chromatin loops, several groups sought to establish if cohesin could 
contribute to such CTCF-anchored chromatin loops. The first direct evidence for this 
hypothesis came from the depletion of cohesin and CTCF and 3C studies at the 
developmentally regulated gene, IFNG in human T-cells. Cohesin and CTCF were 
enriched at the promoter of IFNG as well as distal cis-regulatory elements up- and 
down-stream of it (Hadjur et al., 2009). Using 3C, chromatin loops could be observed 
beween the cohesin/CTCF-bound IFNG promoter and regulatory elements. Using 
siRNA, it was shown that these loops were dependent on cohesin but not directly on 
CTCF, since cohesin depletion didn’t affect CTCF binding from these sites. In 
comparison, siRNA to CTCF led to loss of both cohesin binding and of the contacts. In 
another example, cohesin and CTCF were shown to mediate contacts at the IGF2/H19 
locus, where their presence is important in the formation of the maternal-specific loops 
insulating IGF2 from enhancers downstream and loss of the insulation resulted in 
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increased expression of IGF2 (Nativio et al., 2009). In the CTCF-regulated β-globin 
region, the depletion of the cohesin loading factor Nipbl in mouse and human cells 
caused reduced chromatin interactions between CTCF- and cohesin-bound insulator 
regions at the CTCF flanking sites but also within the LCR (Chien et al., 2011). This 
finding taken with the above examples show that cohesin proteins facilitate CTCF-
anchored chromatin loops that may function to regulate gene expression. 
In addition to cohesin anchoring chromatin loops from CTCF binding sites, chromatin 
loops were identified from cohesin-non-CTCF sites. In a CTCF-independent setting, 
cohesin depletion was linked again to disrupted promoter-enhancer interactions in 
Embryionic stem cells (ESCs) (Kagey et al., 2010). This study used 3C approaches to 
also show that subunits of the transcriptional activator complex (i.e. Mediator) and the 
cohesin loading factor (i.e. Nipbl) were colocalised at cohesin-non-CTCF sites and in 
turn contribute to cohesin’s role in linking tissue-specific enhancers and promoters 
(Kagey et al., 2010).  
Finally, cohesin-anchored chromatin loops have also been reported to structure 
chromatin for purposes other than gene regulation. Cohesin has a role in mediating 
chromatin loops important for DNA replication (Guillou et al., 2010). It was observed 
that cohesin is bound to chromatin at replication origins alongside MCM proteins, 
factors which are important for replication origin ‘licensing’. By using a method they 
developed, the so-called ‘DNA halo’ technique, the authors measured the length of the 
loops at the replication forks. After depletion of Rad21 or Smc3, the length of the 
chromatin loops were bigger and the inter-fork distances increased. They also reported 
that S-phase length was increased but without affecting the number of replication forks. 
This study showed a role for cohesin in mediating chromatin loops at replication origins 
and influencing S-phase progression.  
 
CHROMATIN LOOPS AND GLOBAL GENOME ORGANISATION 
As discussed above, the introduction of 3C and of its global derivatives gave further 
insight into how gene-regulatory chromatin loops could contribute to the overall 
compaction of the chromosome. The Hi-C method is an unbiased analysis of global 
chromosome organisation and is based on the same ‘proximity-ligation’ principle used 
for all ‘3C’ techniques (described previously) (Dekker et al., 2002) (Figure 3). Hi-C is 
different from the other 3C methods in that the ligation junctions are labeled with 
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biotinylated nucleotides, which allows for the enrichment of chromatin fragments which 
were thought to be previously proximal in nuclear space (Lieberman-Aiden et al., 
2009).  
The first Hi-C studies confirmed results originally identified by microscopy methods, 
such as the existence of chromosome territories and open and closed chromatin 
compartments (Lieberman-Aiden et al., 2009) (Figure 6). Due to the increasing 
resolution of Hi-C methods, new levels of genome organisation were uncovered, which 
were not possible to identify using microscopy. Chromatin folds so that it creates 
modular chromatin domains at multiple scales (sometimes called Topologically 
Associating Domains (TADs) (Figure 6). Early definitions suggested that the average 
size of a TAD was ~ 1Mb in mammalian genomes (Dixon et al., 2012). TADs can be 
defined as modular units of chromatin that fold into discrete three-dimensional (3D) 
structures tending to favor internal, rather than external, chromatin interactions. They 
are delimited by sharp boundaries, which contain housekeeping genes and insulator 
sites (Dixon et al., 2012). These structures are found in yeast (Duan et al., 2010; 
Mizuguchi et al., 2014), flies (Sexton et al., 2012), worms (Crane et al., 2015) and 
mammals (Dixon et al., 2012; Nora et al., 2012), suggesting that they represent a 
fundamental feature of genomes.  
The identification of chromosomal domains led to the question of whether this level of 
organisation was functionally important. In Drosophila embryos, TADs were aligned 
with ChIP-Seq datasets of 403 epigenetic marks to ask whether domains could 
represent epigenetic states of chromatin (Sexton et al., 2012). This study identified four 
classes of domains: the ‘Null’ domains covered about half of the genome and not 
associated with any epigenetic marks and have low transcriptional output; the ‘Active’ 
domains represented about 40% of the TADs, characterised from active histone marks 
(i.e. H3K4me3); Two classes of repressive domains, one with Polycomb and one by 
Heterochromatin Protein 1 (HP1) and repressive histone marks. There was not a 
correlation between the category of the TADs or gene density but there was with 
activity, implying their functional roles in transcriptional activity. These findings also 
apply to mammalian cells where it was shown that TADs correlate with epigenetic 
marks and therefore, TAD classes were also identified (Rao et al., 2014). The 
differences in the number and nature of the domain classes could be explained by the 
available data on epigenetic marks in each study. Further, early studies suggested that 
TAD borders remain unchanged during differentiation (Nora et al., 2012) or in a 
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comparison of human and mouse Hi-C maps (Dixon et al., 2012). These early studies 
suggest that TADs might reflect the functional partitioning of the genomes. 
 
Figure 6. The levels of genome organisation. The chromatin fiber of each chromosome is unraveled to 
illustrate four different organisation levels [i.e. the chromosome territories, the compartements, the 
topologically associated domains (TADs) and the chromatin loops]. Chromatin conformations are 
presented from low (upper) to high (lower) resolutions. The chromatin fiber and the corresponding 
chromosome territories are shown in bleu and orange. The A and B compartments visualised at a 
multimegabase scale (Active and repressive chromatin in green and grey, respectively) are shown 
separately to highlight their inherently distinct nature, although there is no evidence that their 
conformations differ at the level of TADs (megabase scale). Two examples of chromatin looping 
(submegabase scale) are shown: 1) enhancer-promoter and 2) enhancer-silencer. E: enhancer; P: 
promoter; I: nsulator. Adapted from Fraser et al. (2015).  
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The functional significance of the TAD border region was shown by their depletion. 
Nora et al. used the 5C method at the X-chromosome inactivation center to look for 
chromatin structure in this region (Nora et al., 2012). They investigated the importance 
of TAD domain borders by deleting a ~50 kb border region. They showed ectopic 
contacts between the neighboring domains and transcriptional up-regulation of genes 
within the domain region by qPCR (e.g. Jpx). It was with a recent study by Lupianez et 
al. that the functional importance of borders was more clearly shown. The authors used 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology to 
generate mouse models for developmental deformities in the limb caused by 
chromosomal re-arrangements. They did 4C-Seq from promoters of genes located in 
three different TADs with the one in the middle enclosing an enhancer element. They 
were able to correlate the chromosomal re-arrangements with changes in the 
transcriptional regulation in cis of genes and consequent phenotypic changes in the 
developing mouse limb (Lupianez et al., 2015). Importantly, all these changes caused 
by the chromosomal re-arrangements were accompagned with the disruption of the 
TADs borders at these regions. For example, a deletion of an extended region crossing 
a TAD border resulted in ectopic enhancer-promoter interactions, which otherwise 
were spatially separated into two neighbouring TADs. This ectopic chromatin contacts 
resulted in the activation of Pax3, which is not expressed in the limb and caused 
developemental defects in the limb (i.e. Brachydactyly-like phenotype). This phenotype 
occurred only if the depleted region disrupted a TAD border, suggesting the functional 
importance of borders in spatial gene regulation with implications in development.  
If TAD borders are important for maintaining TADs and the maintenance of TADs is 
important for correct gene regulation, then it is valuable to know which factors are 
responsible for creating TAD borders. TADs borders are enriched for housekeeping 
genes, SINEs and the insulator proteins, CTCF as well as cohesin (Dixon et al., 2012; 
Nora et al., 2012; Sexton et al., 2012). While CTCF was enriched at the TAD borders, 
most CTCF binding sites were not at TAD borders, but rather within TADs (Dixon et al., 
2012), implying that CTCF may not be sufficient for TAD maintenance. However, one 
should consider that TADs exist at multiple scales in the genome and therefore, CTCF 
could mediate TAD insulation at several scales and not strictly at the 1 Mb scale 
(discussed further below). Later, it has also been suggested that the ‘strength’ of a 
TAD border correlates not only with the presence of insulator proteins bound, but the 
number of proteins at a given TAD. In Drospohila, insulators have diversified, resulting 
in a large number of proteins which function in insulation (including Su(hw), Zw5, 
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CP190, dCTCF, Beaf-32) and found in different combinations across the genome 
(Schwartz et al., 2012). Using ChIP-seq for a selected number of these factors, it was 
suggested that those TAD borders, which were most robust, were associated with the 
largest occupancy of insulator proteins (Van Bortle et al., 2014). Another study raised 
the possibility that their combinatorial presence across the genome might also be 
functionally significant (Schwartz et al., 2012). The authors showed that a number of 
different classes of genomic sites are occupied by specific combinations of insulator 
proteins proposing that this may confer different functions to this insulator ‘spots’ 
across the genome. All these studies implied that CTCF may have a role in TAD 
structure but also that the number (or combinations) of insulators could also be 
involved in this.  
Increased resolution of chromosome contact maps revealed the complexity of TAD 
structure. A study using 5C across seven loci encompassing genes important for 
pluripotency and differentiation (e.g. Oct4, Nanog) and ChIP-Seq for groups of factors 
(e.g. histone marks, CTCF and cohesin) in ESCs and ESC-derived NSCs gave further 
insight to TAD structure. The authors proposed that TADs encompass sub-TADs, 
which were thought to be important for tissue-specific expression since their structure 
changes (5C contact profiles) between cell types (Phillips-Cremins et al., 2013). The 
authors also proposed another class of contact profiles at longer-range which was 
similar to both cell types in this study, namely ‘constitutive’ loops. The proteins that 
were found to be enriched at the basis of the ‘constitutive’ loops were CTCF and 
cohesin whereas at the ‘gene-regulatory’ loops, a combination of architectural proteins 
including Nipbl, the cohesin loading factor was found (Phillips-Cremins et al., 2013).  
Additional molecular methods have been developed to look at global genome 
organisation called CHIA-PET (discussed above). However due to the low coverage 
nature of CHIA-PET, these methods have not been as successful as Hi-C. Despite this, 
both cohesin and CTCF ChIA-PET have been performed (DeMare et al., 2013) 
(Handoko et al., 2011), and broadly these studies have confirmed the results of Hi-C. 
Such studies either looking from cohesin (DeMare et al., 2013) or CTCF (Handoko et 
al., 2011) binding sites in the mouse limb buds and pluripotent cells, respectively, 
captured chromatin loop events shared between cohesin and CTCF. They also 
proposed from analysing for tissue-specific gene activity and histone mark profiles that 
cohesin creates loops around actively transcribed genes but also conserved loops 
between tissues (DeMare et al., 2013) similar to what it was proposed in (Phillips-
Cremins et al., 2013).  
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Altogether the above studies suggested that cohesin and CTCF could have a role in 
TAD organisation, which are highly conserved structures and functional elements of 
genome organisation in a plethora of species.  
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1.2. THESIS AIMS 
The cohesin complex is essential for sister chromatid cohesion during mitosis and 
therefore, fundamental for cell survival. Cohesin has also been shown to function in 
gene regulation from studies in developmental models. Cohesin was shown to regulate 
gene expression via mediating chromatin loops at several loci. I hypothesised that 
cohesin proteins may tether chromatin in cis, similar to the example loci, throughout the 
genome during G1 and that such cohesin-anchored chromatin loops could have a 
global role in mediating genome organisation.  
 
To address this hypothesis, I pursued the following aims: 
1. To establish a cell culture system where the roles of cohesin in gene regulation 
could be analysed separately from its essential roles in mitosis. To do this, mouse 
neural stem cells were differentiated in vitro into post-mitotic astrocytes where Rad21, 
the core cohesin subunit, was genetically depleted by using the inducible Cre-
recombinase system (ERT2-Cre) system.  
2. To determine if the ability of cohesin to mediate long-range interactions between 
distal regulatory elements and target gene promoters at select loci existed throughout 
the genome and how such loops contributed to genome organisation. To do this, a 
genome-wide cohesin chromatin immunoprecipitation analysis was integrated with 
chromosome conformation capture (Hi-C and 4C) studies to characterise the cohesin-
anchored chromosome structure. Furthermore, to determine the functional role of 
cohesin in chromosome structure and transcriptome were analysed in Rad21-deficient 
post-mitotic ASTs.  
3. To determine how known cohesin complex regulators contribute to cohesin stability 
on chromatin and in turn to chromosomal structure in post-mitotic cells. To address 
this, biochemistry methods were employed to identify the cohesin regulators present in 
Rad21-deficient ASTs and genome-wide approaches were used to measure the impact 
of their RNAi-mediated depletion on cohesin stability and chromatin contacts.  
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CHAPTER 2. COHESIN-DEFIECIENT POST-MITOTIC ASTROCYTES EXHIBIT 
GLOBAL DOMAIN DECOMPACTION AND GENOME-WIDE DEREGULATION OF 
TRANSCRIPTION 
 
2.1. INTRODUCTION 
Cohesin proteins are essential for sister chromatid cohesion (SCC) from the point of 
DNA replication until the onset of anaphase (Ciosk et al., 2000; Losada et al., 1998). 
The complexes are loaded onto chromosomes before S-phase and are removed from 
chromosomes by the end of mitosis (Ciosk et al., 2000; Rolef Ben-Shahar et al., 2008; 
Waizenegger et al., 2000).  Mutations in the cohesin complex lead to the human 
developmental disorders Cornelia de Lange (CdLS) and Roberts Syndrome (RS), 
which are associated with transcriptional de-regulation but not SCC defects (Krantz et 
al., 2004; Liu et al., 2009; Musio et al., 2006). These results suggested that cohesin 
proteins could have alternative functions in gene regulation and early studies done in 
Drosophila and zebrafish supported this argument (Horsfield et al., 2007; Rollins et al., 
1999).  
Despite these observations, it was still unclear how a protein involved in SCC could 
also influence gene expression. ChIP studies revealed that cohesin proteins colocalise 
with a known transcriptional regulator, CTCF (Parelho et al., 2008; Rubio et al., 2008; 
Stedman et al., 2008; Wendt et al., 2008). One mechanism by which CTCF was known 
to regulate gene expression was by forming chromatin loops between cis-regulatory 
elements and target genes (Tolhuis et al., 2002). The widespread colocalisation of 
CTCF and cohesin plus the known ability of cohesin to tether DNA molecules in trans 
for SCC, made cohesin-anchored chromatin looping an attractive hypothesis for how 
cohesin could contribute to gene regulation. Indeed, cohesin was shown to regulate 
gene expression via mediating the formation of chromatin loops that bridge cis-
regulatory regions such as promoter-enhancers or enabling the insulator function of 
CTCF at a number of loci in the genome (Hadjur et al., 2009; Kagey et al., 2010; 
Nativio et al., 2009). With these observations in mind, I hypothesised that a vast array 
of cohesin-mediated long-range interactions could contribute to the spatial organisation 
of the genome. In order to be able to study the function of cohesin in gene regulation, it 
was necessary to develop a system by which I could eliminate its essential roles in 
mitosis.  
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The differentiation of mouse neural stem cells into non-dividing post-mitotic astrocytes 
(ASTs) in vitro represents an optimal system for the investigation of cohesin G1 
functions (Conti et al., 2005). First, neural stem cells can be readily expanded in vitro 
into large cell numbers to accommodate the downstream genomic methods. Second, 
neural stem cells can be easily converted into post-mitotic cells by the simple addition 
of a hormone in vitro (i.e. BMP4). Third, cohesin subunits can be depleted with genetic 
tools specifically in post-mitotic cells without the concern that this would influence cell 
cycle effects. Finally, neural stem cells represent a disease-relevant model which may 
contribute to the understanding of CdLS, a developmental syndrome presented with 
mild to severe neurological symptoms (Mannini et al., 2013).  
Using this system, I investigated cohesin roles in genome organisation and 
transcriptional regulation specifically in G1. I used a multidisciplinary approach 
incorporating genetic tools, microscopy, transcriptome analysis, ChIP-seq and 3C 
methods.  
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2.2. RESULTS  
IN VITRO DIFFERENTIATION OF MOUSE NEURAL STEM CELLS INTO POST-MITOTIC ASTROCYTES 
A series of clonal neural stem cell (NSC) lines were previously derived from mouse 
embryonic stem cells (ESCs) carrying a conditional allele of Rad21 gene and the 
tamoxifen-inducible Cre-recombinase (ERT2-Cre) (referred to as Rad21Lox/Lox) by Dr S. 
Hadjur. As a control, NSCs were also prepared which didn’t carry the conditional allele 
for Rad21 but did have the ERT2-Cre (referred to as Rad21WT/WT) (Figure 7). 
 
Figure 7. Graphical representation of the mammalian model and the genetic approach. a) Rad21 
gene is located on the chromosome 15 and has LoxP sites flanking the 5th and 6th exon (bleu) and a 
selection cassette for puromycin (grey). b) Mouse Rad21Lox/Lox and Rad21WT/WT embryonic stem cells 
(ESCs) were converted as monolayers into neural stem cells (NSCs) by EGF and FGF addition and then, 
NSCs were differentiated into astrocytes (ASTs) by BMP4 addition. Rad21 depletion was achieved in 
NSCs and ASTs by 4-hydroxytamoxifen (4-OHT) treatment for 48 hours and Cre-recombinase expressing 
adenoviruses (Cre-Ad) infection for 96 hours, respectively. Epidermal Growth Factor (EGF), Fibroblast 
Growth Factor (FGF), Bone Morphogenetic Protein 4 (BMP4). 
Thereafter, the above NSC lines were induced to differentiate in vitro into post-mitotic 
astrocytes (ASTs). Rad21Lox/Lox and Rad21WT/WT NSCs were maintained under EGF 
plus FGF conditions and were induced to differentiate into ASTs by the addition of 
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BMP4 plus the removal of EGF and significantly decreased amounts of FGF2 to the 
culture media (Figure 7, differentiation conditions described in CHAPTER 5). The 
successful conversion of ESCs to NSCs and the subsequent in vitro differentiation into 
post-mitotic ASTs was confirmed by expression of key lineage-specific marker genes 
(Figure 8, 2 clones per cell type). Oct4, Nanog and Sox2 are core transcription factors 
regulating pluripotency (Silva and Smith, 2008) and were expressed in the mouse 
ESCs used in this study. NSCs expressed the radial glial markers Blbp and Glast as 
well as the neurogenic factors Mash1 and Olig2, while ASTs expressed Gfap, Aqp4, 
Fgfr2, Slc6a8 and Slc1a2 (Conti and Cattaneo, 2010). 
Figure 8. Transcriptional analysis of the in vitro ESC conversion to NSC lines and their 
differentiation into ASTs. Relative mRNA levels by qPCR analysis of housekeeping genes (Ubc, hnRNP 
K, Ybx1), Ctcf and Rad21 genes as well as lineage-specific genes including ESC-specific (Oct4, Nanog, 
Rex and Sox2), NSC-specific (Bplb, Glast, Egfr, Mash1 and Olig2), AST-specific genes (Gfap, Aqp4, 
Fgfr2, Slc6a8 and Slc1a2) in two independent clones of ESC (black and red), NSCs (bleu) and ASTs 
(grey) Rad21Lox/Lox (2 clones per cell type; 1 independent experiment per clone). 
In addition to mRNA analysis, the conversion of ESCs to NSCs and their subsequent 
differentiation to ASTs was confirmed by immunofluorescence experiments to evaluate 
the expression and localisation of a subset of these key lineage-specific proteins. In 
agreement with the mRNA analysis, NSCs were positive for Nestin and Olig2 proteins, 
while ASTs were positive for GFAP (Figure 9).  
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The homogeneity of the ASTs cultures was not evaluated in this study as the aim was 
to create a non-dividing cell population to isolate the role of cohesin in gene regulation 
from its roles in cell cycle. The immunofluorescence experiments for markers of cell 
division, such as Ki67, indicated that Ki67 was expressed in both the ESC and NSC 
dividing cell populations, but it was absent from ASTs (Figure 9). This was further 
confirmed using Propidium iodide (PI) staining during a timecourse of BMP4 addition to 
NSCs (Figure 10a, 2 independent experiments). This analysis showed that more than 
95% of ASTs were enriched in G1 upon treatment with BMP4 for 24 hours (Figure 
10a). As cells differentiated into ASTs in vitro, several morphological changes were 
observed, initiating as early as 12 hours post-BMP4 addition (Figure 10a).  
 
Figure 9. Immunofluorecence analysis of the in vitro ESC conversion to NSC lines and their 
differentiation into ASTs. Bright field images (left panels) of cellular morphology (magnification 20x) and 
maximum projections of immunocytochemistry and subsequent confocal imaging of ESCs, NSCs and 
ASTs after 48 hours of BMP4 addition stained for a proliferation marker (Ki67 in red), lineage-specific 
expression of NSC markers (Nestin and Olig2 in green and red), AST markers (GFAP in green), cohesin 
subunit and actin (Rad21 and actin in red and green). DNA has been counterstained with DAPI (blue) 
(Scale bar=20µm). 
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Figure 10. NSCs differentiated into post-mitotic ASTs by BMP4 addition exit the cell cycle and start 
expressing ASTs-specific genes. a) Distribution of cell cycle phases by flow cytometry and cell cycle 
analysis in a BMP4 timecourse experiment in Rad21Lox/Lox NSCs (10,000 events per sample). Percentages 
in each cell cycle phase, sub-G1, G1, S and G2/M phases, respectively: NSC (5%, 70%,10%, 15%); 
+BMP4 6h (1%, 69%, 12%, 18%); +BMP4 12h (2%, 80%, 2%, 18%); +BMP4 24h (2%, 92%, 1%, 5%); 
+BMP4 48h (8%, 85%, 3%, 4%) (2 independent experiments). Bright field images of cellular morphology 
(magnification 20x) of the timecourse experiment (top right). b) Relative mRNA levels by qPCR analysis 
including NSC-specific (Blbp, Egfr in blue), AST-specific genes (Gfap, Aqp4 in grey), G1-S transition of the 
cell cycle promoter and inhibitor genes (CyclinD1 and p19 in bleu and grey, respectively) during BMP4 
timecourse in NSCs Rad21Lox/Lox normalised to housekeeping genes (Tbp, Ubc) (3 independent 
experiments). Error bars represent the standard deviation and statistical significance was assessed using 
a Wilcoxon Rank Sum and Signed Rank Test, Blbp and Egfr, Gfap and Aqp4, Cyclin D1 and p19: p≤0.045 
for the indicated timepoints of BMP4 addition. 
Future experiments aimed to delete Rad21 specifically in non-dividing cells. Thus, a 
differentiation timecourse analysis was performed in order to determine the point after 
BMP4 addition when NSCs start to express AST-specific markers and it would be 
appropriate to delete Rad21. In addition to the differentiation markers described in 
Figure 10b, genes known to be important during the G1 to S phase transition of the cell 
cycle were also assessed (i.e. CyclinD1, a G1-S transition marker, and p19, a G1-S 
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transition inhibitor) (Figure 10b, 3 independent experiments, p≤0.045 assesed by 
Wilcoxon Rank Sum and Signed Rank Test). This data showed that during NSC 
differentiation by treatment with BMP4, NSC marker genes showed a 8-fold decrease, 
whereas AST marker genes (i.e. Aqp4) an 8-fold increase in mRNA levels by 24 hours. 
By 24 hours, cell cycle promoter genes showed a 40-fold decrease in mRNA levels, 
whereas cell cycle inhibitor genes, which had low basal expression levels, show a 2-
fold increase (Figure 10b, 3 independent experiments, p≤0.045 assesed by Wilcoxon 
Rank Sum and Signed Rank Test). This suggested that NSCs had reached a ‘post-
mitotic-like’ state around 24 hours post-BMP4 treatment.  
While I could confirm that Rad21 protein levels were detected in dividing ESCs and 
NSCs as well as in post-mitotic ASTs (Figure 8, 9), in agreement with previous studies 
(Wendt et al., 2008), I observed a consistent reduction in Rad21 mRNA and protein 
levels in ASTs after 24 hours of differentiation from NSCs (Figure 11a,b, 3 and 2 
independent experiments, respectively). This reduction in Rad21 levels remained 
stable after 96 hours of differentiation (Figure 11a,b; 1 experiment in Rad21Lox/Lox and 
Rad21WT/WT, respectively). The significance of this observation is unknown.  
        
Figure 11. NSCs differentiated into post-mitotic ASTs by BMP4 addition express Rad21, core 
cohesin subunit. a) Relative mRNA levels by qPCR analysis of Rad21 and Ctcf genes (grey) during BMP 
timecourse in NSCs Rad21Lox/Lox normalised to housekeeping genes (Tbp, Ubc) (3 independent 
experiments). b) Western blot analysis for Rad21 and tubulin protein probed on the same membrane 
during a BMP4 timecourse in both Rad21Lox/Lox and Rad21WT/WT NSCs (1 experiment per genotype). 
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In summary, ESCs were converted and cloned to NSC lines expressing markers 
characteristic of NSC biology that were used to derive in vitro AST cultures by adding 
BMP4. NSC cultures treated with BMP4 for 24 hours already were expressing AST-
specific proteins and exited the cell cycle.  
 
GENERATION OF RAD21-DEFICIENT NSCS AND ASTS 
To study the functional effects of cohesin on gene regulation, I first optimised the 
conditions for depletion of Rad21 in NSCs and ASTs. Loss of Rad21 cohesin subunit 
was previously shown to be sufficient to remove the complex off chromatin (Hadjur et 
al., 2009; Parelho et al., 2008). Since Rad21Lox/Lox ESCs carried the ERT2-Cre 
transgene, both NSCs and ASTs were initially treated with various concentrations of 4-
hydroxytamoxifen (OHT) to measure the deletion at the level of Rad21 DNA, RNA and 
protein.  
 
Figure 12. Rad21 is depleted by 4-hydroxytamoxifen treatment in Rad21Lox/Lox NSCs. a) Graphical 
representation of the protocol used to deplete Rad21 in Rad21Lox/Lox NSCs. NSCs were grown for 24 hours 
when 4-hydroxytamoxifen (OHT) was added. Grey arrowheads represent timepoints when samples were 
collected. b) Relative Rad21 mRNA and genomic DNA levels by qPCR analysis (3 and 5 independent 
experiments, respectively) in Rad21Lox/Lox and Rad21Δ/Δ NSCs normalised to housekeeping genes (Gapdh 
and Ubc, Tbp respectively). Error bars represent standard deviation. c) Western blot analysis for Rad21 
and tubulin protein probed on the same membrane during an OHT timecourse in both Rad21Lox/Lox and 
Rad21WT/WT NSCs. Grey box indicates the timepoints used in downstream analysis. 
NSCs treated with OHT for 48 hours resulted in efficient loss of Rad21 DNA, mRNA 
and protein (Figure 12a-c). Specifically, qPCR primers designed to quantitatively 
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analyse the extent of genomic deletion showed that more than 95% of genomic DNA 
was deleted (Figure 12b, 3 independent experiments). Similarly, more than 95% of 
mRNA was reduced upon OHT treatment based on qPCR analysis (Figure 12b, 5 
independent experiments). Rad21 protein levels were assessed in timecourse 
experiments of OHT treatment. Rad21 protein levels were considerably lower in 
Rad21Lox/Lox NSCs after 48 hours of OHT treatment whereas Rad21 protein expression 
remained stable in control Rad21WT/WT NSCs treated under the same conditions 
(Figure 12c).  
Unexpectedly, ASTs did not respond similarly to NSCs when treated with OHT (Figure 
13a, 1 experiment). Although Cre-recombinase was detected in the cytoplasm by 
Western blotting after OHT treatment, its translocation into the nucleus was not 
sufficient to induce the deletion of Rad21 from the nuclear fraction (data not shown).  
 
Figure 13. Rad21 depletion is most efficient by Cre-expressing adenovirus in ASTs. a) Western blot 
analysis for Rad21 and tubulin protein probed on the same membrane during an OHT timecourse in 
Rad21Lox/Lox ASTs where either OHT was added 24 hours post the addition of BMP4 or at the same 
timepoint as BMP4 (1 expreriment). b) Western blot analysis for Rad21 and tubulin protein probed on the 
same membrane during an Cre-Ad timecourse in Rad21Lox/Lox ASTs where either Cre-expressing 
adenoviruses (Cre-Ad) was added 24 hours post the addition of BMP4 or at the same timepoint as BMP4 
(1 experiment). c) Western blot analysis for Rad21 and tubulin protein probed on the same membrane 
during an OHT timecourse in Rad21Lox/Lox ASTs where NSCs were differentiated by the addition of 1% 
Fetal Bovine Serum in the cell culture media (1 experiment). The quantification of Rad21 intensity by 
ImageJ software, normalised to tubulin levels in each timepoint and percentage of Rad21 loss indicated in 
grey (values rounded to the nearest 5%).  
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In order to optimise the conditions under which Rad21 is efficiently depleted from 
ASTs, the following strategies were tested: a) BMP4-induced differentiation and 
subsequent OHT treatment which is the control condition when the levels of Rad21 in 
the controls remained the same (Figure 13a, 1 experiment); b) BMP4-induced 
differentiation and Cre-expressing Adenovirus (here referred as Cre-Ad) addition at the 
same time as BMP4 addition or 24 hours later (Figure 13b, 1 experiment); c) Fetal 
Bovine Serum (FBS)-induced differentiation and subsequent OHT treatment to explore 
the possibility that BMP4-induced differentiation affects OHT-mediated depletion of 
Rad21 (Figure 13c, 1 experiment).  
Based on these optimisations, the condition chosen for downstream experiments was 
the expression of Cre-recombinase by adenoviral infection (Cre-Ad) of Rad21Lox/Lox and 
Rad21Δ/Δ AST for 96 hours (Figure 14). As before, qPCR was used to assess the 
extent of genomic DNA deletion and mRNA levels in ASTs treated with Cre-Ad for 96 
hours. 95% of Rad21 DNA and RNA was depleted, while 85±5% of Rad21 protein was 
depleted from whole cell lysates after 96 hours of Cre-Ad treatment (Figure 14a-c, 3 
independent experiments). Additional immunofluorescence experiments for Rad21 and 
Actin in Rad21Lox/Lox and Rad21Δ/Δ ASTs showed that the majority of cells in the 
population had lost Rad21 protein. Here, the results present a representative maximum 
projection image as well as the quantification of Rad21 fluorescence intensity 
performed by Volocity software. Rad21 intensity is shown as a violin plot to represent 
the data as a quantile distribution (Nuclei=350 from 3 independent experiments, 
p=2.2x10-10 assessed by Wilcoxon Rank Sum and Signed Rank Test) (Figure 14d) and 
implying that the small amount of protein still detectable on the Western blots is not 
from cells in the population which have escaped Cre-Ad treatment or received lower 
amounts of viral particles compared to other cells during the infections. This 
microscopy analysis showed that ASTs uniformly lose cohesin protein 96 hours post 
Cre-Ad infections.  
In summary, NSCs and ASTs deficient for Rad21 cohesin subunit were generated so 
that they could be used in downstream experiments to investigate the effects in 
cohesin deficiency in gene regulation in both dividing and post-mitotic cells.  
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Figure 14. Rad21 is depleted by Cre-expressing adenovirus infections in ASTs. a) Graphical 
representation of the protocol used to deplete Rad21 in Rad21Lox/Lox ASTs. NSCs were plated at optimal 
confluence and grown for 24 hours when BMP4 was added. Then, ASTs 24 hours were infected with Cre-
expressing adenoviruses (Cre-Ad). Grey arrowheads represent timepoints when samples were collected. 
b) Relative Rad21 mRNA and genomic DNA levels by qPCR analysis (3 and 5 independent experiments, 
respectively) in Rad21Lox/Lox and Rad21Δ/Δ ASTs normalised to housekeeping genes (Gapdh and Ubc, Tbp 
respectively). Error bars represent standard deviation. c) Western blot analysis for Rad21 and tubulin 
protein probed on the same membrane during a Cre-Ad timecourse in both Rad21Lox/Lox and Rad21WT/WT 
ASTs. At 96 hours post-infections, 85±5% of total Rad21 protein levels were depleted (3 independent 
experiments, p<0.05 assesed by Wilcoxon Rank Sum and Signed Rank Test). d) Maximum projections of 
immunocytochemistry experiments and confocal imaging of ASTs Rad21Lox/Lox and Rad21Δ/Δ after 96 
hours of infection with Cre-Ad and stained for Rad21 (red) and actin (green). DNA has been 
counterstained with DAPI (blue) (Scale bar=20µm). Rad21 intensity from confocal images was quantified 
by Volocity software and is represented as a violin plot. Median values were as follows: 6x106 
(Rad21Lox/Lox), 1.9x106 (Rad21Δ/Δ) arbitrary units (Nnuclei=350 from 3 independent experiments). Statistical 
significance was assessed using a Wilcoxon Rank Sum and Signed Rank Test (p<2.2x10-16). 
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COHESIN-DEFICIENT ASTS SHOW INCREASED NUCLEAR VOLUMES AND MORPHOLOGICAL 
CHANGES 
Given that previous reports had shown that cells from CdLS patients, or cells 
expressing mutations in cohesin subunits or the cohesin loading factor, exhibit an 
increase in nuclear volume, local de-compaction of chromatin and disruption of 
subnuclear structures without showing cohesion defects or cell cycle changes (Gard et 
al., 2009; Nolen et al., 2013), cohesin-deficient ASTs were checked for similar nuclear 
morphology changes.  
Confocal microscopy was used to assess if cohesin-deficient post-mitotic ASTs 
experienced nuclear changes. First, 3-dimensional images of the nuclei of Rad21WT/WT, 
Rad21WT/WT+Ad-Cre, Rad21Lox/Lox and Rad21Δ/Δ ASTs using DAPI staining were 
collected in order to estimate nuclear volume (‘Find object’ feature of Volocity software) 
(Figure 15a,b, microscopy and analysis described in CHAPTER 5). This analysis 
revealed an 18% increase in nuclear volume in Rad21Δ/Δ ASTs compared to 
Rad21Lox/Lox controls (Nnuclei=350 from 3 independent experiments, p=1.3x10-10 
assessed by Wilcoxon Rank Sum and Signed Rank Test), which was a statistically 
different change compared to the Cre-Ad control alone (8% increase in 
Rad21WT/WT+Ad-Cre compared to Rad21WT/WT ASTs, Nnuclei=229 from 3 independent 
experiments, p=0.04 assessed by Wilcoxon Rank Sum and Signed Rank Test) (Figure 
15a,b). Rad21 intensity was quantified in the same nuclei and showed a 75% decrease 
in Rad21 intensity in Rad21Δ/Δ ASTs compared to Rad21Lox/Lox controls (Nnuclei=350 
from 3 independent experiments, p<2.2x10-16 assessed by Wilcoxon Rank Sum and 
Signed Rank Test), which was not observed in the Cre-Ad control alone 
(Rad21WT/WT+Ad-Cre compared to Rad21WT/WT ASTs, Nnuclei=229 from 3 independent 
experiments, p=0.075) (Figure 15a,b). Therefore, Rad21Δ/Δ ASTs compared to their 
controls have lost the majority of Rad21 protein to a similar extent as that previously 
shown by western blot (Figure 14), which correlated with a significant increase in 
nuclear volume. 
Closer examination of cohesin-deficient ASTs indicated that many nuclei were 
misshapen or exhibited abnormal morphologies, which were not as present in control 
cells (Figure 15c). However, DAPI staining with respect to the heterochromatin regions 
was similar to the Rad21Δ/Δ ASTs compared to Rad21Lox/Lox controls. Based on only 
visual inspection, nuclei were scored as normal (N) or abnormal (AN) shapes and the 
examples of each category are shown in Figure 15c. Twice as many abnormal nuclei 
were found in Rad21Δ/Δ ASTs than in Rad21Lox/Lox (20% and 8%, respectively, 
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Nnuclei=120 from 3 independent experiments) (Figure 15c). Altogether, this data 
indicated that cohesin-deficient post-mitotic ASTs underwent a significant change in 
nuclear volume and exhibit abnormal nuclear morphologies.  
 
Figure 15.Cohesin-deficient ASTs have increased nuclear volumes and morphological changes. a) 
Maximum projections of immunocytochemistry experiments and confocal imaging of AST Rad21Lox/Lox and 
Rad21Δ/Δ nuclei as well as AST Rad21WT/WT and Rad21WT/WT +Ad stained for Rad21 (green) and Lamin A/C 
(red). DNA was counterstained with DAPI (blue) (Scale bar=5µm). b) Whiskers and boxes indicate all and 
50% of values respectively of nuclear volume and Rad21 intensity measurements using the ‘find object’ 
feature of Volocity and they were as follows: 890 and 7.6x106 (Lox/Lox), 1008 and 1.9x106 (Δ/Δ), 853 and 
3.7x106 (WT/WT), 924 and 3.7x106 (WT/WT+Ad) (Nnuclei=350 and 226 from 3 independent experiments) in 
µm3 and arbitrary units. Statistical significance was assessed by Wilcoxon Rank Sum and Signed Rank 
Test (volume and intensity Lox/Lox: p=1.3x10-10, p<2.2x10-16; WT/WT: p=0.04, p=0.75, respectively). c) 
Single plane from confocal images and nuclear morphology was scored as normal (N) or abnormal (AN). 
Graphical representation of the percentages of nuclei found N or AN in AST Rad21Lox/Lox and Rad21Δ/Δ 
cultures, 8% and 20% AN respectively (Nnuclei=120 from 3 independent experiments) (Scale bar=5µm).  
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COHESIN-DEFICIENT CELLS EXHIBIT GLOBAL CHANGES IN GENE REGULATION 
The role of cohesin in regulating gene expression at several loci in the genome 
(Dorsett et al., 2005; Hadjur et al., 2009; Horsfield et al., 2007; Pauli et al., 2008; 
Wendt et al., 2008) taken together with the finding that cohesin-deficient cells exhibited 
changes in nuclear size and shape, prompted me to investigate the possibility that the 
latter were accompanied by changes in gene regulation genome-wide in cohesin-
deficient cells.  
Gene expression was studied using RNA-Seq methods with the aim to 
comprehensively analyse the changes in the global transcriptome upon deletion of 
cohesin in post-mitotic cells. The Illumina Tru-Seq protocol was used, enriching 
specifically for polyA+ mRNA species and allowing for the analysis of known genes. 
Briefly, the protocol involved mRNA extraction followed by DNase treatment to 
fragment the mRNA and enrichment for mRNA species (poly-A+ in this case) and 
finally cDNA library preparation following cluster generation and sequencing. Libraries 
were sequenced in a strand-specific manner on the Genome Analyzer IIx by Illumina 
Inc. The sequencing reads were processed by Dr Wen-Ching Chan (a bioinformatian in 
the Hadjur lab). TopHat was used for the alignment of the reads to the mouse genome 
(mm9) and Cufflinks for the assembly of the transcripts (Trapnell et al., 2010). 
Transcript expression is represented by a value, called FPKM (Fragments Per Kilobase 
of transcript per Million mapped reads). RNA samples were prepared from both 
Rad21Lox/Lox and Rad21Δ/Δ ASTs. RNA was collected in replicate from two time-points 
(72 and 96 hours) post Cre-Ad addition. These samples were used to build confidence 
in the genes which were called differentially expressed since true cohesin gene targets. 
RNA was confirmed to be of good quality before proceeding. Only samples with an 
RNA integrity number (RIN) of 8 or above were processed further in both NSCs and 
ASTs (Figure 16a, 17a). RIN is a tool, which allows the evaluation of RNA integrity by 
considering the entire electrophoretic trace of the RNA sample. This includes the 
presence or absence of degradation products. In this way, interpretation of an 
electropherogram is facilitated, comparison of samples is enabled and repeatability of 
experiments is ensured. The assigned RIN is independent of sample concentration, 
instrument and analyst therefore becoming a de facto standard for RNA integrity. qRT-
PCR and Western blot for the detection of Rad21 mRNA (2 independent experiments) 
and protein levels confirmed that Rad21 was depleted in both Rad21Δ/Δ NSCs and 
ASTs (Figure 16b,c 17b,c).  
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Figure 16. RNA-Seq libraries and transcriptional profiles from Rad21-deficient NSCs.  a) RNA quality 
was assessed using the Agilent Bioanalyser. Electropherograms of Lox/Lox and Δ/Δ NSCs revealed that RIN 
values were all above 8. b) Relative mRNA levels by qPCR analysis of Rad21 and housekeeping genes 
(Tbp, Ubc) in Rad21Lox/Lox and Rad21Δ/Δ NSCs (2 independent experiments). c) Rad21 protein expression 
levels by Western blot for Rad21 and tubulin probed on the same membrane in the samples above. d) 
Scatter plots represent the FPKM values in the logarithmic scale (Log2FPKM) of NSCs Rad21Δ/Δ replicate 
1 versus replicate 2 (Pearson’s correlation coefficient rNSC=0.9890, left plot) and NSCs Rad21Lox/Lox 
versus Rad21Δ/Δ (rNSC=0.9890, right plot). e) Representation of RNA-Seq reads aligned at the Rad21 
gene locus in mouse genome (mm9) as they are represented in the UCSC Genome Browser in NSCs 
Rad21Lox/Lox and Rad21Δ/Δ. 
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Figure 17.RNA-Seq libraries and transcriptional profiles from Rad21-deficient ASTs.  a) RNA quality 
was assessed using the Agilent Bioanalyser. Electropherograms of Rad21Lox/Lox and Rad21Δ/Δ AST 
revealed that RIN values were all above 8. b) Relative mRNA levels by qPCR analysis of Rad21 and 
housekeeping genes (Tbp, Ubc) in Rad21Lox/Lox and Rad21Δ/Δ ASTs 72 hours and 96 hours post infections 
with Cre-Ad (2 independent experiments). c) Rad21 protein expression levels by Western blot for Rad21 
and tubulin probed on the same membrane in the samples above. d,e) Scatter plots represent the FPKM 
values in the logarithmic scale (Log2FPKM) of ASTs Rad21Lox/Lox replicate 1 versus replicate 2 (Pearson’s 
correlation coefficient rAST72h=0.9899, rAST96h=0.9908, upper plots) and ASTs Rad21Lox/Lox versus 
Rad21Δ/Δ (rAST72h=0.9694, rAST96h=0.958, lower plots) in both timepoints.  
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In ASTs Rad21Δ/Δ at 72 and 96 hours, Rad21 mRNA expression was detected at 
similar levels with a percentage of 5% Rad21 expression remaining (Figure 16b 17b), 
whereas the decreasing levels of Rad21 protein was achieved in the two timepoints 
(Figure 17c). Thus, not only did I generate Rad21-deficient NSCs and ASTs but also 
two timepoints of decreasing Rad21 protein levels in post-mitotic ASTs to investigate 
transcriptional changes in Rad21 decreasing dosage. 
Cohesin-deficient NSCs and ASTs exhibit transcriptional changes. A scatter plot of 
FPKM values revealed that there was a greater correlation between the NSCs as well 
as ASTs Rad21Δ/Δ replicates 1 and 2 (Pearson’s correlation coefficient rNSC=0.9890, 
rAST=0.9880) compared to Rad21Lox/Lox and Rad21Δ/Δ (Pearson’s correlation coefficient 
for merged replicates rNSC=0.9791, rAST=0.9554) (Figure 16d, 17d,e, 18-19).  
 
Figure 18. Transcriptional profiles in Rad21-deficient ASTs at 72 post-infections.  Scatter plots 
represent the FPKM values in the logarithmic scale (Log2FPKM) of ASTs Rad21Lox/Lox 72 hours post-
infections with Cre-Ad all replicates and merged versus Rad21Δ/Δ all replicates and merged. (Pearson’s 
correlation coefficient represented in the squares that the two samples in comparison are crossing). 
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Figure 19. Transcriptional profiles in Rad21-deficient ASTs at 96 hours post-infections.  Scatter 
plots represent the FPKM values in the logarithmic scale of ASTs Rad21Lox/Lox 96 hours post-infections 
with Cre-Ad all replicates and merged versus Rad21Δ/Δ all replicates and merged. (Pearson’s correlation 
coefficient represented in the squares that the two samples in comparison are crossing). 
By showing that the replicates of each sample were more correlated than the control 
sample with its respective knockdown sample, it was shown that changes in 
transcription occurred in NSCs and ASTs, respectively, due to Rad21 loss. 
Interestingly, the comparison between all of the AST timepoints (Figure 20) revealed 
that Rad21Lox/Lox ASTs in the two timepoints were less correlated (rAST=0.967) than their 
replicates, implying ongoing transcriptional changes occurring during ASTs 
differentiation by BMP4 treatment between 72 and 96 hours but not as pronounced by 
these caused by Rad21 loss.  
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Figure 20. Transcriptional de-regulation persists in Rad21-deficient ASTs between 72 and 96 hours 
post-infections.  Scatter plots represent the FPKM values in the logarithmic scale (Log2FPKM) of ASTs 
Rad21Lox/Lox and Rad21Δ/Δ 72 hours merged versus Rad21Δ/Δ 96 hours merged post-infections with Cre-Ad 
(Pearson’s correlation coefficient represented in the squares that the two samples in comparison are 
crossing).  
Initially, to identify the set of genes which are differentially expressed (DE), a statistical 
method was employed by Dr W.C. Chan, where a z-score was calculated for each 
FPKM value indicating the distance of that value from the mean in units of standard 
deviations and a z-score of more than 1.5 was set as the threshold. Using this method 
for all identified transcripts, 2,798 genes were identified as being DE in AST Rad21Δ/Δ, 
representing an 11.3% of the genes expressed (Figure 21a, right scatter plot) with an 
average fold change of 4. This method allowed for the identification of DE genes with a 
wide range of expression values, including lowly expressed genes. Differentially 
expressed genes were found to be both up- (4.9%) and down-regulated (6.4%) (Figure 
21b). This observation was in agreement with other published work in mice and flies 
(Dorsett et al., 2005; Pauli et al., 2008; Remeseiro et al., 2012b), where also minor 
fold-changes in gene expression were observed.  
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Figure 21. Cohesin-deficient ASTs exhibit robust changes in gene expression. a) Scatter plots 
represent the FPKM values in the logarithmic scale of AST Rad21Lox/Lox versus Rad21Δ/Δ at 72 hours (left) 
and 96 hours (right) post-infection using z-score method indicating the differentially expressed in both 
timepoints, up-regulated (red) and down-regulated (green). b) Heatmaps representing in colour code the 
changes in FPKM values of 50 genes in three separate classes (up-, down-regulated, non-changing) using 
the z-score method in AST Rad21Lox/Lox and Rad21Δ/Δ at 72 and 96 hours post-infections. Higher and lower 
expression values are represented in bleu and red. The genes and their expression values (FPKM) are 
presented in Table 5 in the APPENDIX.  
Interestingly, AST Rad21Δ/Δ in the two timepoints were shown to be highly correlated 
(Pearson’s correlation coefficient, rAST=0.9733) (Figure 20). Applying the same 
thresholds as described above to the consecutive timepoints revealed that set of genes 
found de-regulated at 72 hours [10.2% of expressed genes, up- (3.6%) and down-
regulated (6.6%)] is very similar to the set of genes at 96 hours (1,190 overlapping DE 
genes) and they followed the same trend of up- or down-regulation in the two 
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consecutive timepoints (Figure 21a,b). The above results support the idea that while 
the changes in transcription are subtle, they do not represent transcriptional noise and 
in fact represent real transcriptional changes due to Rad21 knockdown.  
To investigate potential hotspots or regions in the genome where cohesin is regulating 
transcription, the locations of the transcription start sites of either the up-regulated 
(red), down-regulated (green) or non-changing (grey) genes from ASTs simultaneously 
were represented in the respective colours on all chromosomes (Figure 22). The de-
regulated genes were found evenly distributed throughout the genome indicating that 
there were no obvious hotspots of cohesin-dependent gene deregulation and that 
cohesin has a genome-wide effect on transcriptional regulation (Figure 22). 
 
Figure 22. Cohesin-deficient ASTs exhibit global changes in gene expression. Ideogram represents 
the position of transcription start sites (TSS) (Mb) of the up- (red), down-regulated (green) and non-
changing (grey) genes indicated on the different mouse chromosomes in AST Rad21Δ/Δ at 96 hours post-
infections. 
To determine which of the deregulated genes were directly influenced by Rad21, 
deregulated genes were assayed for the presence of a Rad21 ChIP peak. For this, a 
Rad21 ChIP-Seq analysis in NSCs and ASTs was used. Using the Model-based 
Analysis for ChIP-Seq (MACS) peak calling program, 18,405 and 16,156 Rad21 
binding sites were identified in NSCs and ASTs respectively. MACS is a commonly 
used algorithm that evaluates the significance of enriched ChIP regions and improves 
the spatial resolution of binding sites through combining the information of both the 
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position of the sequencing reads and their orientation. As expected, there was a strong 
overlap (~70%) in Rad21 binding sites between the two cell types. Integrating the RNA-
Seq and ChIP-Seq data identified that 50% of DE genes in ASTs (1,553) contained a 
Rad21 peak within the transcriptional unit. This is enrichment when compared to all 
non-changing genes containing Rad21 (4,549) (p value ≤ 0.001, Fishers Exact Test) 
(Figure 23a). While the majority of DE genes were found to be enriched for cohesin 
binding compared to non-DE genes, the majority of the DE genes had no cohesin at 
their transcriptional unit (Sofueva et al., 2013) (Figure 23b), implying that some of the 
genes which are de-regulated might arise indirectly from changes in cohesin-anchored 
contacts involved in mediating higher-order loops, that form their microenvironment, 
other than gene loops. 
 
Figure 23. De-regulated genes in cohesin-deficient astrocytes are enriched for cohesin binding. a) 
Bargraphs represent the percentages of deregulated genes bound by cohesin at their gene bodies, in the 
no-, up- and down-regulated (NO, UP, DOWN, respectively) groups (p value ≤ 0.001, Fishers Exact Test). 
b) Distribution of a group of 1762 deregulated genes according to cohesin/CTCF occupancy at the 
transcription start site (TSS) (<1  kb), near the TSS (<10  kb) and away from TSS (>10  kb). 
Altogether this analysis revealed that about 11% of transcripts were differentially 
expressed in cohesin-deficient ASTs, that the majority of these had small changes in 
gene expression and were uniformly distributed across the mouse genome. Finally, 
while DE genes were enriched for cohesin binding within their transcriptional unit 
compared to non-changing genes, the majority of DE genes did not have cohesin 
bound. Therefore, by integrating transcriptome analysis with cohesin binding profiles, I 
have revealed that cohesin’s role in gene regulation involves the stabilisation of some 
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specific promoter-enhancers, but these may primarily stem from indirect effects of 
cohesin depletion (discussed below).  
 
RAD21-MEDIATED PROMOTER-ENHANCER INTERACTIONS REGULATE THE PROTOCADHERIN Α 
GENE CLUSTER IN COHESIN-DEFICIENT CELLS. 
To discover if the genes which are sensitive to cohesin deficiency are enriched in a 
particular functional category, a gene enrichment analysis (pathway analysis, Panther 
software, p>0.05) was performed (Figure 24). PANTHER (Protein ANalysis Through 
Evolutionary Relationships) classification system is a large biological database of gene 
families which is used to classify and identify the function of gene product.  
 
Figure 24. The deregulated pathways in cohesin-deficient ASTs. a) Plots representing the number of 
either up- (upper, orange) or, b) down-regulated (lower, green) genes involved in each of the pathways 
indicated in the x axis using Panther software. Numbers in the above bars represent the number of genes 
in each pathway (p>0.05). 
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Among the top ten pathways identified were genes that are involved in cell-to-cell and 
cell-to-cellular matrix contacts, such as the Pcdh gene cluster (Figure 24). The Pcdhα 
gene cluster is a good candidate for the investigation of cohesin role in gene regulation 
via direct cohesin-mediated promoter-enhancer interactions. Cohesin and CTCF have 
been implicated in the stochastic choice of alternative promoter usage in this region 
(Guo et al., 2012; Monahan et al., 2012). This cluster of genes is essential during the 
development and for the physiology of the nervous system (Yagi, 2008) so the neural 
stem cells used for this study were relevant for the investigation of Pcdh gene 
regulation. 
The Pcdhα transcripts are transcribed from one alternative exon (α1-12) and 3 
common constant exons (Figure 25b, UCSC Genome browser view of the Pcdh 
cluster of genes with Pcdhα cluster in blue). In neurons, a combination of monoallelic 
and biallelic expression of the Pcdhα transcripts was shown and individual neurons 
were suggested to express different sets of Pcdhα transcripts (Yagi, 2008). RNA-seq 
analysis revealed that in this particular clone of NSCs, a restricted set of Pcdhα 
transcripts were expressed (α4, α10, αc2) and that after Rad21 loss in either NSCs or 
ASTs, this specific gene set is up-regulated. This was validated using primers designed 
to amplify the individual alternative exons and the common constant exons, and 
transcript levels were assessed by qRT-PCR in Rad21Lox/Lox NSCs where Rad21 
protein was depleted (Figure 25a,c, 3 independent experiments). Mouse liver RNA 
was included as a negative control, where the Pcdh cluster of genes is shown to be 
silent. In order to determine if the Pcdha transcripts were direct targets of Rad21, 
Rad21 ChIP-Seq data were used in the NSC clone which expressed Pcdhα4, α10 and 
αc2. Rad21 binding sites were observed at the promoters of the exons expressed. 
Rad21 binding sites were also mapped between constant exon 2 and 3 as well as 
downstream of it, where the proposed enhancer regions (i.e. HS5-1, HS7, respectively, 
indicated in black arrows) that regulate the expression of the Pcdhα promoters were 
previously mapped (Yagi, 2008). Similar results were reported for Pcdhβ/γ gene 
clusters and their downstream cis-regulatory elements [i.e. cluster control region, Cis 
Control Region (CCR) at the Diap gene located downsteam of the constant exons, 
indicated in black arrows]. These results agree with published studies implicating 
cohesin and/or CTCF in the regulation of Pcdh clusters in neural tissues (Hirayama et 
al., 2012; Kehayova et al., 2011). Thus, these results suggested that cohesin depletion 
directly led to a de-regulation of transcription in the Pcdh cluster.  
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Figure 25. Protocadherin cluster of genes is de-regulated in cohesin-deficient cells. a) Rad21 
protein expression levels by Western blot for Rad21 and tubulin probed on the same membrane in 
Rad21Lox/Lox and Rad21Δ/Δ NSCs used for the qPCR analysis and 4C-Seq down-stream experiments. The 
two replicate samples were from the same parental line. b) UCSC genes in the genomic region where the 
Protocadherin (Pcdh) cluster of genes is located. This includes the alternative exon of Pcdhα, Pcdhβ and 
Pcdhγ clusters. The cis-regulatory elements of Pcdhα and Pcdhβ/γ clusters, such as HS5-1 and Cluster 
Control Region (CCR), respectively, are indicated in bleu arrows. c) Relative mRNA levels by qPCR 
analysis of Pcdhα alternative exons and constant exons normalised for expression of housekeeping genes 
(Tbp, Ubc) in Rad21Lox/Lox and Rad21Δ/Δ NSCs as well as in liver samples, which were used here as a 
negative control (3 independent experiments).  
In order to further investigate the role of cohesin in mediating chromatin interactions 
which may define the transcriptional regulation of the Pcdh cluster, high-resolution 4C-
Seq experiments were performed. 3C techniques have been developed to study 
genome organisation in higher resolution and output than by microscopy methods. The 
premise behind 3C is that when chromatin fragments are ‘proximal’ in nuclear space, 
they will be more likely to be ligated together and could represent interactions between 
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chromatin fragments. A derivative of 3C is 4C-Seq, which captures chromatin 
interactions between one known locus (i.e. bait) and many other possible interactions 
(van de Werken et al., 2012). This technique was optimised for both ASTs and NSCs.  
 
Figure 26. 4C-Seq protocol and quality control steps in mouse NSCs and ASTs. Main steps of the 
protocol were as follows: a) Crosslinking proteins with DNA using 1% folmadahyde (20, 30 minutes) for 
NSCs and ASTs, respectively); b,c,d,e) Two rounds of digestion of DNA fragments (DpnII and Csp6I) and 
ligation to decrease the size of the fragments and increase resolution of the method; f) PCR reaction for 
long-template DNA (Roche) with primers recognising the bait sequence and containing the Illumina 
adapter (red) followed by sequencing. Libraries contain the adapter, the recognition site and the interactor 
fragment sequences so that the libraries with different baits were multiplexed before sequencing. Adapted 
from van de Werken et al. (2012). UND: undigested sample, DpnII Day 1 and Day 2: digested samples 
with DpnII for 1 and 2 days, respectively. 
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By using two consecutive rounds of digestion (with DpnII and Csp6I enzymes) and 
ligations (Figure 26a-e), the pool of possible interacting fragments becomes very 
complex and thus higher confidence interactions can be identified. PCR is performed 
using ‘bait’ primers at the restriction sites of the bait sequence (Figure 26f, in black). 
Therefore, the DNA fragments captured in close proximity with the bait sequence in the 
nucleus will be amplified and the frequency of these interactions will be detected 
(Figure 26f).  
Here, the baits were designed to be located at cohesin (i.e. Rad21) binding sites 
mapped by ChIP-Seq (discussed in the previous paragraph) at expressed promoters 
(i.e. Pcdhα10) or at known enhancer regions (i.e. HS5-1 or CCR, indicated in bleu 
arrows), (Figure 27, top ChIP-Seq panels) in both Rad21Lox/Lox and Rad21Δ/Δ NSCs. 
Interestingly, 4C-Seq results show that HS5-1 enhancer region preferentially interacts 
with the promoters which were expressed in Rad21Lox/Lox cells (Figure 27, middle 4C-
Seq panels). Reciprocal contacts were also detected between one of the expressed 
promoters, namely Pcdhα10, and the HS5-1 enhancer region in Rad21Lox/Lox cells. 
These results show the existence of specific chromatin contacts between the 
expressed promoters and regulatory elelements in cis. Upon cohesin depletion, a 
decrease in the specific chromatin contacts between HS5-1 enhancer region and the 
expressed promoters was reported, implying a role from cohesin in mediating these 
loops. Similar results were obtained from investigating an additional enhancer region 
CCR, which specifically regulates the Pcdhβ-γ clusters and not the Pcdhα. The CCR 
region was preferentially interacting with the Pcdhβ-γ promoters, which is known to 
regulate, and not with the Pcdhα. Upon Rad21 depletion, these specific chromatin 
contacts were also decreased. Thus, cohesin depletion resulted in a loss of long-range 
contacts anchoring distal enhancers required for the expression of genes within the 
Pcdh cluster, which were shown to be de-regulated in cohesin-deficient cells.  
Dr S. Sofueva had established the Hi-C method in the lab to characterise cohesin-
anchored chromatin loops (Sofueva et al., 2013). Hi-C is a derivative of the 4C 
approach described above, but instead of measuring long-range interactions from 
specific viewpoints, it provides a catalogue of all chromatin contacts occurring 
simultaneously and thus leads to an unbiased global analysis of chromatin structure 
(Lieberman-Aiden et al., 2009). Results from a Hi-C experiment are represented in Hi-
C contact maps, such as in Figure 27, where the normalised frequencies (colour scale 
in log) of chromosomal interactions are represented as a matrix with the diagonal 
representing this region in the linear chromosome distance. The Hi-C maps reveal 
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regions of high-contact frequency separated by distinct ‘insulation’ points. Such 
structures had been termed ‘chromosomal domains’ or TADs and the insulation points 
are termed TAD borders (Figure 27). 
 
Figure 27. Cohesin-anchored chromatin contacts shape the regulatory landscape in the 
Protocadherin cluster. HiC contact matrix of a 2 Mb region on chromosome 18 (lower) where the Pcdh 
gene clusters are located in Rad21Lox/Lox NSCs highlighting the topological associated domain 
encompassing the Pcdhα cluster and Pcdhβ,γ (grey). ChIP-Seq signal aligned was for mouse cortex and 
Rad21Lox/Lox, respectively (upper). Results from 4C-seq in Rad21Lox/Lox and Rad21Δ/Δ NSCs for baits 
(indicated in black dots) designed to Rad21 binding site at the promoters of Pcdhα10, at the HS5-1 
enhancer and the Cis Control region (CCR). Each 4C-seq experiment is represented by the median 
normalised coverage in a sliding window of 5 kb (top) and a multi-scale domainogram indicating 
normalised mean coverage (windows range 2-50 kb).  
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I examined the chromosomal structure, determined by Hi-C around the region 
containing the Pcdh gene cluster on chromosome 18. The Pcdhα cluster, together with 
its cis-regulatory elements were found to be located within the same Hi-C domain 
(Figure 27). The Pcdhα and Pcdhβ/γ clusters are located in two separate Hi-C 
domains (Figure 27). Therefore, these findings suggested that cohesin-mediated 
gene-loops may be contained within larger chromatin domains, and that chromosomal 
domain structure may be important for correct gene regulation.  
Hence, Pcdhα and Pcdhβ/γ clusters were found structurally contained within two 
adjacent Hi-C chromatin domains, which also enclosed their respective cis-regulatory 
regions. In Pcdhα, I showed that cohesin contacts mediated promoters and enhancers 
interactions which in turn regulate its expression. This is a characteristic example of 
cohesin-mediated gene regulation via maintaining promoter-enhancer interactions in 
cis. 
 
COHESIN-MEDIATED CHROMATIN INTERACTIONS ORGANISE CHROMOSOMAL DOMAIN 
ARCHITECTURE 
The data described above showed that Rad21Δ/Δ NSCs and ASTs experienced 
transcriptional de-regulation. These results were in line with previously published work 
describing cohesins effect on gene regulation (Dorsett et al., 2005; Pauli et al., 2008; 
Wendt and Peters, 2009). One mechanism by which cohesin can regulate gene 
expression is by anchoring long-range chromatin loops which then physically connect 
cis-regulatory regions to target loci (Hadjur et al., 2009; Kagey et al., 2010; Nativio et 
al., 2009; Seitan et al., 2011) as well as at the Pcdh cluster shown here. We reasoned 
that cohesin might anchor chromatin loops from CTCF binding sites not just at specific 
genes, but also throughout the genome.  To address this, Dr S. Sofueva prepared Hi-C 
libraries from Rad21Δ/Δ NSCs and ASTs to dissect the role of cohesin/CTCF in 
mediating genome-wide chromosomal contacts published in (Sofueva et al., 2013). 
This work revealed that cohesin-anchored chromatin contacts are involved in shaping 
domain structure at different size scales and that cohesin depletion was quantitatively 
correlated with chromatin domain decompaction.  
A particular interesting example which revealed cohesin’s roles in chromosome 
organisation and how this organisation could impact gene expression came from the 
mTOR inhibitor Deptor, and its neighboring gene Col14a1 (Figure 28). The analysis of 
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the RNA-seq datasets in replicates revealed that Deptor is highly expressed and 
becomes 2.6-fold downregulated, while Col14a1 is silenced and becomes 7-fold 
upregulated in Rad21-deficient ASTs (Figure 28a, the RNA-Seq data described in 
CHAPTER 2). Cohesin binding sites are localised to the promoter of the Deptor and 
Col14a1 genes, as well as at sites ~15 kb upstream of Deptor gene. From the Hi-C 
contact maps, it appeared that Deptor and Col14a1 had a ‘nested loop structure’ within 
a larger chromosomal domain. In Rad21-deficient cells, the domain becomes 
decompacted however the overall structure of the domain is retained. To dissect the 
effect of cohesin loss in this region, a timecourse 4C-seq experiment was performed 
from cohesin sites which were at either the Deptor promoter or upstream of it 
demarcating the Hi-C domain enclosing the gene. Rad21 protein levels were quantified 
by western blot and a progressive loss of Rad21 protein levels was observed over time 
(Figure 28b). I prepared 4C-Seq libraries from each timepoint corresponding and 4C 
baits were assayed for their contact profile during the progressive loss of Rad21 
(Figure 28c). The results showed the progressive loss of cohesin-mediated chromatin 
interaction is accompanied with the one in cohesin protein levels at this region either 
from the promoter or upstream of that viewpoints. Interestingly, it also revealed that 
cohesin-anchored contacts mediating gene-loops (i.e. Deptor) were lost quicker than 
the domain-forming loops shown in several regions [(Sofueva et al., 2013) and 
unpublished work arising from this thesis)] (Figure 28d).  
Taken together, these findings proposed that cohesin is a key player in genome 
organisation whether this involved creating ‘gene-loops’ or longer-range ‘gene-free 
loops’. However, while loss of cohesin protein was accompanied with a loss of 
chromatin contacts in the 4C-Seq regions, it was suggested that cohesin-anchored 
contacts at the gene-free loops were more resistant to cohesion depletion. 
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Figure 28. The loss of cohesin-anchored chromatin contacts, either at gene promoters or gene-free 
loops, are accompanied by the loss in cohesin protein levels. a) mRNA expression levels of Deptor 
and Col14a1 expressed as FPKM in Rad21Lox/Lox and Rad21Δ/Δ  ASTs. b) Western blot analysis for Rad21 
and tubulin proteins during OHT timecourse in Rad21Lox/Lox NSCs. Quantification of Rad21 intensity by 
ImageJ software, normalised to tubulin levels in each timepoint and percentage of Rad21 loss indicated 
(grey). c) 4C-seq results in a timecourse of Rad21 depletion in Rad21Lox/Lox NSCs for baits (black dots) 
designed to Rad21 binding site at the promoter of Deptor and at 15 kb upstream of its transcription start 
site (TSS). Shown are the % loss in Rad21 protein levels at each timepoint based on a quantitative 
Western blot analysis. Each 4C-seq experiment is represented by the median normalised coverage in a 
sliding window of 5 kb (top) and a multi-scale domainogram indicating normalised mean coverage 
(windows range 2-50 kb). Also shown are the ChIP-Seq tracks for Rad21, CTCF, TSS locations and gene 
expression. NSCs HiC contact matrix of a 1 Mb region on chromosome 15. d) Graphical representation of 
the proposed model for Deptor region, where cohesin is at the basis of gene-loops and gene-free loops. 
After Rad21 depletion, both chromatin domain decompaction and gene deregulation were observed but 
residual chromatin contacts were still detectable.   
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2.3. DISCUSSION 
To investigate the role of cohesin proteins and their roles in chromatin looping and 
gene regulation in G1, I developed a post-mitotic cell system whereby cohesin deletion 
would not disrupt its essential mitotic functions. ESCs were converted in vitro into NSC 
lines, which were subsequently differentiated into AST cultures by the addition of 
BMP4 growth factor. The Rad21 subunit of the cohesin complex was successfully 
deleted, using Cre-Lox methods in post-mitotic ASTs, thus generating a robust system 
with which to perform downstream experiments.  
Using the above system, I observed that cohesin-deficient post-mitotic cells exhibited 
global de-regulation of transcription, increased nuclear volume and perturbed nuclear 
morphology. This finding is supported by phenotypes seen in CdLS patients or cells 
expressing cohesin mutations (Gard et al., 2009; Nolen et al., 2013). The phenotype of 
perturbed nuclear size and shape can come about when cells are entering the cell 
cycle, or initiate cell death, which we excluded here. An additional reason why these 
changes take place in cohesin-deficient ASTs could be due to changes in the nuclear 
lamina, which is linked to genome organisation and transcription. In progeria 
syndromes, the mutation of one gene involved in the lamina of the nucleus (i.e. LMNA) 
is required for phenotypes such as in cohesin-deficient ASTs and this is sufficient to 
cause pre-mature aging in humans (Goldman et al., 2004). Hence, I propose that the 
phenotype in cohesin-deficient ASTs is more likely to be linked to changes in 
transcription and chromatin organisation.  
These observations supported the decompaction of chromosomal domain structure 
described using Hi-C approaches. The loss in cohesin-mediated chromatin interactions 
often led to the de-regulation of genes flanked by cohesin sites reflecting a direct role 
in gene regulation via anchoring chromatin interactions between regulatory elements 
and promoters. However, a large number of genes did not contain any cohesin binding 
site within their gene body, yet were still de-regulated in Rad21Δ/Δ cells. This suggests 
that cohesin may indirectly regulate gene expression. I propose that this may come 
about cohesin loss actually disrupts the regulatory microenvironment that 
encompasses the affected genes. Simultaneously, the genome-wide and candidate-
based 3C studies to look at genome organisation in cohesin-deficient cells showed 
topologically associated domain relaxation correlated with a specific loss of cohesin-
mediated contact insulation. Taken together, my results support a key role for cohesin 
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in mediating global genome organisation and gene expression, both through direct and 
indirect means (Sofueva et al., 2013).  
These results broadly agree with studies in non-cycling or cycling mammalian cells, 
with either cohesin genetic depletion (Seitan et al., 2013) or TEV-mediated cleavage 
(Zuin et al., 2014), respectively. The study in mouse cohesin-deficient thymocytes 
emphasised their analysis to cohesin transcriptional roles and proposed a role for 
cohesin in gene regulation internally to the TADs (Seitan et al., 2013). Zuin et al. using 
Hi-C and depletion of cohesin or CTCF via TEV-mediated cleavage or RNAi, 
respectively, in 293 cells reported a separate role for CTCF from its role with cohesin 
(Zuin et al., 2014) (discussed in the CHAPTER 4). All three Hi-C studies exploring the 
functional role of cohesin in global genome organiation underline an important role for 
cohesin and CTCF in TAD maintenance and provide further insights to their functions. 
However, it was not clear yet whether cohesin and CTCF have a causal relationship 
with the maintenance of the TADs. While I decreased cohesin levels to about 20% of 
the original amount, I still detected chromatin contacts (i.e. 4C-seq) arising from 
cohesin sites defined by ChIP-Seq (i.e. 1.5 kb upsteam of the Deptor promoter). While 
our methodology (i.e. 4C-Seq) provides high-resolution, it can’t exclude the possibility 
that factors other than cohesin and CTCF, are also present and potentially involved in 
maintaining chromatin loops at these sites. At the same time, recent supportive 
evidence from a study using CRISPR-mediated deletions of specific CTCF binding 
sites, propose a key role for CTCF in chromatin loop maintenance (Narendra et al., 
2015). A 4C-Seq experiment at the HOXA locus revealed that CTCF binding sites were 
located at a border region separating active from inactive domains, based on 
epigenetic marks and transcriptional activity. Importantly, the deletion of the CTCF 
binding site led to the expansion of the active histone marks into an adjacent 
repressive domain resulting in the activation of repressed genes (Narendra et al., 
2015). This was accompanied by ectopic chromatin contacts spreading up to the next 
CTCF binding site within that chromatin domain, implying an essential role for CTCF in 
the maintenance of the chromatin domain borders at this region.  
The importance of CTCF as an insulator with roles in global genome organisation is 
also proposed from another study where a genome-wide Hi-C was integrated with 
ChIP-Seq studies for CTCF in liver tissues from three mammalian species (Vietri 
Rudan et al., 2015). This study showed that conserved CTCF sites mediate conserved 
chromosomal domain structure in mammalian genomes, while divergent (Species-
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specific) CTCF sites mediate insulation specifically in the corresponding genome.  
Such divergent sites could be considered as ‘multiple CRISPR-inserted sites’ and 
reveal that new chromatin loops are found when a new CTCF site emerges.  
In addition, both the above and Sofueva et al. study propose that CTCF and/or cohesin 
mediate chromatin structure at multiple scales and from thousands of sites across the 
genome. Now that it is clear that chromatin domains don’t exist only at the TAD level (1 
Mb) but at multiple scales and in a hierarchical manner, these findings explain why 
while CTCF is enriched at TAD borders, most of the CTCF sites are located within 
TADs (Dixon et al., 2012; Sofueva et al., 2013). The above studies employied 
approaches that measure cohesin/CTCF roles at multiple scales and were able to 
demonstrate their functional roles in genome organisation. All these observations 
further support the key connection between CTCF, cohesin and chromatin looping.   
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CHAPTER 3. COHESIN REGULATORS MODULATE THE STABILITY OF COHESIN 
AND COHESIN-ANCHORED CONTACTS IN POST-MITOTIC ASTROCYTES 
 
3.1. INTRODUCTION 
Genome-wide Hi-C studies in human and mouse cells support the idea that cohesin 
has a widespread role in anchoring long-range chromatin interactions which in turn 
structure chromosomal domains (Seitan et al., 2013; Sofueva et al., 2013; Zuin et al., 
2014). Despite these observations, it was nevertheless difficult to establish cohesin’s 
causal role in facilitating domain structure due to its many direct and indirect effects. 
While cohesin-mediated interactions were significantly reduced in Rad21-deficient 
post-mitotic cells, they were not abolished after cohesin depletion. Several 
explanations are possible; including 1) additional proteins are required for the 
maintenance of domain structure, 2) domain structure is simply maintained in the 
absence of cohesin proteins or, 3) there is sufficient ‘residual’ cohesin in our post-
mitotic system to maintain the observed chromatin interactions. I hypothesised that a 
population of residual cohesin complexes exist in Rad21-deficient post-mitotic cells and 
that these are sufficient to maintain the residual chromatin domain structures observed 
in these cells.  
Residual cohesin could arise due to inefficient depletion experiments, or because a 
subset of protein is extremely long-lived. Indeed, Rad21 DNA and RNA levels were 
efficiently deleted (described in CHAPTER 2). Meanwhile, evidence from the literature 
supports the existence of stable pools of cohesin protein on chromatin. In mouse 
meiosis, cohesin can entrap sister chiasmata for years (Tachibana-Konwalski et al., 
2010). In mitosis, Gerlich et al. used FRAP analysis to show evidence for two G2 
populations of cohesin in HeLa cells, a ‘stable’ pool with a residence time of 25 minutes 
and a more ‘dynamic’ pool with a residence time of 6 hours (Gerlich et al., 2006). In G1-
synchronised HeLa cells, Ladurner et al. showed an additional ‘transient’ pool of 
cohesin with a residence time of less than 1 minute in addition to the ‘dynamic’ pool 
reported previously (Ladurner et al., 2014) agreeing with what it was shown in 
Drosophila (Gause et al., 2010). 
During the cell cycle, the regulation of cohesin association with chromatin involves the 
interplay of several regulators and modifications of the core cohesin complex. Cohesin 
is loaded onto chromatin by the loading factor in an ATP-dependent manner (Ciosk et 
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al., 2000; Ladurner et al., 2014). In G1, cohesin ‘dynamic’ pools depend on a balance 
between the loading by Nipbl and unloading reaction by Wapl and Pds5 (Gandhi et al., 
2006; Kueng et al., 2006). Important for cohesin’s association with chromatin are Stag 
proteins (Murayama and Uhlmann, 2014; Remeseiro et al., 2012b; Sumara et al., 
2000). During S-phase, sororin is recruited by the acetylation of Smc3 and binds to 
Pds5 counteracting the Wapl-unloading reaction (Nishiyama et al., 2010). This 
mechanism and the acetylation of Smc3 during DNA replication by Esco proteins 
(Beckouet et al., 2010; Ben-Shahar et al., 2008; Zhang et al., 2008) is proposed to lead 
to the previously discussed ‘stable’ pool of ‘cohesed’ cohesin. In Drosophila G2 cells, it 
was shown by FRAP studies that changes in the levels of Pds5 and Nipbl leads to 
distinct changes in a proportion of ‘stable’ cohesin on chromatin (Gause et al., 2010). 
In vertebrates, these mechanisms are also essential for cohesin removal and SCC 
dissolution during mitosis (Waizenegger et al., 2000).  
Thus, I hypothesised that de-stabilisation of the residual cohesin complexes off of 
chromatin would lead to distinct changes in chromosome organisation. Thus, in this 
CHAPTER, I explored the possibility that known cohesin regulators may have a role in 
sustaining residual complexes on chromatin. 
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3.2. RESULTS 
RAD21-DEPLETED POST-MITOTIC ASTS HAVE RESIDUAL COHESIN ON CHROMATIN 
Rad21-deficient cells had residual chromatin contacts arising from Rad21 binding sites 
(Figure 28). I hypothesised that these residual contacts were anchored from residual 
cohesin protein and investigated further their existence in Rad21-deficient ASTs.  
 
Figure 29. Cohesin complexes exist on chromatin in Rad21-deficient ASTs. a) Maximum projections 
of immunocytochemistry experiments and confocal imaging of AST Rad21Lox/Lox and Rad21Δ/Δ nuclei 
stained for Rad21 (green) after soluble proteins were extracted with 0.1% Triton-X100. DNA was 
counterstained with DAPI (blue) and Alexa-488 was used as a secondary antibody control. (Scale bar=2.5 
µm). Whiskers and boxes indicate all and 50% of values respectively of Rad21 intensity measurements 
using the ‘find object’ feature of Volocity software and they were: 45 (Lox/Lox), 10 (Δ/Δ) in arbitrary units 
(Nnuclei=250 from 3 independent experiments). Statistical significance has been assessed by Wilcoxon 
Rank Sum and Signed Rank Test (Lox/Lox to Δ/Δ : p<2.2x10-16; Ab CTR to Δ/Δ : p<2.2x10-16). b) Western 
blot analysis for Rad21, tubulin and Histone 3 (H3) protein in Rad21Lox/Lox and Rad21Δ/Δ ASTs. Samples 
were collected for protein analysis after fractionation into soluble (SOL) and chromatin-bound (CH) protein 
fractions. Bargraph represents the percentage of chromatin-bound Rad21 normalised to H3 levels in 
Rad21Lox/Lox and Rad21Δ/Δ ASTs (33±3% from 3 independent experiments). Statistical significance has 
been assessed by Wilcoxon Rank Sum and Signed Rank Test (Rad21Δ/Δ 96h p=0.05). 
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To explore this, I performed immunofluorescence experiments for Rad21 protein after 
pre-extraction of soluble proteins. This approach allowed the quantification specifically 
of the remaining chromatin-bound Rad21 protein in Rad21Δ/Δ ASTs (Figure 29). This 
analysis showed that on average 25% of the total Rad21 chromatin-bound pool is 
residual in Rad21Δ/Δ ASTs (Nnuclei=250, from 3 independent experiments, p<2.2x10-16 
assessed by Wilcoxon Rank Sum and Signed Rank Test) (Figure 29a). This was 
confirmed by protein fractionation experiments, which were designed to follow the 
same principle, revealing that 33±3% of Rad21 protein is bound to chromatin in 
Rad21Δ/Δ ASTs (from 3 independent experiments, p=0.05 assessed by Wilcoxon Rank 
Sum and Signed Rank Test) (Figure 29b). Therefore, the existence of ‘residual’ 
cohesin complexes was confirmed in Rad21-deficient ASTs.  
 
RESIDUAL COMPLEXES ARE SALT-RESISTANT AND ENRICHED FOR SPECIFIC COHESIN 
REGULATORS 
As mentioned previously, there are several known regulators of cohesin stability on 
chromatin, primarily during S- and G2-phase. These include the loading (i.e. Nipbl) 
(Ciosk et al., 2000; Ladurner et al., 2014) and the anti-establishment factors (i.e. Wapl) 
(Gandhi et al., 2006; Kueng et al., 2006) or cohesin modifications such as the 
acetylation of Smc3 by Esco is known to stabilise cohesin on chromatin by creating a 
cohesive form during S-phase and ‘locking’ sister chromatids together (Beckouet et al., 
2010; Unal et al., 2008). In G1, the function of these regulators in cohesin functions in 
gene regulation is still largely unknown. An additional interphase regulator of cohesin 
on chromatin is CTCF (Parelho et al., 2008; Schmidt et al., 2010) and cohesin 
complexes interact with the C-terminus of CTCF through the Stag proteins (Xiao et al., 
2011). I explored whether specific cohesin regulatory factors may be enriched in the 
chromatin-bound pool in Rad21Δ/Δ ASTs and thus contributing to their stability on 
chromatin.  
I first evaluated the expression levels of the main components known to regulate 
cohesin chromatin binding by taking advantage of the RNA-Seq data generated 
previously (Figure 17-20). The expression of cohesin core components and regulators 
was reduced in ASTs compared to NSCs (Figure 30a). The mRNA levels of Rad21, 
Smc1a, Smc3, Stag2, Pds5a/b, Sororin were reduced by up to 50% in ASTs, and the 
expression of two factors, Esco2 and separase was undetectable whereas Esco1 was 
still expressed. Both Esco1 and Esco2 are reported to be responsible for cohesin 
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stabilisation on chromatin during S-phase (Hou and Zou, 2005; Nishiyama et al., 2010) 
and the protease separase removes centromere cohesin by mediating its proteolytic 
cleavage of Rad21 at the onset of anaphase (Nakajima et al., 2007; Uhlmann et al., 
1999). Given these proteins are responsible for SCC, the expression of Esco1 in our 
post-mitotic cells was very unexpected. Their mRNA expression remained unchanged 
upon Rad21 genetic depletion in both cell types and only Rad21 levels were reduced to 
7%. Thus, both cycling and post-mitotic Rad21-deficient cells expressed known 
regulators of cohesin association with chromatin.  
 
Figure 30. Cohesin regulators are expressed and present with residual cohesin complexes in 
Rad21-deficient ASTs. a) mRNA expression levels of cohesin proteins expressed as FPKM values in 
Rad21Lox/Lox and Rad21Δ/Δ NSCs and ASTs (in blue and grey). b) Graphical representation of the standard 
protein fractionation method enriched with a salt-extraction step. This method isolates the cytoplasmic 
(SOL, blue) from the chromatin-bound protein fraction, and which is then separated into a salt-extractable 
(SE. red) and insoluble (IS, yellow) (Martini et al., 1998). c,d) Western blot analysis for Rad21, Smc3, 
Smc3 LysAc, CTCF, Stag1/2, Pds5a/b, tubulin, and histone 3 (H3) protein levels in Rad21Lox/Lox and 
Rad21Δ/Δ ASTs. Samples were collected for protein analysis after soluble protein fractions were separated 
from chromatin fractions and a salt-extracted chromatin fraction was prepared by the addition of 300 and 
600 mM NaCl, respectively. WCE: Whole cell extract  
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To further characterise the residual chromatin-bound complexes at the protein level, a 
standard protein fractionation technique enriched with a salt-extraction step was used 
(Figure 30b). This method allowed for the isolation of chromatin bound proteins into 
salt-extractable and insoluble protein fractions (Martini et al., 1998). We reasoned that 
insoluble proteins are more stably bound to chromatin than proteins, which can be 
extracted with high salt. As controls, Histone 3 (H3) was enriched in the insoluble 
fraction and tubulin was enriched in the soluble fraction. Initially, the experiment was 
performed with 300 mM salt to the chromatin bound fraction of both Rad21Lox/Lox and 
Rad21Δ/Δ ASTs (Figure 30c,d). As before, Rad21 protein was reduced to 80% in 
Rad21Δ/Δ ASTs (Figure 14c). In Rad21Lox/Lox ASTs, Rad21 was primarily enriched in the 
salt-extractable fraction, whereas in Rad21Δ/Δ cells, the remaining Rad21 was enriched 
in the insoluble fraction. As expected, another cohesin core component, Smc3, was 
shown to translocate from the chromatin-bound fraction to the soluble fraction in 
Rad21Δ/Δ ASTs (Laugsch et al., 2013). CTCF was found in the insoluble fraction in both 
Rad21Lox/Lox and Rad21Δ/Δ ASTs and the total amounts of CTCF remained unchanged 
in both conditions (Figure 30c). Stag1 was found mainly in the insoluble fraction and 
after Rad21 depletion, it remained enriched in the same fraction, however its total 
levels were significantly decreased. Stag2 showed enrichment in the salt-extractable 
fraction and after Rad21 depletion, it was enriched at the insoluble fraction while its 
total levels were decreased similarly to Stag1. Pds5a and b were both enriched at the 
salt-extractable fraction but their total levels were not affected significantly by Rad21 
depletion. Acetylated-Smc3 was enriched in the insoluble fraction and remained 
enriched here in the Rad21-deficient ASTs. These results showed that the remaining 
cohesin complexes in Rad21?/? ASTs were primarily found in the insoluble fraction of 
chromatin, were enriched for marks associated with stable cohesin and were 
associated with an insoluble CTCF pool. When the fractionations were performed in 
600 mM salt, the insoluble chromatin-bound Rad21 fraction in Rad21?/? ASTs was 
enriched for Stag1, Smc3ac and CTCF, further supporting the above results (Figure 
30d).  
Thus, these results support the initial hypothesis, which predicts that there are residual 
chromatin-bound cohesin complexes and further implied that this residual pool may 
represent a stable chromatin fraction. 
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CTCF AND STAG DEPLETION DESTABILISES RESIDUAL CHROMATIN-BOUND COHESIN IN RAD21-
DEFICIENT ASTS 
CTCF and Stag proteins are enriched in the chromatin fraction along with residual 
Rad21 in Rad21?/? ASTs. Thus, I hypothesised that depletion of CTCF or Stag proteins 
may lead to the destabilisation of residual cohesin complexes on chromatin in Rad21?/? 
ASTs.  
To knock-down CTCF and Stag1/2 in Rad21Δ/Δ ASTs, siRNA oligos against CTCF or 
Stag mRNA were transfected into Rad21Δ/Δ ASTs 72 hours post-infection (Figure 31a). 
The efficiency of transfection in both Rad21Δ/Δ and Rad21Lox/Lox ASTs was evaluated 
using siGLO-488 (siRNA-attached to a fluorochrome, described in CHAPTER 5) 
reagent. Using flow cytometry as a read-out, more than 90% of ASTs were 
successfully transfected (Figure 31b). 
To determine the optimal time of knockdown using siRNAs in ASTs, I transfected 
siRNAs and collected cells at various timepoints post-transfection to evaluate protein 
levels. Specifically, Stag1 and Stag2 were considerably depleted from chromatin by 2 
days post-transfection (Figure 32a,b). The same timepoint was chosen for CTCF 
(Figure 32c). Stag1 knockdown did not affect the levels of Stag2, confirming the 
specificity of the knockdowns, especially as these are highly conserved proteins (Roig 
et al., 2014). Previous studies have shown that the depletion of Stag1 doesn’t affect 
Stag2 levels (Xiao et al. 2011, Remeseiro et al., 2012).  
Of the residual Rad21, a further 91%, 87% and 84% was depleted after Rad21Δ/Δ ASTs 
were treated with CTCF, Stag1 and Stag2 RNAi for 3 days, respectively (Figure 32b) 
(Rad21Δ/Δ to siCTCF, siStag1, siStag2: 91±2.8%, 89±6.8%, 84±6.7%, from 3 
independent experiments, respectively, p=0.05 assessed by Wilcoxon Rank Sum and 
Signed Rank Test). Due to experimental variability, statistical significance between 
control and siRNA-treated Rad21?/? was not established but this analysis already 
suggests that the depletion of CTCF and Stag1/2 in Rad21Δ/Δ ASTs leads to the 
destabilisation of the residual Rad21.  
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Figure 31. Post-mitotic Rad21-deficient ASTs are successfully transfected with siRNA oligos 
against cohesin regulators. a) Graphical representation of the protocol used to knock-down cohesin 
regulators in Rad21Lox/Lox ASTs. ASTs were infected with Cre-expressing adenoviruses (Cre-Ad) and 72 
hours post-infection, they were transfected with siRNAs against the cohesin regulator mRNA. Grey 
arrowheads represent timepoint when samples were collected. b) Transfection efficiency by flow cytometry 
for green fluorescence after 48 hours of transfection with either siRNA non-targeting control (siNTR) or 
siGLO-488 (siRNA-attached to a fluorochrome) (50 nM) in Rad21Lox/Lox and Rad21Δ/Δ ASTs. ASTs were 
plated at densities of 0.4x106 per 6-well and at a two-fold density in Rad21Δ/Δ ASTs (2xN) was tested. 
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Figure 32. Depletion of cohesin regulators results in cohesin destabilisation off chromatin in 
control and Rad21-deficient ASTs. a) Western blot analysis for Stag1, Stag2, Rad21, H3 and tubulin 
protein in a timecourse of siRNA for Stag1 transfection in Rad21Lox/Lox and Rad21Δ/Δ ASTs. b) Western blot 
analysis for Stag2, Rad21, H3 and tubulin protein in a timecourse of siRNA for Stag2 transfection in 
Rad21Lox/Lox and Rad21Δ/Δ ASTs. c) Western blot analysis for CTCF, Rad21, H3 and tubulin protein in a 
timecourse of siRNA for CTCF transfection in Rad21Lox/Lox and Rad21Δ/Δ ASTs. All samples were collected 
for protein analysis after fractionation into soluble and chromatin-bound protein fractions (SOL: Soluble 
proteins, CH: Chromatin-bound proteins). d) Graph represents the percentage of chromatin-bound Rad21 
normalised to H3 levels for siNTR and siCTCF, siStag1, siStag2 Rad21Δ/Δ ASTs (91±2.8%, 89±6.8%, 
84±6.7%, from 3 independent experiments, respectively). Statistical significance has been assessed using 
a Wilcoxon Rank Sum and Signed Rank Test (p=0.05). 
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These experiments were repeated such that all knockdowns were performed from the 
same parental pool of Rad21Δ/Δ ASTs and protein levels could be assessed from all 
samples simultaneously (Figure 33). In addition to using siRNAs for CTCF, Stag1 and 
Stag2 as before, siRNAs to Esco1 were also included because the insoluble pool of 
residual Rad21 was enriched for Smc3 acetylation (Figure 30c-d). Depletion of CTCF 
caused the most pronounced decrease in Rad21 protein levels, with 91% of residual 
cohesin being depleted and a decrease in Stag1, Stag2 and Smc3 acetylation levels 
were also observed. These findings indicated that there were Smc3 acetylated residual 
cohesin-Stag1 or Stag2 complexes which were sensitive to CTCF depletion. As 
expected, Esco1 depletion resulted in undetectable levels of Smc3 acetylation. 
Interestingly, the depletion of Esco1 led to a 61% decrease in Rad21 levels compared 
to Rad21Δ/Δ ASTs and in both Stag1 and Stag2 levels without affecting CTCF levels on 
chromatin. This implied that both residual cohesin-Stag1 or Stag2 complexes were 
sensitive to the depletion of Smc3 acetylation. Co-immunoprecipitation experiments 
were attempted in order to confirm the composition of the residual complexes, however 
these were not successful due to the prohibitive amount of material required. Despite 
this, these results showed that Smc3 acetylated residual cohesin-Stag1 or Stag2 
complexes were sensitive to CTCF and Esco1 depletion. Overall, they underlined the 
role of CTCF in maintaining their stability on chromatin. 
Thus, I confirmed that the RNAi-mediated depletion of a series of cohesin regulators in 
cohesin-deficient ASTs led to further destabilisation of the residual chromatin-bound 
cohesin complexes. This analysis also revealed different sensitivities to the different 
regulators, highlighting that the residual complexes are most sensitive to CTCF 
depletion and uncovered a potential dependency of a fraction of them on Smc3 
acetylation via the depletion of Esco1.  
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Figure 33. Residual chromatin-bound Rad21 is most sensitive to CTCF and Esco1 depletion in 
Rad21-deficient ASTs. Western blot analysis for Stag1, Stag2, Rad21, H3 and tubulin protein in 
Rad21Lox/Lox and transfected with siRNA for Stag1, Stag2, CTCF and Esco1 Rad21Δ/Δ ASTs for 3 days. 
Samples were collected for protein analysis after fractionation into soluble and chromatin-bound protein 
fractions (SOL: Soluble proteins, CH: Chromatin-bound proteins). Chromatin-bound Rad21 was 
normalised to H3 levels and the percentages of Rad21 loss calculated for the different samples in this 
experiment is indicated in grey (1 experiment). 
 
RAD21 BINDING IS SENSITIVE TO CTCF DEPLETION IN COHESIN-DEFICIENT ASTS 
To understand the effect of CTCF and Stag1 depletion on residual cohesin binding 
sites, I performed a genome-wide analysis of cohesin binding in CTCF-depleted 
Rad21Δ/Δ and Stag1-depleted Rad21Δ/Δ ASTs.  
For this purpose, Rad21 ChIP-Seq libraries were prepared from control Rad21Lox/Lox, 
Rad21Δ/Δ, CTCF-depleted Rad21Δ/Δ and Stag1-depleted Rad21Δ/Δ ASTs. The ChIP-Seq 
protocol was further optimised so that the ChIP efficiency was increased and therefore 
allowed me to produce libraries from cells that have low amounts of Rad21 protein on 
chromatin (Figure 32-33). Optimisations included increasing the time of formaldehyde 
fixation from 10 (Sofueva et al., 2013) to 30 minutes and using three timepoints of 
sonication to test ChIP efficiency by western blot and ChIP-qPCR. The comparison 
between the different conditions and with known NSC conditions showed that 30 
minutes fixation and 8 minutes sonication were optimal to achieve maximum efficiency 
of Rad21 ChIP in ASTs (Figure 34b,d). Next, I prepared ChIP-Seq libraries by using 
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equal amounts of DNA from the series of samples in the NEB Illumina ChIP-Seq 
Library preparation kit (NEB). The consequent sequencing in the Illumina MiSeq 
platform yielded comparable numbers and quality of sequencing single-end 75 bp 
reads for the different libraries (Table 4 in the APPENDIX, 2 replicates per library). 
 
Figure 34.The ChIP-Seq protocol and quality control steps used to increase the efficiency of Rad21 
chromatin-immunoprecipitation in NSCs and ASTs. Main steps of the protocol are as follows: a) 
crosslinking proteins with DNA using 1% folmadahyde (20,30 minutes); b) Chromatin fragmentation by 
sonication (4,6,8 minutes); c) Chromatin-Immunoprecipitation (ChIP) of Rad21 protein by using 
monoclonal Rad21 antibody (Ab922); d1, d2) Protein or DNA elution to test efficiency by western blot or 
ChIP-qPCR (09:44, 16:23, 01:22 positive and Xist, 10:14 negative control Rad21 sites). Finally, DNA 
purification, library preparation (NEB) (optimal size of the library is 300 bp) and sequencing via the Illumina 
standard protocol.   
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The analysis of the ChIP-Seq dataset was performed as described in (Sofueva et al., 
2013) by Dr C. Barrington (a bioinformatician in the Hadjur lab), where mapped reads 
were assigned to 50 bp bins genome-wide which allows the unbiased investigation of 
the ChIP signal from tens of thousands of sites across the genome. The reads were 
transformed into percentiles log10(1-quantile(v)) to allow us to compare ChIP-seq 
libraries between datasets. ChIP libraries were well replicated for all datasets (Figure 
35a), allowing us to choose robust thresholds for Rad21 peaks (i.e top 1% of ChIP-Seq 
signal). To determine which Rad21 peaks changed during treatment, signals in control 
Rad21Lox/Lox ASTs were plotted against each experimental condition (Figure 35b). This 
analysis revealed global changes in Rad21 signals in each experimental sample, with 
the largest changes in Rad21 signal observed in CTCF-depleted Rad21Δ/Δ ASTs.  
To more carefully assess the impact of the knockdowns on different kinds of cohesin 
binding sites, Rad21 sites were grouped according to signal strength in Rad21Lox/Lox 
ASTs into high, medium and low signal sites. For this purpose, the top, medium, and 
lower 10% of signal values were utilised. The distribution of the ChIP signal in each 
group is shown for each of the experimental samples (Figure 35c). As expected, the 
median signal for Rad21Δ/Δ ASTs was less than in control Rad21Lox/Lox cells, evident at 
each signal group (Figure 35c,d). Thus, a decrease in overall protein levels (as seen 
by Western blots in Figure 32-33) was accompanied by decreased Rad21 ChIP 
signals. Stag1-depleted Rad21Δ/Δ ASTs had an effect on Rad21 signal which was 
similar to the effect observed in Rad21Δ/Δ ASTs. However, CTCF-depleted Rad21Lox/Lox 
ASTs had the most pronounced effect on Rad21 signal in all signal categories 
compared to Rad21Lox/Lox ASTs. Similarly, looking at an example region in the genome 
browser, the ChIP-Seq data again show that CTCF knock-down in Rad21Δ/Δ ASTs has 
the greatest effect on cohesin binding (Figure 35d).  
Hence, a genome-wide analysis of cohesin binding sites revealed that a further 
decrease in cohesin protein levels translated into a decrease in cohesin ChIP signal 
upon the depletion of cohesin regulator proteins. This analysis emphasised a role for 
CTCF in all ChIP signal ranges, even in the high-signal Rad21 sites, which are more 
likely to regulate domain structure.  
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Figure 35. Rad21 binding profiles are most sensitive to CTCF depletion in Rad21-deficient ASTs. a) 
Correlation of Rad21 ChIP signal (50 bp) after quantile normalisation between the two replicates of control 
Rad21Lox/Lox and Rad21Δ/Δ, CTCF- and Stag1-depleted Rad21Δ/Δ ASTs (top 1% of bins) and b) between 
Rad21Lox/Lox and control, CTCF-, Stag1-depleted Rad21Δ/Δ ASTs, respectively (top 1% of bins). c) Using 
the top (High), medium (Medium) and lower (Low) 10% of signal bins in Rad21Lox/Lox ASTs, the ChIP signal 
in the different samples (Rad21Lox/Lox and CTCF-, Stag1-depleted, control Rad21Δ/Δ ASTs) were plotted. d) 
Representation of ChIP-Seq reads aligned in mouse genome (mm10) as they are represented in the 
Genome Browser in Rad21Lox/Lox and control, CTCF-, Stag1-depleted Rad21Δ/Δ ASTs. 
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STAG1 AND CTCF DEPLETION IN COHESIN-DEFICIENT ASTS COMPROMISES CHROMATIN 
DOMAIN STRUCTURE  
Previous results indicated that CTCF/cohesin ChIP signal correlates well with the 
extent of contact insulation (Sofueva et al., 2013), in other words, strong ChIP signals 
are associated with strong ‘domain borders’. Given that CTCF-depleted Rad21Δ/Δ ASTs 
had a pronounced effect on Rad21 signal, including in the ‘high signal’ category, I 
explored the effect of CTCF, Stag1 and Stag2 loss on residual chromatin structure in 
Rad21Δ/Δ ASTs.  
To do this, I employed the in nucleo Hi-C method previously used in the lab (Sofueva 
et al., 2013). As before, the Hi-C method is an unbiased analysis of global 
chromosome organisation and is based on the same ‘proximity-ligation’ principle used 
for all ‘C’ techniques (Dekker et al., 2002) (Figure 36). Hi-C is different from 4C 
methods in that ligation junctions are labeled with biotinylated nucleotides, which 
allows for the enrichment of chromatin fragments which were thought to be previously 
proximal in nuclear space (Lieberman-Aiden et al., 2009). While Hi-C libraries were 
prepared form the siStag2 and siNon-targeting control (siNTR) Rad21Δ/Δ ASTs with no 
changes to the standard protocol, the siCTCF and siStag1 cells required significant 
optimisations. The CTCF- and Stag1-depleted Rad21Δ/Δ samples were over-digested 
and the consequent ligation efficiency was poor (Figure 36a-c). After the decrease in 
digestion time to 1 day and a 2-fold increase in T4 DNA Ligase concentration, the 
ligation efficiency was similar between all libraries. Next, Hi-C libraries prepared from 
Rad21Lox/Lox, Rad21Δ/Δ, CTCF- depleted Rad21Δ/Δ, Stag1-depleted Rad21Δ/Δ and Stag2-
depleted Rad21Δ/Δ ASTs were sequenced using the Illumina HiSeq 2500 platform. 
Comparable number of paired-end 50 bp reads were obtained between the datasets. 
After alignment and filtering for biases (performed by Dr C. Barrington) the final Hi-C 
contact maps were prepared from similar numbers of read pairs (Library information in 
Table 4 in the APPENDIX).  
Results from the ChIP-seq analysis (Figure 35c) revealed that high signal Rad21 
binding sites may be affected in CTCF and Stag1-depleted Rad21Δ/Δ ASTs. 
Furthermore, high-signal Rad21 sites were associated with strong contact insulation, or 
‘domain borders’ (Sofueva et al., 2013) as these were defined in CHAPTER 1. Thus, 
we performed a global contact insulation analysis from the perspective of 
cohesin/CTCF binding sites in the genome after depletion for CTCF, Stag1 or Stag2. 
Contact insulation is a computational method, which allows the quantification of the 
average frequency of contacts between all loci that lie within a certain distance ‘band’ 
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(here 80-120 kb) on either side of a Rad21/CTCF binding site (‘0’ point). When the 
distribution of contact frequency is plotted, insulation at Rad21 sites is visualised by 
fewer contacts crossing the ‘0’ point compared to the neighboring regions (Figure 
37a).  
 
Figure 36. The HiC protocol and quality control steps used to optimise efficiency in siRNA-treated 
ASTs. Main steps of the protocol were as follows: a) crosslinking proteins with DNA using 1% 
formadahyde (20, 30 minutes); b,c) Digestion of DNA fragments with HindIII, fill-in of the nicked ends with 
biotin-dCTP and ligation reactions (1x and 2x Ligase concentration); d,e) Sonication of the ligation 
products, size selection (200-400 bp) and enrichment of the biotin-containing fragments; f) Illumina paired-
end adapter ligation and PCR reactions (300-500 bp) followed by sequencing. UND: Undigested sample, 
HindIII 1d and 2d: Digested sample with HindIII for 1 and 2 days, Ligation 2x: Ligated samples with double 
the amount of T4 Ligase. 
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Figure 37. Stag2, Stag1 and CTCF depletion leads to a progressive loss in contact insulation in 
Rad21-deficient ASTs. a) A schematic representation of the method used to calculate contact insulation 
for a given locus in the genome. If insulation is occurring from a given point in the genome (green arrows), 
then you detect fewer contacts crossing the point compared to the neighboring regions. This depletion of 
contacts represents contact insulation. Conversely, if many contacts are detected across a point this 
represents little or no insulation (compare white triangles in Hi-C matrix, top). Using the Hi-C matrix, the 
average intensity of contacts is calculated between all chromosomal elements that lie within a certain 
distance band (white horizontal lines) on either side (e.g. +/-200 kb) of a given feature in genome, for 
example Rad21 binding sites (green arrows). This distribution of contact frequency is plotted below the Hi-
C matrix. b) specifically 400 bp region centered about Rad21 binding sites (points 0) and stratified by 
Rad21 signal in the Rad21Lox/Lox ASTs ChIP-Seq dataset to 10% of the Low, Medium and High signals 
(from left to right panels), co-localising with CTCF sites (ChIP-signal>2.3). 
In this analysis, insulation from Rad21 co-localising with CTCF sites (mouse cortex; 
ENCODE) was calculated for the different Rad21 signal intensity categories, namely 
‘Low’, ‘Medium’ and ‘High’ which were described previously (Figure 35c). Rad21 
binding sites with ‘Low’ and ‘Medium’ signal were shown to have minimal genome-wide 
insulation profile but the ‘High’ signal sites mediate strong insulation confirming what 
was shown before (Sofueva et al., 2013) (Figure 37b). Interestingly, contact insulation 
progressively decreased from control Rad21Lox/Lox to control Rad21Δ/Δ, Stag2-, Stag1- 
and CTCF-depleted Rad21Δ/Δ (Figure 37b). This analysis uncovered a significant drop 
in cohesin-mediated insulation across the genome upon the depletion of cohesin 
regulators while pointed to a different sensitivity to the different factors.  
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As an example for the global effects described above, we selected sites in the genome 
based on the change of Rad21 signal after knockdown with CTCF, Stag1 or Stag2. In 
the first example (Figure 38), a Hi-C contact map is shown for a 4 Mb region on 
chromosome 1. In addition are shown the CTCF and Rad21 ChIP-Seq signals. In 
control Rad21Lox/Lox ASTs, this region had several chromatin domains at the megabase 
and sub-megabase scales flanked by high signal cohesin and CTCF sites. As 
observed, Hi-C maps prepared from Rad21Δ/Δ ASTs had a loss of contacts within 
domains without a significant change to the chromosome domain borders. Knockdown 
of Stag2 in Rad21Δ/Δ ASTs did not dramatically change the domain structure compared 
to Rad21Δ/Δ ASTs. Meanwhile, depletion of CTCF and Stag1 in Rad21Δ/Δ ASTs leads to 
a dramatic change in domain structure in this region. Importantly this loss of domain 
structure was associated with Rad21 binding sites which were themselves lost, 
revealing that the loss of specific Rad21 binding sites leads to a corresponding loss of 
long-range contacts and domain structure.  
In another example, I examined the Pcdh gene cluster, where I had previously 
performed 4C-seq analysis and could confirm the presence of cohesin-anchored 
enhancer-promoter chromatin loops (Figure 39). In Figure 39, a wider region around 
the Pcdh cluster is flanked by several cohesin and CTCF binding sites which were 
shown to be disrupted in the Pcdhα cluster and which in turn disrupted its regulation 
and choice of promoters (described in CHAPTER 2). The additional depletion of CTCF 
and Stag1 resulted in ectopic chromatin contacts from the Pcdhβ cluster to the 
downstream domain resulting from a widespread loss of cohesin sites spanning both 
the cluster and the downstream domain. Therefore, the Hi-C results showed that the 
depletion of CTCF and Stag1 in Rad21Δ/Δ ASTs led to the loss of Rad21 binding at 
specific sites in the genome and thus was accompanied with a corresponding loss in 
the chromatin contacts from these cohesin binding sites.  
Therefore, the depletion of cohesin regulators in Rad21-deficient ASTs resulted in loss 
of cohesin binding sites, which was correlated in a genome-wide analysis with striking 
decrease in cohesin-mediated contact insulation. The results were supportive of an 
important role for CTCF in all signal strengths.  
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Figure 38. CTCF and Stag depletion lead to the dissolution of sub-domains, internal to a 4 Mb 
domain, accompanied by the loss of cohesin binding in cohesin-deficient ASTs. H-iC contact maps 
of a wide 4 Mb region on chromosome 1, where two sub-domains are located within each of the two 1.5 
Mb domain flanked all by Rad21 and CTCF binding sites in Rad21Lox/Lox and in CTCF-, Stag1, Stag2-
depleted, control Rad21Δ/Δ ASTs. Aligned are the genes spanning the region (top panel in Rad21Lox/Lox), 
CTCF and Rad21 ChIP-Seq signal (top 1%) in the samples indicated on the left side of the tracks. CTCF 
ChIP-Seq from mouse cortex from ENCODE, Rad21 ChIP-Seq from Rad21Lox/Lox (L/L_Rad21), CTCF-, 
Stag1, Stag2-depleted (Δ/Δ+siRNA_Rad21, aligned with the respective sample) and control Rad21Δ/Δ 
ASTs (Δ/Δ_Rad21). White squares highlight the 1.5 Mb chromatin domain described.  
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Figure 39. CTCF and Stag depletion lead to ectopic chromatin contacts from the cohesin/CTCF-
regulated Pcdh cluster to the neighbouring domains in cohesin-deficient ASTs. Hi-C contact maps 
of a wide 5 kb region on chromosome 18, encompassing the Pcdh cluster of genes, in Rad21Lox/Lox and in 
CTCF-, Stag1, Stag2-depleted, control Rad21Δ/Δ ASTs. Aligned are the genes spanning the region (top 
panel in Rad21Lox/Lox), CTCF and Rad21 ChIP-Seq signal (top 1%) in the samples indicated on the left side 
of the tracks. CTCF ChIP-Seq from mouse cortex from ENCODE, Rad21 ChIP-Seq from Rad21Lox/Lox 
(L/L_Rad21), CTCF-, Stag1, Stag2-depleted (Δ/Δ+siRNA_Rad21, aligned with the respective sample) and 
control Rad21Δ/Δ ASTs (Δ/Δ_Rad21). White squares highlight the two neighbouring chromatin domain of 
interest.  
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CTCF DEPLETION CORRELATES WITH INCREASED CELL DEATH IN COHESIN-DEFICIENT ASTS 
Depletion of Rad21 in cycling NSCs leads to cell death, however post-mitotic ASTs do 
not experience cell death upon Rad21 depletion (described in CHAPTER 2). I explored 
whether this was due to the residual cohesin protein in post-mitotic ASTs, and 
examined the status of cell survival once ASTs were treated with siCTCF when levels 
of Rad21 had dropped further.  
I observed that upon transfection with siRNAs, CTCF-depleted Rad21Δ/Δ ASTs had 
significantly more cells floating in the media compared to their respective controls. So 
to quantify potential changes in cell viability or cell cycle, PI staining and cell cycle 
analysis in cell pellets fixed with EtOH was performed. Using this method, not only cells 
found in the different cell cycle phases are quantified but also dead and dying cells are 
found in the sub-G1 fraction. This method is not able to distinguish between different 
cell death pathways and therefore represents a broader quantification of cell death.  
I performed the analyses using the adherent cultures including the supernatants, which 
represented the whole population including dying or dead cells. The results were 
obtained from two timepoints (48 hours and 75 hour) post transfections with siRNA-
mediated knock-downs (siNTR and siCTCF). Since ASTs are not cycling, NSCs were 
also included as a control for the investigation of potential cell cycle effects. Initially, I 
didn’t observe any changes in sub-G1 population transfected with siNTR compared to 
untransfected control ASTs. This result suggests that the transfection doesn’t lead to 
an increase in cell death. However, I observed a 2-fold increase in the sub-G1 
population in Rad21Δ/Δ ASTs 48 hours after siRNA transfection for CTCF, implying that 
CTCF depletion leads to a decrease in cell viability already at 48 hours post 
transfections (5% to 10% Sub-G1 population). A similar increase in cell death (10% to 
20% Sub-G1 population) was again noted at 75 hours post transfection with siCTCF in 
Rad21Δ/Δ ASTs (Figure 40). This analysis also showed that there was no cell cycle re-
entry due to transfections or RNAi-mediated depletion.  
Thus, CTCF depletion in cohesin-deficient ASTs causes an increase in cell death. 
However, it should be noted that enrichment of the viable and non-cycling cells were 
collected for all the experiments (i.e. ChIP-Seq, Hi-C and protein analysis) without 
supernatants so that a degradation of the genomic or protein material would not 
interfere with the interpretation of the results.   
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Figure 40. CTCF depletion causes increased cell death in Rad21-deficient ASTs. Flow cytometry 
results in left panels depicting the side scatter (i.e. conformation of the inner morphology) to the forward 
scatter (i.e. cell diameter) areas and cell cycle analysis after PI staining in Rad21Lox/Lox ASTs and NSCs 
used as a control for cell cycle changes and Rad21Δ/Δ ASTs transfected with siRNA for CTCF and non-
targeting control (NTR) for 48 and 75 hours (10,000 events per sample). (Sub-G1%; indicated above). 
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3.3. DISCUSSION 
In CHAPTER 2, it was shown that genetic deletion of Rad21 led to chromosomal 
domain decompaction, loss of specific long-range contacts and subsequent gene 
deregulation. However, the gene expression and genome structure changes were 
subtle and the cells were viable. I explored the hypothesis that the existing cohesin 
complexes in Rad21-deficient ASTs are sufficient to maintain chromatin structure. I 
tested how the destabilisation of residual cohesin would influence chromatin 
organsation.  
Residual chromatin-bound cohesin complexes were present in Rad21Δ/Δ post-mitotic 
ASTs. Residual cohesin was enriched for known regulators of cohesin association with 
chromatin. Upon DNA replication, some of the regulators stabilise cohesin on 
chromatin allowing SCC (i.e. Smc3 acetylation) (Beckouet et al., 2010; Ben-Shahar et 
al., 2008). This type of ‘cohesed’ cohesin is proposed to be the ‘stable’ pool with a time 
of residence of 6 hours in G2 mammalian cells (Gerlich et al., 2006) and to topologically 
embrace sister chromatids in yeast (Gligoris et al., 2014). I hypothesise that by 
depleting Rad21, I enriched for a more ‘stable’ cohesin pool that has lower turn-over on 
chromatin. This hypothesis is supported by the fact that Rad21 mRNA levels were 
almost undetectable. Furthermore, the 4C-seq timecourse experiments (discussed in 
CHAPTER 2) also support this hypothesis. Other than stability, the residual cohesin 
complexes could be enriched for complexes, which associate with chromatin as this 
proposed by the handcuff model (discussed in CHAPTER 1). The model would predict 
that two cohesin rings entrap two different DNA strands and as they are associated via 
Stag and Pds5 proteins, they create a chromatin loop. However, this doesn’t exclude 
the possibility that stability and different modes of cohesin association co-exist in 
Rad21-deficient cells. 
I hypothesised that the depletion of cohesin regulators would destabilise cohesin in 
Rad21-depleted cells. Indeed, preliminary results showed that the depletion of selected 
regulators led to further decrease in cohesin chromatin levels as well as at selected 
cohesin binding sites across the genome and consequently, to loss of cohesin-
anchored contacts globally. Interestingly, we noted a different sensitivity of cohesin-
mediated insulation upon depletion of the different factors, with CTCF and Stag1 
having the most prominent effects. These results were supported by the decreased 
number of cohesin binding sites in CTCF RNAi-depleted (Schmidt et al., 2010) or 
Stag1-null (Remeseiro et al., 2012b) mammalian cells. However, one should bear in 
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mind that the above studies target the total cohesin population whereas we target the 
residual cohesin pool after Rad21 genetic depletion. 
Given that CTCF and cohesin are directly interacting through Stag1 or Stag2 (Xiao et 
al., 2011), one would expect an additive effect after CTCF depletion in cohesin 
chromatin binding and chromatin structure. The difference in the effect from Stag2 
compared to Stag1 on the Hi-C analysis that I reported could be explained by that they 
have different basal levels in ASTs and after the similar decrease they experience in 
Rad21-deficient cells, one of them could be in very low levels on chromatin. So its 
further depletion wouldn’t add an effect in our experiments (discussed in CHAPTER 4). 
Another possibility is that the interface between CTCF and Stag proteins differs 
between Stag1 and Stag2 (e.g. protein modifications) and in turn, confer different 
stabilities and/or functions to the cohesin complex. Showing that depleting Stag1 didn’t 
affect Stag2 levels and vice versa, I propose that residual Stag1-cohesin complexes 
are more essential to cohesin-mediated domain structure than Stag2 is in this post-
mitotic system.  
Cells treated with siCTCF experience changes at Rad21 binding sites as well as a loss 
of contact insulation from changing sites. These changes included loss of internal 
domain structure and new long-range interactions whereby domains became ‘merged’. 
siCTCF cells also experienced an increase in cell death compared to control cells 
which may arise by the low levels of cohesin reached only by siCTCF. This implies that 
there might be a threshold of cohesin levels necessary for the maintenance of 
chromatin structure and cell viability in ASTs. There is evidence in the literature of such 
examples. In CdLS, mutation in the cohesin loading factors cause 30% decrease in its 
protein levels but cells do manage to survive and create a human being (Kawauchi et 
al., 2009).  While the cell death phenotype is unlikely due to ASTs re-entering the cell 
cycle, it may be a function of the structural changes we observed, and it may also be 
linked to specific changes in transcription which the cells are very sensitive to.  
In this context, I excluded the effects of CTCF-independent cohesin functions in 
chromatin architecture. Several evidence point out that cohesin facilitates CTCF 
insulator functions. Sofueva et al. showed that CTCF sites not co-localising with 
cohesin show minimal contact insulation profiles at multiple scales. Therefore, if there 
is an effect from CTCF sites, this wouldn’t be able to completely account for the 
changes we see here. Additional evidence suggest that the minimal insulation seen in 
CTCF-only sites is due to the presence of cohesin/CTCF sites near them and therefore 
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influencing the chromatin folding around the area (M. Vietri Rudan, unpublished data). I 
proposed that the effect I observed by Hi-C is due to the role of CTCF in maintaining 
cohesin stability on chromatin and therefore its functions in chromatin architecture.  
Taken together with previous data, I have showed that the decrease in cohesin levels 
on chromatin were accompanied with decreased cohesin binding and loss of cohesin-
anchored contacts that shape chromatin domains. Here, cohesin destabilisation off 
chromatin was achieved by depleting a series of cohesin regulators and the results 
highlighted different sensitivity to the different factors. This finding implied that cohesin 
may be stabilised by different mechanisms on chromatin and that these mechanisms in 
turn mediate different functional chromatin contacts. Additional high-resolution 4C-Seq 
experiments from different classes of cohesin sites would aid us to dissect further 
these different mechanisms.  
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CHAPTER 4. DISCUSSION 
A closer look of genome organisation and gene regulation showed that chromatin is not 
organised randomly and it is interlinked to its functions (Cremer and Cremer, 2001; de 
Wit and de Laat, 2012). Factors which were central to such studies are cohesin and 
CTCF proteins, which have essential roles in mediating gene regulation in cis (Hadjur 
et al., 2009; Kagey et al., 2010; Nativio et al., 2009; Seitan et al., 2011). The field 
progressed from descriptive studies (Dixon et al., 2012; Sexton et al., 2012) to 
functional studies asking about the role of chromatin domains (Lupianez et al., 2015; 
Nora et al., 2012) and proteins, such as cohesin, in these.  
First, we showed that the cohesin complex has a global role in chromatin domain 
maintenance forming the basis for gene expression. Cohesin-deficient post-mitotic 
ASTs experienced a genome-wide perturbation of transcription and loss of specific 
cohesin-anchored chromatin contacts leading to chromatin domain decompaction. 
These changes were accompanied by a significant increase in nuclear volume and 
perturbed nuclear morphology.  
Subsequently, we showed a role for cohesin regulators in cohesin stabilisation on 
chromatin and therefore, in cohesin-mediated chromatin domain maintenance. The 
depletion of CTCF and Stag proteins resulted in a further decrease in Rad21 levels and 
binding on chromatin which were correlated with a change in chromatin domain border 
definition. Importantly, this led to a decrease in cell viability in cohesin-deficient post-
mitotic cells.   
 
4.1. COHESIN’S ROLES IN THE POSTMITOTIC NUCLEUS 
COHESIN DOSAGE AND COHESIN FUNCTIONS 
Cohesin proteins have critical roles in DNA replication and chromosome segregation, 
both during mitosis and meiosis (Hirano, 2006; Merkenschlager and Odom, 2013; 
Nasmyth and Haering, 2009; Peters et al., 2008). Initial studies and our findings 
suggest that different cohesin dosage may play a role in the different cohesin functions. 
Cohesin is expressed in post-mitotic cells and tissues, such as mouse cortex 
(Remeseiro et al., 2012b; Wendt et al., 2008), which is supported by my observations 
that cohesin subunits are expressed in post-mitotic ASTs. Interestingly, Rad21 mRNA 
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and protein expression was decreased in ASTs to roughly half of the amount in NSCs. 
This might be explained by that fact that ASTs don’t require cohesin’s chromosome 
segregation functions and only require cohesin’s gene regulation functions. All these 
findings imply that different cohesin levels may be required for its different functions. In 
yeast, a study where cohesin amounts were titrated showed that different amounts are 
required for a group of cohesin functions they investigated (Heidinger-Pauli et al., 
2010). 30% of the original amount of cohesin in yeast is enough to maintain its function 
in cohesion but not those in DNA repair, making cells sensitive to double-strand break 
reagents. For cohesion to be impaired, cohesin levels needed to be further decreased 
to 13%. In humans, an example is CdL syndromes, where lower cohesin dosage 
doesn’t cause cohesion defects but alters gene expression profiles in CdLS mouse 
models and patient samples (Fullwood et al., 2009a; Liu and Krantz, 2009). In these 
examples, the decrease in cohesin levels was not sufficient to compromise the growth 
of an embryo but instead led to defects in its development. Therefore, it might be 
possible that only mild changes in cohesin levels are required for its gene regulator 
function whereas more dramatic or complete ablation of its levels leads to SCC defects 
and cell death. These thresholds could be different in different species (e.g. yeast 
versus mammals) or even different tissues.  
Which are the mechanism(s) involved in regulating cohesin dosage? Together with the 
decrease in mRNA levels of the cohesin genes upon differentiation of NSCs to ASTs, I 
observed a decrease in expression of cell cycle regulated genes by RNA-Seq and 
qPCR. This set of genes (e.g. cyclin D1) is responsible for the initiating events which 
promote the G1-to-S transition. One mechanism which regulates such events is the 
phosphorylation of retinoblastoma protein (pRb) which, prior to its phosphorylation, 
inhibits E2F-mediated transcription (Dimova and Dyson, 2005). E2F transcription factor 
targets the transcription of genes involved in DNA replication and in turn, is 
fundamental for the transition of the cell from G1-to-S transition. In the transcriptional 
analysis by RNA-Seq, many of the E2F target-genes are down-regulated upon 
differentiation of NSCs to ASTs (e.g. Mini-Chromosome Maitenance, MCM, proteins). 
Could it be that cohesin gene dosage is regulated by such cell cycle ‘sensing’ 
mechanisms? If I was to investigate this further, I would analyse the binding profiles of 
factors, such as E2F, around the transcriptional unit of cohesin genes, such as Rad21, 
by ChIP methods and quantify cohesin mRNA levels as cells exit mitosis. Evidence 
about the regulation of cohesin gene expression are lacking so this approach would 
provide insight into the presence or absence of such cell cycle ‘sensing’ factors in the 
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regulation of cohesin genes. If this is true, it would be essential to our knowledge on 
cohesin roles in development and disease.   
 
COHESIN AND THE MORPHOLOGY OF THE POST-MITOTIC NUCLEUS 
Studies looking at the nuclear volumes in cells from CdLS patients or cells expressing 
cohesin mutations (Gard et al., 2009; Nolen et al., 2013) suggest a role for cohesin 
proteins in nuclear size and morphology. When I decreased cohesin levels in cohesin-
deficient post-mitotic cells, I reported a similar effect on nuclear volume and changes in 
nuclear morphology. Nuclear size and morphology can arise due to changes in the 
inner nuclear structures, such as the nuclear lamina layer (Goldman et al., 2004). 
Nuclear lamina is linked to chromatin organisation and transcriptional activity as well as 
the tension mechanisms that hold the nuclei together (Webster et al., 2009). I 
hypothesise that changes in cohesin levels may influence inner nuclear structures and 
interfere with their association with the lamina. Indeed, a study on nuclear lamina 
components and their interaction with the genome in human fibroblasts, showed that 
CTCF is enriched at the borders of lamina-associated domains (LADs) (Guelen et al., 
2008). So it was proposed that CTCF might have a role in maintaining the LADs. If that 
is true, it is possible that cohesin is also involved since it is known to facilitate CTCF 
insulator function. Therefore, cohesin depletion may disrupt the lamina-chromatin 
association. One could expect that if these cells were challenged further (i.e. 
mechanical stress or cell cycle re-entry), they would not be able to maintain their 
viability since their nucleus is already compromised, possibly leading to the phenotypes 
described herein.  
 
COHESIN AND CTCF ARE KEY ELEMENTS OF GENOME ORGANISATION  
It has been suggested that TADs are functionally important, even during development, 
evolution and disease (Lupianez et al., 2015; Nora et al., 2012; Vietri Rudan et al., 
2015). Several important questions remain. Which proteins are involved in forming 
and/or maintaining TADs? Through the study of cohesin-deficient post-mitotic cells, 
cohesin with CTCF were shown to have a functional role in the regulation of chromatin 
contacts that partition the genome. Cohesin depletion in post-mitotic cells leads to 
global topological domain decompaction with decreased contacts within and increased 
contacts between TADs (Sofueva et al., 2013). The decreased contacts within TADs 
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and global gene de-regulation agree with studies in non-cycling or cycling mammalian 
cells, with either cohesin genetic depletion (Seitan et al., 2013) or TEV-mediated 
cleavage (Zuin et al., 2014), respectively. Support to our phenotype in cohesin-
deficient ASTs also comes from a recent study, which combined 5C and mathematical 
modeling with single-cell methods to predict different conformations of the chromatin 
fibers at the X-inactivation centre. The authors ‘deleted’ in silico a CTCF/cohesin 
binding site located internally to a TAD from their model and saw both a decrease in 
intra-domain contacts and an increase in inter-domain contacts (Giorgetti et al., 2014). 
This candidate in silico approach also supports a cohesin/CTCF role in TAD structure 
maintenance. 
However, there are differences in the models proposed by the above studies. Zuin et 
al. proposed a role for CTCF in maintaining TAD structure, and for cohesin in 
maintaining their internal chromatin contacts (Zuin et al., 2014). However, Zuin et al. 
study doesn’t accommodate for cell death caused by cohesin depletion in cycling cells 
or differences between the siRNA-mediated CTCF depletion and TEV-mediated 
cleavage of cohesin. The proposed model, where CTCF has different roles than 
cohesin, is not supported by our data since CTCF-only sites were shown to engage in 
minimal contact insulation (Sofueva et al., 2013). In our study, contact insulation was 
undetectable when it was calculated from CTCF-only sites located 50kb away from 
other CTCF/cohesin sites (M.Vietri Rudan; unpublished data). So I propose that CTCF 
and cohesin are both required to mediate genome organisation. 
However, the demarcation of the TADs was still identifiable in the studies discussed 
above, which suggests that cohesin may not be involved in TAD maintenance or that 
additional factors are required.  In Drosophila, there is a group of proteins involved in 
insulation and implicated in chromatin domain structure. It was proposed that the 
number of insulators is correlated to the strength of the border of the TADs (Van Bortle 
et al., 2014). This simplistic view explaining border strength probably does not reflect 
the complexity of genome organisation but it does give an indication that multiple 
proteins may be involved in TAD maintenance. This hypothesis would predict that 
depleting one protein at a time wouldn’t be suffient to disrupt chromatin domains. In 
agreement with this, I reported that the most pronounced effect on global contact 
insulation profiles resulted from CTCF/Rad21 depletion than with Rad21-alone. 
Therefore, it is conceivable that more than one protein may be required to mediate 
chromatin domains at the TAD level. But which proteins could be involved, if not 
cohesin proteins, in holding the TAD structures. Alternative candidates could be other 
122 
 
members of the SMC family of proteins, such as condensins. In C. elegans, where 
CTCF is not present, the dosage-compensation complex (DCC) was proposed to have 
direct roles in the maintenance of the TADs on the X-chromosome (Crane et al., 2015). 
DCC is able to do this by localising to specific sites, called Rex, which are enriched at 
the border regions of the TADs. Therefore, TADs may require additional factors for 
their maintenance. 
Another possibility could be that cohesin and CTCF are required to establish formation 
of TADs as cells exit mitosis, and are not required for their maintenance. Our study and 
others wouldn’t be able to distinguise the above. What if cohesin and CTCF demarcate 
the sites where the domains first emerge in G1? A similar idea is gene bookmarking 
according to which binding of certain transcription factors is maintained at promoters as 
cells exit mitosis. This mechanism is essential for cell identity (Zaidi et al., 2010). So 
cohesin, and more likely CTCF, could be ‘bookmarking’ the formation of TADs. Given 
that CTCF recognises a specific sequence motif, one which is encoded directly in the 
DNA sequence, CTCF could be a plausible candidate for ‘TAD bookmarking’. A recent 
study comes to argue for a CTCF role in mitotic bookmarking in Drosophila. The 
authors found a class of CTCF sites, which are maintained through interphase and 
mitosis (i.e. MI sites), frequently enriched at TADs borders (Shen et al., 2015). If we 
wanted to explore a more functional role of CTCF in ‘bookmarking’ the formation of 
TADs, we would first perform ChIP-Seq experiments to investigate the sites in the 
genome where CTCF is enriched as cells exit mitosis and then, delete these CTCF 
sites to evaluate their functional significance in chromatin structure by using a 
combination of CRISPR and 3C methods. Using this approach, I would be able to 
investigate the roles of either cohesin or CTCF in ‘bookmarking’ the formation of 
chromatin domains and provide direct evidence as to their roles in genome 
organisation as it emerges in G1. 
Taken together, these functional studies suggest an important role for cohesin and 
CTCF in TAD maintenance providing insights to its functions. However, it remains 
unclear whether cohesin and CTCF have a causal relationship with the maintenance 
and or establishment of the TADs.  
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RESIDUAL COHESIN COMPLEXES 
Residual cohesin complexes were present on chromatin in cohesin-deficient ASTs. 
What is the reason why some cohesin complexes remain on chromatin upon Rad21 
genetic deletion? Is it possible that I enriched for stable complexes in cohesin-deficient 
ASTs with longer residence time on chromatin? Our data indicate that residual cohesin 
complexes are enriched for Smc3 acetylation. This modification is known to mark 
cohesin complexes during SCC establishment in S-phase (Beckouet et al., 2010). One 
way to investigate cohesin stability on chromatin is by using FRAP after introducing a 
GFP-tag in the endogenous floxed Rad21 locus. This way we can investigate whether 
the residual cohesin has increased time of residence in chromatin compared to the 
cohesin population in control ASTs. An alternative way to test whether specific sites in 
the genome are more stable than others uses a variation of the ChIP method, namely 
Cross-Linking Kinetic (CLK) (Poorey et al., 2013). In yeast, a timecourse of 
formaldehyde fixation between 1 second and 30 minutes and ChIP-qPCR experiments 
were used to predict the kinetics of DNA-binding proteins on chromatin at specific sites. 
The principle is that when formaldehyde is added to the cell cross-linking occurs rapidly 
and therefore protein occupancy is captured so the off rate of crosslinked proteins is 
eliminated. If the time that formaldehyde is present increases, more protein binding 
events will be captured. However, the timepoints need to be in a lesser time of the off 
rate of the protein so that the kinetics are captured. Using these methods, I would be 
able to explore whether the residual cohesin complexes are more stably bound to 
chromatin in ASTs. 
Is it possible that cohesin is associated with chromatin in a different way at the sites 
where it remains in Rad21-depleted ASTs? In yeast cells, cohesin has been shown to 
entrap single DNA fibers and replicated DNA (i.e. two DNA fibers), namely with the 
‘embrace’ model (Huis in ’t Veld et al., 2014). In mammalian cells, another model, 
namely the ‘handcuff’ model, which predicts that a single chromatid is entrapped by a 
single cohesin ring, and that the two cohesin rings then interact with one another to 
connect the two sister chromatids (Huang et al. 2005; Zhang et al. 2008b). This could 
occur via one molecule of Pds5A/B and one of Stag1/2 proteins connecting the two 
kleisin subunits (Zhang et al., 2013) and therefore, hold the cohesin ‘handcuff’ 
together. However, the evidence supporting the presence of either model doesn’t 
exclude their combination on mammalian chromosomes. If both modes exist in ASTs, 
they may or not have different stabilities on chromatin. In this respect, one might 
hypothesise that the depletion of Pds5 or Stag proteins would compromise the 
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connection between the two rings in a ‘handcuff’ conformation but without removal of 
the cohesin ring off chromatin. In support of this argument, a study in yeast shows that 
either Stag or Pds5 depletion lead to SCC problems but not to cohesin removal off 
chromosomes (Kulemzina et al., 2012). This becomes central if you consider that 
different combinations of the components, such as Stag1-Pds5A, might themselves 
confer different stabilities to the complex (discussed below).  
 
STAG2, STAG1 AND CTCF DEPLETION LEAD TO A PROGRESSIVE LOSS IN CHROMATIN 
STRUCTURE 
The depletion of selected cohesin regulators led to further destabilisation of residual 
cohesin off chromatin and in turn, changes in chromosomal domain structures. I 
showed that CTCF and Stag1 depletion have a bigger effect on chromatin domains 
and contact insulation profiles around cohesin/CTCF sites than Stag2 in Rad21-
deficient ASTs.  
Why did I observe this difference between Stag1 and Stag2 in cohesin-deficient ASTs? 
Given that their levels are equally affected in Rad21-deficient ASTs and that Stag1 
doesn’t compensate for Stag2 upon its depletion and vice versa, one possible 
explanation for the difference I observed in the contact insulation profiles (i.e. Stag1 
depletion influenced contact insulation more than Stag2) is that the absolute levels of 
Stag1 and Stag2 protein are different in ASTs. Indeed, it has been shown that the 
levels of Stag1 and Stag2 proteins are different in some tissues, and that the 
proportion varies depending on the tissue type (Canudas and Smith, 2009; Remeseiro 
et al., 2012b). If we wanted to test this hypothesis, we would use quantitate mass 
spectrometry analysis after immunoprecipitation of the cohesin complexes for robust 
quantification of the Stag1/2 relative amount in ASTs.   
Another explanation for the differences between Stag1 and Stag2 could be that the 
interface of CTCF-Stag is different between Stag1- and Stag2-cohesin complexes. 
While the homology of the sequence between Stag1 and Stag2 is 70%, the 75 amino 
acids of their N-terminal region is divergent between them (Xiao et al., 2011). It is with 
their N-terminal region that Stag proteins associate with the C-terminal region of CTCF. 
This difference in sequence of Stag1 and Stag2, where they associate with CTCF, may 
influence the stability of their interaction with CTCF and therefore, that of the cohesin 
complex at CTCF sites on chromatin.   
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Post-translational modifications on Stag1/2 and/or CTCF might change their 
conformation or their susceptibility to other cohesin regulators. This could have an 
impact on either cohesin stability or function. The CTCF C-terminal region, is where the 
CTCF-Stag association is reported to occur (Xiao et al., 2011) and this region is known 
to undergo phosphorylation on CTCF. This modification has been reported to modulate 
CTCF function as an insulator without interfering with its binding to DNA (El-Kady and 
Klenova, 2005; Klenova et al., 2001). This modification could lead to de-stabilisation or 
ablation of Stag1/2-CTCF interaction and in turn, have a functional impact on 
CTCF/cohesin roles in mediating chromatin loops; whether this modification has a 
different impact on Stag1 versus Stag2 is yet to be clarified.  
Also there are post-translational modifications on Stag proteins, which are shown to be 
important for SCC and cohesin removal during the ’prophase pathway’. PLK-mediated 
phosphorylation of the C-terminal domain of Stag1/2 decrease cohesin association with 
DNA (Hauf et al., 2005; Sumara et al., 2002). These modifications have been are 
characterised for cohesin’s roles in mitosis, but as we found several components of 
cohesin regulation during cell cycle expressed in post-mitotic ASTs (e.g. Esco1), it 
wouldn’t be surprising to find also the modifications on Stag proteins.  
While the modifications (e.g. phosphorylation) on Stag proteins are not on the region 
where it interacts with CTCF, they might be changing its conformation and therefore 
impacting its stability or interactions with other factors, such as Wapl. Thus, this 
interface could be the target of several proteins and modification that confers different 
stabilities and possibly different functions to the Stag1- and Stag2-cohesin/CTCF 
complexes. If this is true, given that the Pds5A and B can associate with either Stag1 
and 2 (Losada et al., 2005), they increase the diversity of cohesin complexes and their 
stability on chromatin. In this context, if cohesin rings were associated with chromatin 
with the handcuff model, they could be more sensitive to changing levels of the factors 
described above or to their modifications, either Pds5 or Stag proteins. Indeed, Pds5 or 
Stag depletion in yeast leads to loss of cohesion but not to a decrease in cohesin 
levels on chromatin (Kulemzina et al., 2012), implying that the depletion of selected 
cohesin regulators may disrupt its functions but not its association/presence with/on 
chromatin. Whether this finding is due to the depletion of the proteins holding the 
‘handcuff’ together (i.e. Pds5, Stag) and how this might be influenced by the depletion 
of the different paralogues (i.e. Stag1 versus Stag2), is yet to be clarified. Since 
cohesin functions are linked to how it associates with chromatin, it is vital to understand 
deeply the modes of cohesin association and the stability these may confer.  
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Figure 41. Stag2, Stag1 and CTCF depletion lead to a progressive loss in chromatin structure 
following the decreasing cohesin levels on chromatin. Graphical representation of the proposed model 
where cohesin (i.e. Rad21) decreasing levels (blue triangle) due to the knock-down of the cohesin 
regulators (i.e. Stag1/2 and CTCF) in Rad21Δ/Δ ASTs leads to a further decompaction of topological 
domains and an increase in cell death (grey triangle). In ASTs, two neighbouring domains are depicted 
(grey and blue) and cohesin (dark blue) is mediating both large scale domain loops as well as smaller, 
internal domain loops. After Rad21 genetic deletion, domains were decompacted but domain borders 
remained intact in Rad21Δ/Δ ASTs. The additional depletion via RNAi methods of the main cohesin 
regulators led to further decrease in cohesin levels on chromatin, which resulted in the loss of domain 
borders and cell death in the case of CTCF knock-down. This evidence come to support a key role for 
cohesin proteins in genome organisation in a post-mitotic model system where the roles of cohesin in 
sister chromatid cohesion were eliminated.  
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CTCF AND COHESIN MEDIATE GLOBAL GENOME ORGANISATION 
CTCF depletion had the strongest effect in cohesin protein levels, binding and contact 
insulation profiles. This effect in protein levels and contact insulation resembles the 
sum of the two Stag1 and Stag2 together. These findings underline the role of CTCF 
and cohesin in global genome organisation. Although CTCF has been suggested to 
mediate contact insulation independent of cohesin, as indicated by studies in cycling 
cells (Phillips-Cremins et al., 2013; Wendt et al., 2008) Phillips-Cremins et al. 2013), 
our data don’t agree with this model (discussed above). Further, it would be interesting 
to investigate how chromosome structure is affected in Esco1- in comparison to CTCF-
depleted Rad21-deficient ASTs. Like CTCF, in Esco1-depleted cells both Stag1 and 
Stag2 complexes were reduced. The fact that cohesin levels were also decreased 
upon Esco1 depletion could mean that Smc3 acetylation is involved in maintaining 
cohesin on chromatin even in post-mitotic cells.  
The depletion of CTCF led to a further decrease in Rad21 protein levels on chromatin. 
This results are supported by the decreased cohesin binding sites in CTCF RNAi-
depleted (Schmidt et al., 2010) or Stag1-null (Remeseiro et al., 2012b) mammalian 
cells. It would be interesting to quantify the changes in cohesin binding profiles with 
those in chromatin structure to show their correlation. For this, we need to quantify 
robustly the changes in ChIP signal between the different conditions, so additional 
strategies would be useful. One could be to include either an exogenous DNA control 
throughout the protocol (Orlando et al., 2014) or treat all libraries simultaneously by 
multiplexing them before the ChIP enrichment step (Lara-Astiaso et al., 2014).  
Surprisingly, CTCF depletion in cohesin-deficient ASTs decreased cell viability. The 
changes in chromatin organisation cannot be directly linked to the cell death phenotype 
because the methods used were not sufficient to exclude the CTCF-dependent 
deregulation of single genes important for cell viability. In order to investigate this 
further a dissection of the transcriptional profiles of these cells through RNA-seq would 
be necessary. Taken together, the decrease in cohesin levels, the decrease in contact 
insulation and the increased cell death we observed in CTCF-depleted Rad21-deficient 
ASTs support the argument that different cohesin amounts are essential for different 
cohesin functions. The low amounts of cohesin reached with CTCF depletion could be 
the threshold for cell viability in this post-mitotic system.  
In an elegant approach combining 5C, modeling and single-cell methods, it was 
proposed that chromatin loops within TADs may be responsible for stability of the TAD 
128 
 
borders (Giorgetti et al., 2014). In this context, it is conceivable that cohesin and CTCF 
together stabilise chromatin contacts that otherwise engage in random movements in 
the nucleus. At TAD borders, more stable interactions between CTCF/cohesin sites 
might participate in the definition of large-scale chromatin domains within which 
functional interactions happen; within a domain, CTCF/cohesin might help define more 
dynamic gene-regulatory loops. This spectrum of stability might be essential for the 
role of cohesin in genome functionality and it might rely on a diverse range of 
regulation (e.g. post-translational modifications), composition of the complexes (e.g. 
Stag1/2) and modes of association of the cohesin rings with chromatin (e.g. ‘embrace’ 
vs ‘hancuff’ models).  
 
4.2. CONCLUSION AND FUTURE PERSPECTIVES 
It is clear that the structure of the genome is interlinked to its functions in propagating 
and expressing genetic information. All these processes are crucial for a single cell and 
its fate to the development of an organism and the evolution of the species. Disruption 
of nuclear lamina by a mutation of a single gene or genome architecture even at 
localised sites had dramatic effects in human development and disease. But is yet to 
be elucidated which are the mechanisms by which key protein players are mediating 
the interplay between chromatin structure and functions with implications in 
development and disease. In this thesis, I showed that cohesin is one of those key 
factors with functional roles in global chromatin domain maintenance and gene 
regulation while suggesting different mechanisms by which cohesin and chromatin 
interaction are stabilsed in post-mitotic nuclei with implications in cell viability. Hence, 
these and future findings in this context would be fundamental to our understanding of 
how the genome folds and functions in a way that allows or prevents cell survival, 
development and disease. 
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CHAPTER 5. METHODOLOGY 
 
5.1. MAMMALIAN CELL CULTURE  
IN VITRO ADHERENT CULTURES OF MOUSE NSCS 
The mouse embryonic stem cells (ESCs) contained LoxP sites flanking the fifth and 
sixth exon of Rad21, the core cohesin subunit gene, on both alleles and an insertion of 
the estrogen receptor (ER) fused to Cre recombinase (ERT2-Cre system) within the 
Rosa locus (herein reffered as ESCs Rad21Lox/Lox). When Cre-Recombinase was 
expressed, after ER substrate delivery (i.e. 4-hydroxytamoxifen addition, OHT), it 
mediated recombination between the LoxP sites, which resulted in the deletion of the 
flanking sequences. Adherent neural stem cells (NSCs) were derived from ESCs and 
clones were collected and expanded previously by Dr S.Hadjur according to the 
protocol in (Conti and Cattaneo, 2010; Conti et al., 2005) (herein reffered as NSCs 
Rad21Lox/Lox). As a control, NSCs were obtained, which were wild type for Rad21 gene 
while they were expressing the fusion protein (NSCs Rad21WT/WT). Mouse NSC cultures 
were maintained as adherent monolayers in condition media DMEM/Ham’s F-12 media 
with supplements [For 500 ml DMEM/Ham’s F-12 (Sigma): 7.25 ml D-glucose (2 M, 
SIGMA), 5 ml Non-Essential Amino Acids (100x, PAA), 0.5 ml 2-mercaptoethanol (50 
mM, Invitrogen), 0.8 ml BSA solution (75 mM, Invitrogen), 5 ml B27 supplement 
(Invitrogen), N2 (Invitrogen)] and murine epidermal growth factor (mEGF, Peprotech), 
human fibroblast growth factor 2 (hFGF-2, Peprotech), and Laminin from Engelbreth-
Holm-Swarm murine sarcoma basement membrane (Sigma) at final concentration of 
10 ng/ml. As described in (Conti et al., 2005), the extrinsic factors EGF and FGF-2 are 
sufficient to sustain symmetrical self-renewing divisions of NSCs. NSC cultures were 
expanded by using accutase (Sigma) for 5 minutes at room temperature followed by a 
wash with 10 ml of NSC media and centrifugation at 1,200 rpm for 4 minutes.  
 
IN VITRO DIFFERENTIATION OF MOUSE NSCS INTO POST-MITOTIC ASTS 
Post-mitotic ASTs were obtained by the differentiation of NSCs so that the roles of 
cohesin proteins in G1/G0 were investigated while the cell cycle bias in eliminated. 
NSCs were plated in Laminin-coated plates (10 ng/ml in PBS; 2 hours to overnight at 
37oC) so that they reached 60% confluence by 24 hours. Then, they were treated with 
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10 ng/ml of human bone morphogenetic protein 4 (BMP4, R&D Systems) while EGF 
was withdrawn from the media and the concentration of FGF was decreased to 1 
ng/ml. ASTs were maintained as adherent cultures until they were harvested for 
downstream experiments. In the case that the re-plating of ASTs was required for 
down-stream experiments, ASTs were plated by using accutase (PAA) for 10-15 
minutes at room temperature followed by a wash with 10 ml of AST media and 
centrifugation at 1,200 rpm for 4 minutes.  
 
RAD21 COHESIN SUBUNIT DELETION FROM NSCS AND ASTS 
Rad21 depletion was necessary and sufficient in both cell types in order to investigate 
its impact both in dividing and post-mitotic cells in different experimental settings 
(Hadjur et al., 2009). In NSCs, Rad21 was depleted by the addition of 200 nM OHT to 
the condition NSC media for 48 hours. In ASTs, NSCs were initially platted with respect 
to optimal differentiation conditions (i.e. 60% confluency) and after 24 hours, they were 
differentiated into ASTs in the presence of BMP4. After an additional 24 hours, Rad21 
was depleted by infections with 107 plaque-forming unit (PFU) of Adenovirus-CMV-Cre 
(Cre-Ad, Vector Biolabs) per ml to the AST media for 96 hours. 
 
TRANSFECTION OF MOUSE ASTS WITH SIRNA OLIGOS 
Transfection of mouse post-mitotic ASTs with siRNAs was crucial for the investigation 
of the effect that the transient knockdown of the cohesion-associated proteins have in 
G1/G0 phase of the cell cycle. SiRNAs are cut from shRNA or from long synthetic 
dsRNA by the Dicer enzyme, and are later separated into two short strands, one of 
which binds to the target mRNA and cleaves it, preventing the target protein from being 
made. In the siRNA approach, specific siRNAs are synthesised to silence specific 
proteins in target cells. Because siRNA is composed of RNA and is inherently fragile, it 
is difficult to get into the cytoplasm and, once there, is quickly degraded. This means 
that relatively high doses (i.e. in the nmol range) are needed to achieve the desired 
level of gene silencing (Moore et al., 2010).  
For this purpose, NSCs were initially platted with respect to optimal differentiation 
conditions and after 24 hours, they were differentiated into ASTs in the presence of 
BMP4. After an additional 24 hours, Rad21 was depleted by infections with 107 plaque-
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forming unit (PFU) of Adenovirus-CMV-Cre (Cre-Ad, Vector Biolabs) per ml to the AST 
media for 48 hours. After 48 hours, ASTs Rad21Lox/Lox and Rad21Δ/Δ were re-plated at 
optimal confluence (60%; 400,000 cells per well in 6-well plates) and after an additional 
24 hours, ASTs were transfected according to RNAi Max Lipofectamine protocol. Each 
culture (each well per 6-well plate) was transfected with 50 µM of the mouse 
siGENOME pool, 4.2 µl of RNAiMax Lipofectamine in 200 µl of OPTIMEM (GIMCO) 
and a total volume of 1.7 ml per well. The transfections were performed with the 
respective siGENOME pools for Stag1 (M-041989-01), Stag2 (M-057033-01), CTCF 
(M-044693-01), Esco1 (M-066117-00) and siGENOME pool non-targeting control (D-
001206-13) (Dharmacon). At specific timepoints, between 48 hours and 72 hours post-
transfection, ASTs were collected by using accutase (PAA) for 15 minutes at 37oC 
followed by a wash with media and centrifugation at 1,200 rpm for 4 minutes. The 
supernatant was poured off and cell pellets were collected same as above for 
downstream experiments. 
Prior to the transfection experiments, the efficiency of the transfection in both NSCs 
and ASTs was evaluated by performing the transfections as described above using the 
mouse siGLO Green Transfection Indicator (siGLO-488, Dharmacon) and 48 hours 
post-transfections performing FACS analysis (described in CELL BIOLOGY 
METHODS).  
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5.2. CELL BIOLOGY METHODS 
CELL CYCLE ANALYSIS AND FLOW CYTOMETRY OF MOUSE ASTS 
Propidium iodide (PI) is a DNA binding dye, which is used to quantify the fluorescence 
intensity of the stained cells at certain wavelengths and correlates with the amount of 
DNA they contain. Thus, PI is very useful for cell cycle analysis since during the cell 
cycle the DNA content of cells changes were being duplicated in G2/M phase of the cell 
cycle from what it was in G1.  
For this purpose, NSCs were collected at different time-points after BMP4 addition and 
fixed in 70% ethanol (106 of cells in 1 ml of 70% EtOH). The fixed cells were stored at 
4oC and then when all time-points were collected, they were stained with PI solution 
(100 µg/ml PI, 100 µg/ml RNase A and 0.05% Triton X-100 in PBS) for 40 minutes on 
ice at a concentration of 1x106 cells per ml. Cells were monitored for clumping and 
passed over a 70 mm filter before proceeding to flow cytometry on a CyAn ADP 
Analyzer (Beckman Coulter) (10,000 events count per sample). Viable cells were 
selected using scatter plots of forward scatter (FSC) against site scatter (SSC) of each 
sample indicating size and the granularity of the cell, respectively. PI has a maximum 
emission of 605 nm so PI staining in this experiment was measured accordingly. The 
results were represented using the Flo-Jo software.  
 
FLOW CYTOMETRY AFTER SIRNA TRANSFECTION OF MOUSE ASTS 
NSCs and ASTs were collected as described above at 48 hours after siGLO-488 
transfection, the supernatant was poured off and cell pellets were re-suspended as 
10x106 per ml of sorting media in order to be sorted for green-positive cells using the 
488 nm laser (10,000 events count per sample). Viable cells were selected using 
scatter plots of FSC against site scatter SSC of each sample indicating size and the 
granularity of the cell, respectively. Then, GFP positive cells were sorted using the 488 
nm blue laser (Log GFP Intensity > 103). The results of the cell sorting experiments 
were represented using the Flo-Jo software.  
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5.3. MOLECULAR BIOLOGY METHODS 
PROTEIN EXTRACTION AND FRACTIONATION METHODS 
Whole cell lysates  
Whole protein lysate was purified for protein analysis from NSC and AST pellets. Cell 
pellets were collected and re-suspended in RIPA buffer (30 µl RIPA buffer per 5x106 
cells) and 25x protease inhibitor mix EDTA-free (Invitrogen) following incubation on ice 
for 10 minutes. Then, cell lysates were centrifuged at 13,000 rpm for 10 minutes at 4oC 
and protein containing supernatants were stored at -80oC.  
 
Protein fractionation 
Soluble and chromatin-bound protein fractions were collected separately to investigate 
the effect of the knock-down of Rad21 and the cohesin-associated proteins, on 
chromatin-bound proteins of interest. Initially, cell pellets were re-suspended in 
Fractionation Buffer 1 (10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M 
Glycerol, 1 mM DTT, 0.1% TritonX-100; 106 cells in 40 µl) and incubated on ice for 10 
minutes. The soluble fraction was collected as the supernatant after spinning at 1,300 
rcf for 10 minutes at 40C and the pellet was re-suspended in Fractionation Buffer 2 (3 
mM EDTA, 0.2 mM EGTA, 1 mM DTT; 106 cells in 40 µl) and incubated on ice for 30 
minutes. The nuclear soluble fraction was collected as the supernatant after spinning at 
1,900 rcf for 10 minutes at 4oC and the pellet representing the chromatin fraction was 
re-suspended in 2x Laemmli Buffer (Bio-rad) (106 cells in 40 µl). 
 
Protein salt-dependent fractionation (Martini extracts) 
Soluble and chromatin-bound protein fractions were collected separately and a certain 
concentration of NaCl was used to remove salt-extractable from the chromatin-bound 
proteins in order to understand the effect of the Rad21 depletion on chromatin-bound 
proteins of interest according to the protocol described in (Cook et al., 2011; Martini et 
al., 1998). Initially, the media was removed carefully from the culture plates and 10 ml 
of Buffer E (20 mM Hepes-KOH pH7.8; 5 mM KOAc, 0.5 mM MgCl2, 0.5 mM DTT) per 
150 cm2 dish was added slowly and cells were incubated for 10 minutes at 4oC. Then, 
Buffer E was removed, 50 ml of Buffer E with 25x protease inhibitor mix EDTA-free 
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(Invitrogen) per plate was added and cells were incubated for 10 minutes at 4oC. 
Buffers were removed and after plates were dried for 2 minutes, cells were removed 
with a cell scraper carefully so that the nuclei remained intact. Cells were transferred in 
a loose homogenizer vessel where the cells were mechanically lysed with 25 strokes. 
The soluble fraction was collected with the supernatant after spinning at spin 1,500 rcf 
for 5 minutes at 4oC and Buffer N (10% glycerol and 1 M NaCl topped up to 10 ml with 
Buffer E) was added to the pellet respectively so that final salt concentration was 300 
or 600 mM NaCl for the experiments shown here. Then, nuclear pellets were incubated 
for 90 minutes in the rotator at 4oC. The volume of Buffer N that was added to the 
nuclear pellets was calculated as follows: V2=V1/0.67 (Final salt concentration 600 mM 
NaCl), where V1=Volume of the Pellet (salt-extract/chromatin bound), V2=Volume of 
Buffer N added to the pellet. To collect the salt-extractable chromatin fraction, pellets 
were span at 14,000 rcf for 20 minutes at 4oC and supernatant was removed. The 
pellets represented the salt-resistant chromatin fraction and were re-suspended in 2x 
Laemmli Buffer (Bio-rad). Protein concentration was calculated in the soluble fraction 
samples using the Bradford assay (described in PROTEIN QUATIFICATION AND 
WESTERN BLOT) and the volume used from each fraction was the same percentage 
of the total volume used in the respective sample of soluble, salt-extractable and 
insoluble fraction. Between samples, 10 µg of the soluble fraction of each sample were 
loaded per well of the SDS-PAGE gel so that the downstream Western blot analysis 
was performed. 
 
PROTEIN QUANTIFICATION AND WESTERN BLOT 
Protein samples were quantified by using the Bradford assay (BioRad) and the BSA 
standard curve method. Western blot analysis was performed for Rad21 (Abcam, 
ab992), Smc3 (Abcam, ab9263), Cre Recombinase (CreR) (Novagen, 69050), CTCF 
(Abcam, ab70303), Histone 3 (Abcam, ab1791), Hsp90 (Abcam, ab13494), tubulin 
(alpha) (Sigma, T5168), Stag2 (Bethyl, A300-158A), Stag1, Pds5a and Pds5b 
antibodies from A. Losada and Smc3 acetylation from K. Shirahige laboratories. Each 
protein sample (10µg) was diluted in a total volume of 15-30 µl with 2x Laemmli Buffer 
(Bio-rad). The samples were boiled at 95oC for 5 minutes and loaded on 6-8% SDS-
PAGE gels or 4-12% SDS-PAGE pre-cast gels (Bio-Rad) along with 10 ml of protein 
ladder (Bio-Rad). Gels were electrophorised at 100 Volts in SDS-PAGE 1x Tris-Glycine 
Running buffer (1x Tris-Glycine with 0.1% SDS) and proteins were transferred onto an 
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immune-Blot nitrocellulose membrane (Bio-Rad) by wet transfer at 160 mA per 1.0 mm 
gel for 2 hours in a wet transfer apparatus (Bio-Rad) with an appropriate amount of 
SDS-PAGE 1x Tris-Glycine transfer buffer (1x Tris-Glycine with 20% methanol). After 
blocking [5% (w/v) milk (Sigma), 0.1% Tween20 (Sigma) in Tris Buffered Saline (TBS)] 
for 1 hour at room temperature, incubation with primary and secondary antibodies was 
performed overnight at 4oC and 1 hour at room temperature in blocking solution, 
respectively. Before and after the incubation of the secondary antibody three washes of 
10 minutes with TBS-Tween (0.05% Tween20 in TBS) were performed at room 
temperature. Finally, the detection was performed using ECL plus kit (GE healthcare) 
and they were developed according to the manufacturer’s protocol. 
 
IMMUNOFLUORESCENCE AND MICROSCOPY 
ESCs, NSCs and ASTs were plated in 6-well plates (300,000 cells per well) on glass 
coverslips laminin-coated (10 ng/ml in PBS; overnight). Initially, cells were fixed with 
4% paraformaldehyde for 10 minutes, washed with PBS, and permeabilised with PBS-
Triton X-100 (0.1%) for 10 minutes. For specific experiments, to visualise chromatin 
bound proteins only, a pre-extraction step was added before the fixation step with PE 
Buffer (100 mM PIPES, 30% glycerol, 1 mM EGTA, 5 mM MgCl2, and 0.1% Triton X-
100) for 5 minutes at room temperature. Then, fixed cell cultures were blocked with 3% 
goat serum in PBS-Triton X-100 (0.1%) for 30 minutes. Incubation with both primary 
and secondary antibodies was performed for 30 minutes at room temperature in 
blocking solution. Three washes with PBS-Triton X-100 (0.1%) were performed 
between antibody incubations and after incubation with the secondary antibody. 
Finally, coverslips were washed with PBS and mounted with Vectashield containing 1.5 
mg/ml DAPI. Images were acquired using a Leica TCS SP5 confocal microscope at a 
63x magnification. Stacks were collected with a z step size of 0.3 mm. Nuclear volume 
and staining intensity were quantified by ‘Find Objects’ feature of the Volocity software 
(Perkin Elmer) and the box or violin plots were generated using R programing 
language.  
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DNA ANALYSIS 
Genomic DNA purification 
Genomic DNA was extracted from NSCs and ASTs using the QIAamp DNA Mini Kit 
(Quiagen) according to the DNA purification from blood or body fluids protocol. The 
DNA concentrations of the samples were then measured using the NanoDrop 
Ultraviolet (UV) spectrophotometer.  
 
Quantitative Polymerase Chain Reaction (qPCR) 
Genomic DNA was used as a template for the quantitative Polymerase Chain Reaction 
(qPCR) in order to determine the percentage of the depletion at the genomic locus 
between exons 5 and 6 of Rad21 in Rad21Δ/Δ NSCs and ASTs. The final volume of 
genomic DNA was diluted up to a concentration of 100 ng/ml and DNA was used as a 
template for qPCR. The reaction was performed according to the LC480 SYBR Green 
1 Master protocol (Roche) by using 2 µl of the diluted DNA library, 1.5 µl of each primer 
(10 mM), 10 µl SYBR green Master Mix (Roche) made up with water to a volume of 20 
µl per reaction. The qPCR conditions used were as follows: 95°C for 5 minutes (1 
cycle); 95°C for 10 seconds; 60°C for 30 seconds; 72°C for 30 seconds and single read 
(40 cycles). The qPCR was performed using the LightCycler 480 System (Roche). 
Amplification results were obtained using the manufacturer algorithm for ‘fit points’. The 
quantification of the gene copy number under investigation (i.e. Rad21) was relative to 
the expression of the housekeeping genes (Gapdh) (primer sequences in Table 1). 
 
RNA ANALYSIS 
RNA extraction and cDNA synthesis 
Total RNA was extracted from ESC, NSC and AST pellets using the RNeasy Kit 
(Qiagen) and was eluted as 10x106 cells in 50 µl of RNase/DNase-free H2O. As a 
template for cDNA synthesis, total RNA of 1 µg in 11 µl of RNAase-free water was 
used per reaction. The cDNA reaction was performed according to the SuperScript II 
Reverse Transcriptase (1 µl/reaction, 200 units) protocol (Invitrogen) using 50-250 ng 
of random primers (RP) (5 µM, Invitrogen), 4 µl of 5x First Strand Buffer (Invitrogen), 10 
mM DTT (0.1 M, Invitrogen), 0.5 mM dNTPs (10 mM, Yorkshire Biosciences), 40 Units 
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of RNase OUT Ribonuclease Inhibitor (Invitrogen) and 200 Units of SuperScript II 
reverse transcriptase (Invitrogen) made up with water to a total volume of 20 µl per 
reaction. cDNA synthesis was performed on a Mastercycler Realplex PCR machine 
(Eppendorf) with the following conditions: 65oC for 5 minutes; 25oC for 5 minutes; 50oC 
for 60 minutes; 70oC for 15 minutes.  
 
qRT-PCR 
The final volume of cDNA was diluted up to 250 µl of dH2O to get to an approximate 
concentration of 100 ng/µl. cDNA was used as a template for qPCR. The qPCR 
reaction was performed according to the LC480 SYBR Green 1 Master protocol 
(Roche) by using 200 ng in 2 µl of the diluted cDNA library, 0.75 µM primer (10 µM, 
Sigma), 10 µl of 2x SYBR green Master Mix (Roche) made up with water to a volume 
of 20 µl per reaction. The qPCR conditions used were as follows: 95°C for 5 minutes (1 
cycle); 95°C for 10 seconds, 60°C for 30 seconds, 72°C for 30 seconds and single read 
measurement, (40 cycles). The qPCR was performed using the LightCycler 480 
System (Roche). Amplification results were obtained using the manufacturer algorithm 
for fit points. The quantification of the expression of the gene under investigation (i.e. 
Rad21) was relative to the expression of the housekeeping genes (i.e. Tbp, Ubc) 
(primer sequences in Table 1 in the APPENDIX).  
 
RNA extraction, RNA-Seq libraries and analysis 
Total RNA was extracted from pellets from 5x106  Rad21Lox/Lox and Rad21Δ/Δ NSCs and 
ASTs in duplicates using the mRNeasy Kit (Qiagen) according to the manufacturer’s 
protocol. Then, samples were treated with DNase (Ambion) according to 
manufacturer’s instructions. Quality assessment of the RNA samples was performed 
using the RNA 6000 Nano Kit in the 2100 Bioanalyzer (Agilent). An RNA integrity 
number (RIN) of at least 8 was obtained from the samples which were used for library 
preparation. RIN is a tool, which allows the evaluation of RNA integrity by considering 
the entire electrophoretic trace of the RNA sample. This includes the presence or 
absence of degradation products. In this way, interpretation of an electropherogram is 
facilitated, comparison of samples is enabled and repeatability of experiments is 
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ensured. The assigned RIN is independent of sample concentration, instrument and 
analyst therefore becoming a de facto standard for RNA integrity.  
RNA samples were sent to Illumina Inc. for the RNA-seq library preparations. Strand-
specific polyA+ libraries were prepared and sequencing was performed using the 
Illumina platforms (Genome Analyzer IIx) (library information in Table 4 in the 
APPENDIX). Filtered reads were aligned to the genome using TopHat and transcript 
assembly was performed using Cufflinks (Trapnell et al., 2010) and the aligned reads 
were imported in the UCSC Genome Browser to be visualised with respect to the 
mouse genome. Expression was expressed as fragments per kilobase of exon per 
million mapped reads (FPKM). The de-regulated genes were defined the group of 
genes that had z-score or standard score more than or equal to 1.5 where z-score 
allowed the calculation of the probability of an FPKM occurring within a normal 
distribution and enables the comparison two FPKM values that are from different 
normal distributions.  
Finally, the results presented here were statistically analysed and graphically 
represented in by using R statistics software. The gene enrichment analysis regarding 
the pathways that the de-regulated genes were involved in was done by 
Protein ANalysis THrough Evolutionary Relationships (Panther) classification system. 
 
CHROMATIN IMMUNOPRECIPITATION (CHIP)-SEQ LIBRARIES AND ANALYSIS 
Genome-wide mapping of protein–DNA interactions and epigenetic marks is 
fundamental for the deeper understanding of transcriptional regulation. A precise map 
of binding sites for transcription factors and other DNA-binding proteins is vital for 
reading the gene regulatory networks that underlie various biological or disease-related 
processes. So Chromatin Immunoprecipitation experiments followed by sequencing 
(ChIP-seq) allow for the detection protein–DNA binding events in high-resolution and 
throughout the genome (Furey, 2012).  
The main steps of the protocol are the following (Figure 34): a) crosslinking proteins 
with DNA using formaldahyde solution; b) Chromatin fragmentation by sonication; c) 
Immunoprecipitation for the protein of interest; d) DNA purification, library preparation 
and sequencing by using the Illumina standard protocol. Challenges in the standard 
ChIP–seq protocol have motivated recent advancements in this approach; such as 
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modifying the protocol so that the resolution is increased (Rhee and Pugh, 2012) or 
challenges in the analysis of the data such as the inability to quantitatively compare 
datasets genome-wide, which has been proposed to be overcome by introducing equal 
amounts of reference genomes into the ChIP so that in the analysis step the original 
ChIP is normalised to the exogenous sample (Orlando et al. 2014). 
 
Preparation of chromatin and fragmentation 
Cell pellets from NSCs and ASTs were collected and re-suspend in neural stem cell 
media with 1% formadehyde (SIGMA) (35-40x106 cells in 20 ml media) for 20 minutes 
at room temperature (Figure 34). Crosslinking reaction was terminated by the addition 
of 0.125 M glycine for 5 minutes at room temperature. Then, cell pellets were collected 
by spinning at 2,500 rpm for 5 minutes at 4oC and washed twice with PBS (GIBCO) (10 
ml per pellet) before they were stored at -80oC not more than three weeks. Cell pellets 
were thawed at 37oC briefly and washed with Wash Buffer 1 (10 mM Hepes pH 7.5, 10 
mM EDTA, 0.5 mM EGTA, 0.75% Triton X-100) and Wash Buffer 2 (10 M Hepes pH 
7.5, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) for 10 minutes at 4oC, respectively. 
Then, nuclei were collected by spinning at 2,500 rpm for 5 minutes at 4oC and lysed 
with Lysis Buffer without SDS for 30 minutes (150 mM NaCl, 25 mM Tris-HCl pH7.5, 5 
mM EDTA, 1% Triton X-100, 0.5% NaDeoxycholate) at a final concentration of 2x106 
cells in 100 µl. Then, a final concentration of 0.2% SDS was added and NSC or AST 
lysates were sonicated using the Bioruptor Pico Sonication system (Diagenode) for a 
total of 4 or 8 minutes at 4oC, respectively. Sonicated lysates were span at 13,200 rpm 
for 30 minutes at 4oC so that non-soluble chromatin was removed and supernatants 
were used for the following immunoprecipitation step.  
 
Quantity and quality control of sonicated chromatin 
Quantity and quality controls were performed at this stage by a sample representing 
10% of the initial sonicated lysates (Figure 34). Initially, proteins were decross-linked 
from DNA by adding to 10 µl of the sample, 10 µg/ml of proteinase K (Bioline) and 10 
mM of Tris-HCl (pH7.5) up to a total volume of 100 µl, overnight at 65oC. Then, DNA 
was extracted by the addition of equal volume of phenol/chloroform and the top 
aqueous phase was collected via spinning at 12,400 rpm for 5 minutes at room 
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temperature (herein refered as phenol/chloroform extraction method). Finally, DNA was 
precipitated by the addition of 0.3 M sodium acetate (SIGMA), 1 µl of GlycoBlue and 
2.5 volumes of 100% EtOH and incubation at -80oC for minimum 2 hours (herein 
reffered as EtOH precipitation). Then, precipitated DNA was isolated by spinning at 
13,200 rpm for 30 minutes at 4oC, washed twice with 70% EtOH, air-dried for 30 
minutes and re-suspend in 30 µl of 1x Tris-EDTA (TE). For quantity control, the Qubit 
quantitation system with the dsDNA HS kit (Invitrogen) was used to quantify the DNA 
content of the sample according to the manufacturer’s instructions and approximate the 
total amount in the original sample (about 6x106 ASTs yield about 25 µg of DNA). For 
quality control of the sonication efficiency and the extent of DNA fragmentation, 15 µl of 
the purified DNA were electrophoresed on a 1% agarose gel to see the extent of 
sonication. Optimal condition was considered a smear representing a wide range of 
fragment sizes with the majority of fragments being between 2-6 kb. At this step 
chromatin was frozen at -800C before use and protease inhibitors were added upon 
thawing. 
 
Chromatin immunoprecipitation (ChIP) 
For the preparation of a ChIP-Seq library 100 µg of chromatin was an optimal amount 
as an input to the chromatin immunoprecipitation step (ChIP). For the Rad21 ChIP, 40 
µg of the Rad21 antibody (1 µg/µl, Abcam Ab992) conjugated with 100 µl Protein G 
(PG) Dynabeads (10 mg/ml, Life Technologies). In addition, a control for unspecific 
chromatin binding was also included for every ChIP experiment, where 4 µg Rabbit 
anti-mouse polyclonal immunoglobulins (10 mg/ml, Dako) control was conjugated with 
20 µl PG beads. Initially, PG beads were washed with 1 ml of Wash Buffer A (50 mM 
Tris-HCl pH8.0, 150 mM NaCl, 0.1% SDS, 0.5% NaDeoxycholate, 1% NP-40, 1 mM 
EDTA) twice on the magnetic rack and then, re-suspended in Wash Buffer A to a final 
concentration of 100 ng/µl and were blocked with 0.1 mg/ml of BSA (NEB) for 1 hour at 
4oC, rotating. Then, PG beads were washed twice with 1 ml Wash Buffer A and re-
suspended in Wash Buffer A to a final concentration of 100 ng/µl. Conjugation of the 
blocked PG beads with the antibody at the analogies described above was performed 
for 4 hours at 4oC, rotating. At the same time, chromatin was diluted with Lysis Buffer 
at a final concentration of 0.1% SDS and pre-cleared with the same amount of PG 
beads as conjugated with the antibody at the same conditions. Finally, the PG beads 
with conjugated antibody were pulled together with the chromatin lysates and 
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incubated over-night at 4oC, rotating. Before the conjugation, a percentage of 1% of the 
input sample was stored at -80oC. After 16-20 hours, lysates were removed from beads 
and kept at -80oC as the post-IP samples and DNA was eluted with consecutive 
washes with 1 ml of Wash Buffer A, B (50 mM Tris-HCl pH8.0, 500 mM NaCl, 0.1% 
SDS, 0.5% NaDeoxycholate, 1% NP-40, 1 mM EDTA) and C (50 mM Tris-HCl pH8.0, 
250 mM LiCl, 0.5% NaDeoxycholate, 1% NP-40, 1 mM EDTA) for 10 minutes at 4oC, 
rotating. Finally, a quick wash with 1x TE buffer was performed and DNA on the beads 
was decrosslinked with 400 µl of Elution Buffer (1% SDS, 0.1 M NaHCO3, and 75 µg/ml 
Proteinase K up to a volume of 400 µl with dH2O) at 65oC overnight. Then, samples 
were treated with 37.5 µg/ml of RNase A (Invitrogen) for 2 hours at 37oC and DNA was 
precipitated as described in quality and quantity control paragraph.  
 
Western blot and ChIP-qPCR quality control 
To check whether the fixation conditions and the sonication conditions were optimal in 
order to precipitate most of the protein of interest, IP sample, an input sample and a 
sample from the post-IP supernatant were electrophorised on an SDS-PAGE gel and 
the amounts of protein in those fractions were compared. For such tests, IPs of 20 µg 
of chromatin were used. For this protocol, after the washes with Wash Buffers A/B/C 
and TE, the beads were re-suspended in a volume of Lysis Buffer (no SDS) equal to 
the original volume of the chromatin you used for the IP. Samples were loaded on a 1.5 
mm SDS-PAGE gel and the Western blotting protocol was followed.  
Additionally, an IP sample, an input sample and a sample from an IgG control were 
used as an input to the qPCR. For such tests, IPs of 20 µg chromatin were used and 5 
primer sets in replicates were tested. Primers were previously described in (Parelho et 
al., 2008) and found to be positive for Rad21 binding (i.e. Chr 9:4457) or negative (i.e. 
Xist, Chr 10:2448) (primer sequences in Table 2 in the APPENDIX) (Figure 34).  
 
ChIP-seq library preparation, sequencing and analysis 
The optimal input DNA for the library preparation used was 50 ng using the NEBNext 
ChIP-Seq Library preparation kit for Illumina (NEB) according to the manufacturer’s 
instructions. After each enzymatic reaction, the DNA was extracted using 1.8 volumes 
of Agencourt AMPureXP beads (Beckman Coulter) and eluted into the volume required 
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for the next reaction. The reactions were the following: 1) Repair the ends: 50 ng of 
DNA, 5 µl of 10x End Repair Buffer and 1 µl of End Repair Enzyme up to a total 
volume of 50 µl of water and incubated for 30 minutes at 20oC; 2) Add A-tails: 44 µl of 
the DNA from previous reaction, 5 µl of 10x dA-tailing Buffer and 1 µl of the Klenow 
fragment (3’-5’ exo) up to a total volume of 50 µl of water and incubated for 30 minutes 
at 37oC; 3) Ligate the Illumina adaptors: 19 µl of the DNA from previous reaction, 6 µl 
of the 5x Quick Ligation Reaction Buffer, 1 µl of the Illumina Adaptors (1.5 µM) and 4 µl 
of the Quick T4 DNA Ligase up to a total volume of 30 µl and incubated for 15 minutes 
at 20oC. After the incubation 3 µl of the USER Enzyme Mix was added to the reaction 
and samples were incubated for 15 minutes at 37oC. At this point DNA was eluted into 
23 µl dH2O following the AMPure beads purification; 4) PCR: 11.5 µl of DNA, 12.5 µl of 
the Phusion Polymerase Mix, 0.5 µl of the Universal PCR Primer and 0.5 µl of the 
Index Primer up to a total volume of 25 µl and incubated as follows: 98oC for 30 
seconds (1 cycle); 98oC for 10 seconds, 65oC for 30 seconds, 72oC for 30 seconds (12-
15 cycles); 72oC for 5 minutes (1 cycle). If two libraries were multiplexed later prior to 
sequencing, Index 6 and Index 12 from the NEBNext ChIP-Seq Library preparation kit 
for Illumina (NEB) were used. The correct combinations, which depend on the number 
of libraries multiplexed, was determined according to NEB/Illumina manufacturer’s 
protocol.  
Following the PCR, samples were purified using a 1:1 ratio of AMPure beads. This 
removed the majority of adaptors and samples were eluted in 6 µl of 1x TE and 1 µl 
was used for the Bioanalyzer according to the DNA 1000 kit (Agilent). Optimal ChIP 
library Bioanalyzer smear showed the average size of the library at about 300 bp and 
the consequent sequencing of the libraries was performed following the Illumina 
protocol for the MiSeq platform. Based on the above Bioanalyzer results, the libraries 
were multiplexed. Here, the molarity was about 10 nM as predicted by the Bioanalyzer 
and the library mix was diluted to a final concentration of 2 nM with water in a volume 
of 10 µl. Then, equal volume of 0.2 N NaOH was added and samples were incubated 
for 5 minutes at room temperature. Finally, 980 µl Hybridisation buffer (Illumina) was 
added to the sample on ice and 500 µl of the sample were further diluted with 500 µl of 
Hybridisation buffer up to 1 ml total volume to achieve 10 pM as final concentration of 
the sample. For sequencing on the MiSeq platform, 600 µl of the sample above are 
optimal and a single-end read length of 75 bp sequencing to collect ChIP-Seq data.   
The analysis of the ChIP-Seq dataset was performed as described in (Sofueva et al., 
2013) by Dr C. Barrington, where the coverage of mapped reads was assigned to 50 
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bp bins across the genome. Quantile value for each bin was transformed by log10(1-
quantile(v)) to compare between datasets. Bins with signal values above 2.3 were 
identified as Rad21-bound. 
 
CHROMOSOME CONFORMATION CAPTURE (3C) METHODS 
Chromosome conformation capture (3C) methods have been developed to study 
genome organisation in higher resolution by measuring quantitatively chromatin 
interactions (Figure 3). Briefly, 3C techniques include the following main steps: a) 
crosslinking proteins with DNA using folmadehyde solution so that DNA fragments are 
crosslinked together when they are in close proximity to each other in three-
dimensional space within intact nuclei; b) DNA fragments are digested with a restriction 
endonuclease and ligated and the closer the fragments are, the more often they will 
ligate to each other; c) PCR of the ligation junctions. In recent years, 3C has been 
modified to allow for simultaneous assessment of interactions between multiple loci 
(4C (de Wit and de Laat, 2012) and 5C (Dostie et al., 2006)), as well as the discovery 
of novel interactions in the presence (ChIA-PET) (Fullwood et al., 2009a) or absence 
(Hi-C) (Lieberman-Aiden et al., 2009) of a protein-based pre-enrichment step 
(described in CHAPTER 1).  
Here, the candidate-based high-resolution 4C-Seq (van de Werken et al., 2012) and 
the genome-wide Hi-C protocols were used, which both follow the above principle and 
were performed in nucleo, which preserved the natural environment of these 
interactions (Figure 26). The aim of 4C-Seq is to measure how often a particular 
restriction fragment (herein referred as bait) interacts with many other restriction 
fragments in the genome allowing the modeling of the three-dimensional chromatin 
folding from the perspective of a specific locus of interest. More specifically, following 
the first ligation step DNA concatamers are formed, containing multiple restriction 
fragments, which precludes efficient amplification and sequencing across the region of 
interest. Therefore, the second round of digestion and ligation was used to reduce the 
size of the circularised fragments. Importantly, using two rounds of 4 bp restriction 
enzymes significantly increases the complexity of the fragment pool and thus the 
resolution of the resulting data. Finally, libraries were prepared by amplifying the 
circularised products after the second round of digestion and ligation using primers 
specific to the site of interest and containing an overhang with the Illumina adaptor 
sequences (Figure 26). By comparison the aim of the HiC protocol is to measure how 
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frequently all fragments in the genome interact with all fragments (all-to-all approach) 
and therefore probing for global genome architecture. This is achieved by the 
incorporation of a biotin-labelled nucleotide at the ligation junction, enabling selective 
purification of chimeric DNA ligation junctions followed by deep sequencing (Figure 
26).  
 
Cell lysis and chromatin preparation for 3C methods (4C-Seq and Hi-C) 
Cell pellets were isolated and re-suspend in neural stem cell media with 1% 
formaldehyde (SIGMA) (10x106 cells in 20 ml media) for 20 minutes for NSCs and 30 
minutes for ASTs at room temperature. Crosslinking reaction was terminated by the 
addition of 0.125 M glycine for 5 minutes at room temperature. Then, cell pellets were 
isolated by spinning at 2500 rpm 5 minutes at 4oC and washed twice with PBS (10 ml 
per pellet, GIBCO) before they were stored at -80oC. Cell pellets were thawed and 
lysed in 10 ml of Lysis Buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.2% NP-40) for 
20 minutes on ice. Then, nuclei were collected by spinning at 1800 rpm for 5 minutes 
at 4oC and re-suspended in 0.5 ml 1.2x DpnII buffer and transferred to a Protein 
LoBind tube (Eppendorf). At this point the concentration of nuclei was quantified using 
a haemocytometer with 2.5 µl of the sample and 47.5 µl of Crystal violet dye (1% final 
dilution).  
 
CIRCULARISED CHROMOSOME CONFORMATION CAPTURE (4C-SEQ) 
Digestion (DpnII) and Ligation I, Digestion II (Csp6I) and Ligation II 
An initial number of 7-8x106 nuclei were re-suspended in 0.5 ml of 1x DpnII buffer and 
0.3% SDS and aliquots were incubated at 37oC for 1 hour. Then, 2% Triton X-100 was 
added per aliquot and aliquots were incubated at 37oC for 1 hour. At this point, 10 µl of 
the aliquots were collected and stored as the undigested control sample. Then, 750 
Units of DpnII were added to each aliquot and aliquots were incubated at 37oC 
overnight, rotating. At this point, 10 µl of the aliquots were also collected as a digested 
for 24 hours digestion control and DpnII buffer was re-newed (1.2x DpnII Buffer with 
0.3% SDS and 2% Triton X-100) with 750 Units of DpnII and aliquots were incubated at 
37oC overnight, rotating. Finally, 10 µl of the aliquots were collected as a digested for 2 
days control. All control samples were decrosslinked and 30 µl per sample of the 
aqueous phase after phenol/chloroform extraction was run on a 1% agarose gel. A 
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second digestion should lead to a shift in the average fragment size in the case of 
NSCs and ASTs. Different cell types can vary and occasionally one night of digestion 
may be enough. Generally, a pool of fragments below the 3 kb mark is optimal as an 
input to the next step of the protocol.  
Digested fragments were collected by spinning briefly, re-suspended in 100 µl of the 1x 
T4 DNA Ligase buffer with 1600 Units of T4 DNA Ligase and incubated at 16oC 
overnight. At this point, ligation efficiency was evaluated the same way digestion was 
checked by 2.5 µl of the sample. A successfully ligated sample usually runs as a single 
band, slightly smaller in size than the undigested band (Figure 26). However, note that 
a different profile for ligated samples has been reported in (van de Werken et al., 2012) 
depending on the cell type. Based on an optimal ligation profile, 300 µl of 1x TE (pH 
8.0) and 1 mg/ml of Proteinase K (Bioline) were added and aliquots were incubated 
overnight at 65oC to reverse crosslinking reaction. Then, 75 µg/ml of RNase A 
(Invitrogen) were added and aliquots were incubated at 37oC for 2 hours. Then, DNA 
was extracted by phenol/chloroform extraction method, was precipitated using EtOH 
and re-suspend in 50 µl 1x TE. 
The concentration of purified ligated DNA was quantified using the Qubit quantitation 
system with the dsDNA HS kit (Invitrogen) and 1 µl was collected as a sample of 
undigested controls II. Then, the second digestion reaction was set up as follows: 
about 19 µl (5.5 ug) of sample, 30 µl of 10x Buffer B (NEB) and 120 Units of Csp6I 
(NEB) up to a total volume of 300 µl with water. The reactions were incubated 
overnight at 37oC. At this point, a sample of 10 µl was collected to check the digestion 
efficiency on a 1% agarose gel. Similarly to DpnII digestion, a pool of fragments below 
the 3 kb mark is optimal as an input to the next step of the protocol (Figure 26). Based 
on optimal digestion profiles, DNA was purified via phenol/chloroform extraction 
method and precipitated using EtOH and re-suspended in 50 µl of water. Ligation 
reaction was set up as follows: 50 µl of the sample, 600 µl of the 10x T4 DNA Ligase 
buffer, 1,600 Units of T4 DNA Ligase up to a total volume of 6 ml with water and 
samples were incubated overnight at 16oC. Finally, DNA was purified by using the 
phenol/chloroform method, precipitated using EtOH and re-suspended in 30 µl of Tris-
HCl (10 mM, pH 7.5).  
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4C-Seq library preparation, sequencing and analysis 
DNA concentration was quantified using the Invitrogen Qubit quantitation system and 
primer mix was prepared (0.85 µg/µl in 10 mM Tris pH 7.5). Next the PCR reaction 
used primers from the perspective of any bait sequence. Once the site is chosen, 
primers are designed to the two ends of the nearest DpnII-Csp6I restriction fragment. 
The primer at the DpnII end should contain the DpnII recognition site. The primer at the 
Csp6I end can be away from the recognition site, usually within a restricted distance 
(e.g. 100 bp). The database of pre-designed 4C-Seq primers for mouse can be found 
in (van de Werken et al., 2012) (primer sequences in Table 3 in the APPENDIX). PCR 
reaction was performed with the Expand Long Template PCR System (Roche) and 
was set up as follows: 100 ng of 4C template, 2.5 µl of 10x Buffer 1, 0.2 mM dNTPs 
(Invitrogen), 0.05 µg/µl of the primer mix, 0.35 µl of the Expand Long Template 
Polymerase (Roche) up to a total volume of 25 µl of water. Reaction conditions were 
the following: 94oC for 3 minutes (1 cycle); 94oC for 10 seconds, 55oC for 1 minutes, 
68oC for 3 minutes (30 cycles); 68oC for 10 minutes (1 cycle). Then, the PCR product 
was purified with the High Pure PCR Product Purification kit (Roche) according to the 
manufacturer’s instructions to remove primer dimers and concentrated to about 15 µl 
using AMPureXP beads according to the manufacturer’s instructions. Finally, 1 µl of 
the sample was evaluated on a Bioanalyzer chip using the Agilent DNA 1000 kit. In 
optimal conditions, the Bioanalyzer profile of each library should contain two prominent 
bands (one for the undigested product and one for the self-circularised product) on a 
smeared background of fragments (Figure 26). If the two theoretically prominent bands 
are too large or too small, they will not be visible on the profile. This variable product 
size does make the sequencing reaction less efficient; however, usually more than 
95% of clusters pass the filters. 
Based on the above Bioanalyzer results, each library was diluted to 10 nM and equal 
volumes of the libraries intended to be sequences in the same MiSeq flow cell were 
mixed. The library mix was quantified using the Invitrogen Qubit quantitation system 
and the theoretical molarity of the library mix was estimated using the following 
formula: [Library mix [c] µg/µl : (650 x 600)] x 109 = nM library mix]. Here, the molarity 
was about 10 nM as predicted by the Bioanalyzer and the library mix was diluted to a 
final concentration of 2 nM with water in a total volume of 10 µl. Then, samples were 
prepared for sequencing in the MiSeq platform (described in ChIP-Seq method). For 
sequencing, a single-end read length of 50 bp or more sequencing is optimal to collect 
4C-Seq data. A detailed description of the pipeline used to visualise data from 4C-Seq 
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experiments are described in (van de Werken et al., 2012). Briefly, libraries were 
classified based on the sequencing reads containing the forward primer (Primer 1), 
which serves as a tag for individual baits. The first 18-20 bp of the reads was trimmed 
and the remaining 30 or more bp were mapped to the mouse genome. The pipeline 
visualises normalised reads by representing the median of the reads either as a black 
line using a sliding window of 5 kb or as a heatmap using a range of sliding windows 
from 2 to 50 kb.  
 
HI-C  
Digestion (HindIII), Fragment fill-in reaction and Ligation 
An initial number of 7-8x106 nuclei were re-suspended in 0.5 ml of 1x NEB2 buffer and 
0.3% SDS and aliquots were incubated at 37oC for 1 hour. Then, 2% Triton X-100 was 
added per aliquot and aliquots were incubated at 37oC for 1 hour. At this point, 10 µl of 
the aliquots were collected and stored as the undigested control sample. Then, 1500 
Units of HindIII were added to each aliquot and aliquots were incubated at 370C 
overnight, rotating. At this point, 10 µl of the aliquots were also collected as a digested 
control. For ASTs, the digestion was performed with 0.6% SDS and 4% Triton X-100 
and was efficient by 1 day of digestion. All control samples were de-crosslinked and 30 
µl per sample of the aqueous phase after phenol/chloroform extraction was run on a 
1% agarose gel.  
Digested fragments were collected by spinning briefly, re-suspended in 100 µl of the 1x 
T4 DNA Ligase buffer with 1600 Units of T4 DNA Ligase and incubated at 16oC 
overnight. At this point, ligation efficiency was evaluated the same way digestion was 
checked by 2.5 µl of the sample (Figure 36). After a quick-spin to isolate the nuclei, 
103.4 µl of the mixture was added to the pellet [20 µl of 10x NEB2, 0.1 mM Biotin dNTP 
mix (0.36 mM of biotin-dCTP, dGTP, dTTP and dATP, Invitrogen), 25 Units of DNA 
polymerase I Large (NEB)] and an additional 85 µl of dH2O. The samples were 
incubated at 37oC for 45-50 minutes and they were inverted to mix every 15 minutes.  
Digested fragments after fill-in reaction were collected by spinning briefly, re-
suspended in 100 µl of the 1x T4 DNA Ligase buffer with 1,600 Units of T4 DNA Ligase 
and incubated at 16oC overnight. At this point, ligation efficiency was evaluated the 
same way digestion was checked by 2.5µl. A successfully ligated sample usually runs 
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as a single band, slightly smaller in size than the undigested band (Figure 36). Based 
on an optimal ligation profile, 300 µl of 1x TE (pH 8.0) and 1 mg/ml of Proteinase K 
(Bioline) were added and aliquots were incubated overnight at 65oC to reverse 
crosslinking reaction. Then, 75 µg/ml of RNase A (Invitrogen) were added and aliquots 
were incubated at 37oC for 2 hours. Then, DNA was extracted by using the 
phenol/chloroform method, was precipitated using EtOH and re-suspend in 100 µl of 1x 
TE. 
 
Hi-C library preparation, sequencing and analysis 
DNA concentration was quantified using the Invitrogen Qubit quantitation system and 
to remove biotin from unligated ends, the following reaction was set up for 5 µg of 
DNA:  10 µl of 10x NEB2, 10 µl of 10x BSA, 5 Units of T4 DNA Polymerase 0.1 mM 
dATP, 0.1 mM dGTP topped up with dH2O to a final volume of 100 µl. The reaction was 
incubated for 2 hours at 12oC and 2 µl of 0.5 M EDTA (pH8.0) was added to stop the 
reaction. DNA (10x reactions, 40-50 µg of DNA) was phenol/chloroform extracted, 
EtOH precipitated and re-suspend in 100 µl 1xTE (10 mM Tris-HCl pH8.0; 0.1 mM 
EDTA). DNA concentration was quantified using the Invitrogen Qubit quantitation 
system and 4 µg of DNA were diluted up to 120 µl 1x TE to be sonicated by the S220 
Covaris sonicator system (AFA Technology) for 140 seconds using the following 
settings: 20% duty cycle, 5 intensity, 200 cycle burst. Finally, 1 µl of the sample was 
evaluated on a Bioanalyzer chip using the Agilent DNA 1000 kit. In optimal conditions, 
the Bioanalyzer profile of each library should be between 150 to 250 bp sizes (Figure 
36).  
To repair the sonicated ends, the following reaction was set up for 4 µg of DNA:  16.8 
µl 10x Ligase buffer, 0.25 mM dNTP mix, 15 Units of T4 DNA polymerase (NEB), 50 
Units of T4 Polynucleotide Kinase (NEB) and 5 Units of DNA polymerase I Large 
(NEB) topped up with dH2O up to a final volume of 168 µl. The reaction was incubated 
for 30 minutes at 22oC and DNA was eluted in 30 µl 1x TE using MinElute kit (Quigen) 
according to the manufacturer’s instructions. Size selection of 200-400 bp fragments 
was performed by using 1.5% agarose (UltraPure, Invitrogen) in 1x Tris-Boric Acid-
EDTA (TBE) gels where its lane represented the 4 µg of DNA and each band was 
eluted in 18 µl 1x TE using Gel Extraction kit (Quigen) according to the manufacturer’s 
instructions.  
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DNA concentration was quantified using the Invitrogen Qubit quantitation system and 
to select for the biotinylated ligated restriction sites, 180 µl of eluted DNA was 
incubated with 50 µl of Dynabeads MyOne Streptavidin C1 (Invitrogen) for 1 hour 
rotating at room temperature. Prior to the conjugation, the 50 µl Dynabeads were 
washed twice with 400 µl Tween buffer (5 mM Tris-HCl pH 8.0, 500 µM EDTA pH 8.0, 
1 M NaCl, 0.05% Tween20) for 3 minutes rotating at room temperature and re-
suspended in 180 µl of 2x no Tween buffer (5 mM Tris-HCl pH 8.0, 500 µM EDTA pH 
8.0, 1M NaCl). After 1 hour incubation of the Dynabeads with the DNA, beads were 
washed twice with 400 µl of 1x no Tween buffer for 3 minutes rotating at room 
temperature and once with 400 µl of 1x NEB2.  
Each aliquot of Dynabeads was re-suspended in 50 µl of 1x NEB2 and to add polyA-
tails to the fragment ends, the following reaction was set up: 5 µl of 10x NEB2, 0.1 mM 
dATP, 5 Units of Klenow fragment (3’-5’ exo) (NEB) topped up with dH2O to a final 
volume of 100 µl. The reaction was incubated for 45 minutes at 37oC and beads were 
washed twice with 100 µl of 1x no Tween buffer for 3 minutes rotating at room 
temperature and once with 100 µl of 1x T4 DNA ligase Buffer. Each aliquot of 
Dynabeads was re-suspended in 50 µl of 1x T4 DNA ligase Buffer and to ligate the 
Illumina adapters the following reaction was set up: 5 µl of 10x T4 DNA ligase Buffer, 
1,200 Units of T4 DNA ligase, 6 pmol Pair-end (PE) Adapters 1.0/2.0 (Illumina) per µg 
of DNA (as measured after the gel extraction step described above) topped up with up 
with dH2O to a final volume of 50 µl. The reaction was incubated for 14 hours at room 
temperature and for 30 minutes at 4oC. Then beads were washed twice with 200 µl 1x 
Tween buffer, four times with 200 µl of 1x no Tween buffer, with 200 µl of 1x NEB2 
buffer and re-suspended in 50 µl of 1x NEB2 buffer. The Hi-C library was amplified by 
the PCR reaction with the Heculase Fusion II fusion DNA polymerase (Agilent) protocol 
for DNA targets 1-10 kb and was set up as follows: 10 µl of the above beads dilution, 
10 µl of 5x Heculase Fusion II buffer, 2.5 µl DMSO, 1 mM dNTP mix, 25 µM Illumina 
PE primer 1.0 and 2.0, 1 µl of Heculase Fusion II Polymerase topped up with dH2O to a 
final volume of 50 µl. The reaction conditions were as follows: 98oC for 2 minutes (1 
cycle); 98oC for 20 seconds, 65oC for 30 seconds, 72oC for 30 seconds (8 cycles); 
72oC for 5 minutes (1 cycle). Then, the PCR product was purified into 20 µl dH2O using 
AMPureXP beads according to the manufacturer’s instructions. Finally, 1 µl of the 
sample was evaluated on a Bioanalyzer chip using the Agilent DNA 1000 kit. In optimal 
conditions, the Bioanalyzer profile of each library should be between 300 to 500 bp 
sizes (Figure 36). 
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Based on the above Bioanalyzer results, each library was diluted to 10 nM and the 
libraries were sequenced in the HiSeq 2500 Ultra-High-Throughput Sequencing 
System by UCL Genomics based at the UCL Cancer Institute. Comparable number of 
paired-end 50 bp reads between datasets were generated to be aligned by Dr C. 
Barrington to the mouse genome (mm10) and inputted to the Hi-C analysis pipeline to 
generate the Hi-C contact maps (Yaffe and Tanay, 2011) (library information in Table 4 
in the APPENDIX).  
The Hi-C contact maps allowed for the visualisation of a certain genomic region of 
variable sizes. The diagonal in the map depicts the linear space of the chromosome or 
of a certain region of interest on a particular chromosome and each each pixel-square 
in the map represents the normalised value (observed/expected) of frequency of 
contacts between to restriction fragments in colour-code at a certain distance in cis. 
This linear distance on the chromosome of the two fragments can be defined if two 
lines are drawn from this pixel to the diagonal, where these lines form two sides of an 
equilateral triangle with the linear distance of the fragments.  
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APPENDIX  
 
Gene Symbol Forward Primer 5’-3’ Reverse Primer 5’-3’ 
Tbp CTGAAGAAAGGGAGAATCATGG TGTCTTTGTTGCTCTTCCAAAA 
Ubc AGGAGGCTGATGAAGGAGCTTGA TGGTTTGAATGGATACTCTGCTGGA 
Gfap TGCAAGAGACAGAGGAGTGGTA CGATAGTCGTTAGCTTCGTGCT 
Aqp4 CAGCTGTGATTCCAAACGAA GCCCAGTTTCCCATGATAAC 
Egfr ATGTGCAAAGGAATTACGACCT CTAAGCCCAGTTCTGTTTGTCC 
Blbp AAGGATGGTAGATGCTTTCTGC TGCCACCTTCCTGACTGATAAT 
Ccnd1 TGAAGGAGACCATTCCCTTG CTGGCATTTTGGAGAGGAAG 
Cdkn2d GTTCTTGGTCACTGTGAGGATTCAG CCATCATCATCACCTGGTCCAG 
Rad21 ACGAAGAAGCTTTTGCGTTG CGCTAAGCTGGGCTCTAATG 
Oct4 CCCAAGGTGATCCTCTTCTGCTT GAGAAGGTGGAACCAACTCCCG 
Nanog GCATCTTCTGCTTCCTGGCAA GAACTATTCTTGCTTACAAGGGTCTG 
Sox2 TGGACTGCGAACTGGAGAAGG CGCCCGGAGTCTAGCTCTAAATATT 
Rex1 GAGCTGAACTCCTAGCCGCCTAGATT TTTGGTCAGTGGTATTTGGGGACA 
Glast GTCGCGGTGATAATGTGGTA AATCTTCCCTGCGATCAAGA 
Olig2 CCAGAGCCAGGTTCTCCTC CCCCAGGGATGATCTAAGC 
Mash1 TCTTAGCCCAGAGGAACAAGAG GAATGCAGAGACACTGTTGGAG 
Fgfr3 CCTGGCGGGCAATTCTAT GCCACCACCAGGATGAAG 
Slc6a8 AGCCACTGGTCTACAACAACA CTCTGCCATGGTTCCTTTTG 
Slc1a2 GGAAGAAGAACGACGAGGTG GCCTCGTTCATGGTTTCATT 
Ctcf GTGGCCAAATTTCATTGTCC CGCTCATGAAACACAGCATC 
Pcdha1 CTGGTCATACTCGCAGCAGA TGCTCTTAGCGAGGCAGAGT 
Pcdha2 CTGGTCATACTCGCAGCAGA TGCTCTTAGCGAGGCAGAGT 
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Pcdha3 TGCTGTCGAGCTATGTGTCC GTCGTTCTCATCCAGCACAA 
Pcdha4 CTACGCGCATACTGGATGAA CGTTGACATCCACCAGTGAC 
Pcdha5 AAAATACACCCAACGGGACA CGTAATCCAGTTCGCCCTTA 
Pcdha6 CCAGCGAATACTTTGGGCTA CAGGAGCATCCTCTCTGTCC 
Pcdha8 TCACCGTGCTGGTGTCTCTA CAGATGGCGATGATCAGGTA 
Pcdha9 GGTGGAGGTGAGGGACATTA AGGCGCCTTCTAGTGGAAAT 
Pcdha10 AGTGGGTTCAGGGCATGTAG CAGAGCGCGAGTGATACTGA 
Pcdha11 GGGAGCTGGTCCTACTCACA TGCTCTTAGCGAGGCAGAGT 
Pcdha12 TCCTTCAGACGGCCTGTATC GCCTCCACGGGTATCTCATA 
Pcdhac1 GCCTAAGCATTAGCCAGCAC GTTGGTGTCCACCACAGTGA 
Pcdhac2 ATGTGAATGACAACGCTCCA GGAGTTTCCAAAGCCATTCA 
Pcdhcon1-2 CGCTACTCTGCCTCGCTAAG GGATACTGTTGGCCACTGCT 
Table 1. Sequences of the primers used in the real time PCR assays. The genes and the primer 
sequences (5’-3’) used to investigate the mRNA expression. The stock concentration of each primer was 
10µΜ (Sigma) and they were all used for the Roche SYBR green qPCR assays.  
 
Genomic location Forward Primer  Forward Primer  
Chr 9:44574238 GCGGCTACTGTGTTCTAGCC CTCCAGCGTCTTTTTGGAAG 
XIST 7N TGGCTTGTACTTCCAGATCAT AATGTAAAGCAAGCTAGTACGCA 
Chr 1:22250000 TGGTAAAGACAGTTTCCGAGGT AACAAATGTAGTGGGGCATTTC 
Chr 16:23980000 TTGAGATCCACAGAGCTCACAT AGGAAGGGTCCTTGGTTCTTAG 
Chr 10:2448 CCACATAACTCCAGTTCATCCA CTTCCTTCTTGCTCTTTTGCAT 
Table 2. Sequences of the primers used in the real time PCR assays for ChIP-qPCR. The 
chromosome locations and the primer sequences (5’-3’) used to investigate Rad21 binding enrichment. 
The stock concentration of each primer was 10µΜ (Sigma) and they were all used for the Roche SYBR 
green ChIP-qPCR assays.  
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Genomic location of 
Rad21 peak 
Primers 
to 
Rad21 
peak 
(bp) 
Reading primer Non-reading primer 
Chr 15: 54928695-985 123 GATGGAAACTGGGAATGATC CCTGGAACTCTCTGTGTTTT 
Chr 15: 54944702-980 843 GGCTACCCTGGCTAGTGATC ATTTGAATTTGAGGGTATGC 
Chr 18: 37180253-494 1,523 TGTAAAGCAGCAGCGTGATC TGTGTCACAAACTGGAAAAA 
Chr 18: 37377915-8314 432 GTATTGTAAAGTGGTCGATC AAGTTGTAGTGGCAGGATTG 
Chr 18: 38039914-40097 432 GATTCTGAACCCGACAGATC TTTATCAGTGTTGGAGTAGCTT 
Table 3. Sequences of the primers used in the 4C-Seq. The chromosome locations of the Rad21 ChIP-
Seq peak that 4C-Seq baits were designed to, their distance from the primers and the primer sequences 
(5’-3’) used to investigate the frequency of chromatin contacts from the Rad21 peaks as 4C-Seq baits. The 
stock concentration of each primer was 10 µΜ (Sigma) and they were all used for the Roche Expand Long 
Template PCR at the library preparation step.  
 
Experiment Cell type Library Total reads Aligned reads     
RNA-Seq 
NS 
Rad21Lox/Lox Rep1 197,575,770 171,847,072 
Rad21Δ/Δ Rep1 196,824,172 172,370,348 
Rad21Δ/Δ Rep2 196,389,640 173,230,450 
AST 
Rad21Lox/Lox 72h Rep1 64,617,898 44,991,352 
Rad21Lox/Lox 72h Rep2 128,034,010 99,372,356 
Rad21Δ/Δ 72h Rep1 171,500,112 161,007,519 
Rad21Δ/Δ 72h Rep2 161,582,478 151,628,664 
Rad21Lox/Lox 96h Rep1 96,652,864 73,299,209 
Rad21Lox/Lox 96h Rep2 157,608,996 142,134,841 
Rad21Δ/Δ 96h Rep1 135,376,776 108,848,912 
Rad21Δ/Δ 96h Rep2 162,328,468 140,294,262 
ChIP-Seq AST Rad21Lox/Lox Rep1 17,965,132 15,791,351 
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(Rad21) 
Rad21Lox/Lox Rep2 16,148,475 14,057,247 
Rad21Δ/Δ Rep1 17,238,004 13,928,307 
Rad21Δ/Δ Rep2 14,650,933 11,544,935 
Rad21Δ/Δ+siCTCF Rep1 15,871,143 12,811,186 
Rad21Δ/Δ+siCTCF Rep2 13,720,983 10,935,623 
Rad21Δ/Δ+siStag1 Rep1 15,797,332 11,587,343 
Rad21Δ/Δ+siStag1 Rep2 12,526,791 8,580,851 
Hi-C AST 
Rad21Lox/Lox 1,486,886,140 1,089,408,144 
Rad21Δ/Δ 1,481,910,324 1,075,343,153 
Rad21Δ/Δ+siCTCF 726,282,526 527,498,617 
Rad21Δ/Δ+siStag1 790,839,396 572,000,000 
Rad21Δ/Δ+siStag2 1,019,219,572 735,000,000 
Table 4. Read statistics from the RNA-Seq, ChIP-Seq, Hi-C datasets. The RNA-Seq libraries (strand-
specific, paired-end) were sequenced on the Genome Analyzer II in Illumina Inc (San Diego), the ChIP-
Seq libraries (single-end, 75 bp) were sequenced at the MiSeq and the Hi-C libraries (paired-end, 55 bp) 
at the HiSeq 2500 platform at the UCL Cancer Institute. Hi-C dataset for Rad21Lox/Lox and Rad21Δ/Δ ASTs 
are from Sofueva et al. 2013. 
 
GENE 
Rad21Lox/Lox  
72h 
Rad21Δ/Δ 
72h 
z-score 
Rad21Lox/Lox  
96h 
Rad21Δ/Δ 
96h 
z-score 
Gm13086 8.81148 98.5163 5.401992241 11.8397 163.853 6.700495939 
Gm12896 2.36206 34.8014 4.393411014 82.1765 141.015 1.645215459 
Mest 2.83287 18.2394 3.398818291 3.01778 24.084 3.889358405 
Trnp1 1.79835 17.117 3.733834528 2.09028 21.7046 4.058876085 
Defb1 1.61934 10.6937 3.327630071 2.85344 29.1799 4.326688744 
Rnf128 29.4029 399.714 7.94524525 20.065 417.774 7.749511085 
Mt1 12.8972 1467.12 14.47680019 22.4887 1483.58 10.61899005 
Iapp 0.119478 2.06734 3.182294222 0.378566 3.00049 2.98536858 
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Speer4e 0.13384 2.0213 3.029364688 0.226124 4.42014 3.892522929 
Npr3 0.0968771 3.37565 3.969246799 0.103743 4.2716 3.731825378 
BC061195 0.0302345 2.97502 3.820358403 0.137195 6.81096 3.925473441 
Samd12 0.238474 1.23587 2.483642587 0.413658 2.03968 2.366705748 
Ccdc114 0.24689 1.14786 2.337618029 0.46448 3.04139 2.736422308 
Dlk1 0.151372 0.844544 2.273679475 0.136416 2.34986 2.829700107 
U3 0.121821 0.617459 1.801978385 0.495544 2.41495 2.351414937 
Palm3 0.336436 4.00718 3.758285507 0.741746 7.07671 3.538341176 
Myoc 0.257904 3.55419 3.799207284 0.249788 3.88767 3.604098176 
1700003M07Rik 0.408371 1.3001 1.862910452 0.501229 1.46139 1.681831603 
Myh4,Myh8 0.933143 7.46827 3.358213052 1.27053 9.99609 3.42941743 
Igf1 0.580717 10.0001 4.145074262 0.829627 11.232 4.039837328 
Col8a1 0.485236 15.3176 4.835037319 0.807769 19.5105 4.869319406 
Slc26a9 0.0608132 0.471801 1.968184692 0.081763 0.864865 1.830484574 
AK129341 0.0506297 0.430783 2.062083242 0.0575654 0.741352 2.00250157 
Lrrc3 0.249716 1.1144 2.282515599 0.231226 1.15364 2.164228653 
Lhx6 0.0569908 0.308604 1.602437952 0.0195456 0.510736 2.321644928 
Tmem119 0.418853 2.62746 2.741595413 0.180128 1.36091 2.351753937 
Vmn1r42 0.0546975 0.378378 1.851543758 0.0671455 0.541621 1.593579416 
Col6a3 0.0551425 0.483308 2.092259182 0.0656358 0.499253 1.542261606 
Kcnj15 0.103081 0.645534 2.039748887 0.0692834 0.902711 2.012678329 
Speer4d 0.102199 0.561817 1.893256694 0.0545315 1.37136 2.58743629 
Ada 0.131018 0.867638 2.10256561 0.0771176 1.16663 2.143213619 
Acer2 0.22664 1.04526 2.326784881 0.225565 1.51636 2.541611178 
Spna1 0.0577946 0.828453 2.592625199 0.0703837 1.1145 2.183119493 
Grip1 0.0450979 0.601088 2.518618577 0.437009 1.6398 2.010688361 
157 
 
Cdh26 0.041571 0.710329 2.771297747 0.161693 2.7059 3.269106964 
Cyp2f2 0.0222837 0.667915 2.719884653 0.0451997 2.0694 3.111116037 
Igf2bp1 0.0140265 0.734597 3.236525234 0.00264511 4.11413 5.661322962 
Gprc5a 0.0123218 0.135148 1.789207414 0.0200721 0.213128 1.585657432 
Pkp1 0.0108971 0.136081 1.909328495 0.0135211 0.263226 2.081087893 
Ptprt 0.00821497 0.154839 2.290442455 0.00844722 0.294947 2.558536154 
C230038L03Rik 0.00991746 0.111136 1.809071959 0.00857343 0.409006 2.813610066 
Ndst3 0.0171898 0.166387 1.673486469 0.0116311 0.173445 1.863216336 
Col3a1 0.0208555 0.20002 1.664968907 0.0181734 0.89172 2.836600984 
Ces2e 0.301736 1.03501 2.043618196 0.141412 5.01215 4.134784832 
Scn4b 0.0052858 0.107401 2.359983912 0.0167228 0.246456 1.85359901 
Gpr64 0.00506897 0.0461808 1.617409369 0.0046287 0.0857873 2.040905334 
       
Gm12198 0.0923883 0.0162902 -1.973627034 0.0481436 0.00746377 -1.860506835 
Prdx6b 0.0964527 0.0193958 -1.825862309 0.0217277 0.00498973 -1.547578148 
5830403L16Rik 0.108221 0.0124842 -2.450594849 0.0348876 0.00492918 -1.94457073 
0610040F04Rik 0.110221 0.0210584 -1.883411797 0.0748873 0.00779949 -2.20820126 
Serpind1 0.139388 0.0210789 -2.164460328 0.114124 0.0079789 -2.8711939 
Fgd2 0.0969444 0.0118638 -2.384193459 0.117982 0.0030143 -3.913338521 
Icosl 3.33109 1.15271 -1.533753246 4.20406 1.18189 -2.300470937 
Grin2c 0.204522 0.00977981 -3.819104734 0.0864308 0.00699194 -2.720154913 
Cacna2d4 0.180361 0.0241657 -2.313344338 0.152318 0.0134702 -2.778889549 
Gm15641 0.195101 0.0260372 -2.318221511 0.0782451 0.0116786 -1.893686121 
1700066J2Rik 0.147765 0.024192 -2.06680809 0.0729887 0.010902 -1.893048308 
Kcnj9 0.167166 0.0407379 -1.577520756 0.11581 0.0083676 -2.837133587 
Slc25a41 0.0484402 0.00640911 -2.172982806 0.0578875 0.00601631 -2.210037971 
158 
 
Afp 0.0634709 0.00688368 -2.375210253 0.0507024 0.00640325 -2.039721399 
Gm5648 0.0682871 0.00928488 -2.145239106 0.0285772 0.00621498 -1.592070941 
Rgsl1 0.0572239 0.00403701 -2.812622879 0.0575989 0.0017844 -3.267978878 
BC024139 0.325101 0.0627286 -1.920562783 0.280647 0.0166723 -3.361822593 
Gm12009 0.625937 0.055816 -2.901388677 0.124484 0.0142289 -2.362292557 
Gm2636 0.341801 0.0270234 -3.149525141 0.153884 0.0176729 -2.47744154 
Vwa3b 0.377673 0.0642599 -2.093809727 0.338788 0.0329508 -2.723689747 
Gm7932 0.541635 0.0633163 -2.53892304 1.45356 0.0330654 -5.522580682 
Vtcn1 0.340156 0.0439137 -2.474100495 0.60068 0.0396247 -3.379559478 
Gm14556 1.06824 0.242929 -1.837890289 0.266694 0.0642012 -1.672351582 
Wnt5b 1.82706 0.156845 -3.373984658 1.5022 0.0519849 -4.880125862 
Slpi 1.5912 0.285665 -2.388067978 0.590734 0.0253367 -3.964983792 
Gm12891 0.916581 0.0778744 -3.274579662 0.806232 0.0584968 -3.45268526 
Gm12460 1.03968 0.100033 -3.093073563 0.19175 0.0342852 -1.966782514 
Atp5o 0.594341 0.140189 -1.599103199 0.482797 0.0273995 -3.452689135 
Fabp4 14.5039 4.36269 -3.731948452 16.8257 0.529234 -8.411807692 
Lpl 19.8603 3.99584 -4.618271887 16.8136 1.25936 -6.252930428 
Kcnj8 11.6163 1.66264 -5.106401597 12.8065 0.737547 -6.968182758 
Opn4 15.0501 5.45982 -3.157159202 14.532 1.72544 -5.164171867 
Gm14287 90.5907 5.15413 -5.511812585 6.84835 1.89348 -2.552419392 
Gm11572 58.384 5.69616 -6.719529671 1.98497 0.551881 -1.889321597 
Mmp11 165.786 37.9115 -2.778655466 47.812 14.1363 -3.063836724 
Smpd3 4.07774 0.873131 -2.343670822 3.21328 0.238736 -4.360072087 
Gm6166 4.81436 0.693743 -3.723515742 4.54199 0.405709 -4.552422407 
Adora1 19.5058 8.46308 -2.389340906 20.8429 8.45271 -2.050222962 
Gpr37l1 3.481 0.459668 -3.159205351 4.41941 0.288557 -5.16794511 
159 
 
Nrtn 1.77017 0.26018 -2.562199257 0.955361 0.194693 -1.972887044 
Lrtm2 1.49727 0.227043 -2.655750619 0.877486 0.158592 -2.144921419 
Gm16379 9.55139 3.18239 -2.859613196 0.416325 0.0351264 -2.93579187 
Gm11512 20.6419 0.839963 -9.253964935 0.308336 0.0290344 -2.765563711 
Gm14472 3.90165 0.881563 -2.252975197 0.840607 0.0518264 -3.685996291 
Mxra8 5.65332 1.01894 -3.273051058 0.296025 0.0450997 -2.142769069 
       Table 5. The expression of de-regulated genes in Rad21Lox/Lox and Rad21? /?  ASTs at 72 and 96 
hours post Cre-expressing adenovirus-infections. The RNA-Seq expression data (FPKM values) and 
z-scores of the top up- and down-regulated genes in Rad21Lox/Lox and Rad21Δ/Δ ASTs at 72 and 96 hours 
post-infections used for the heatmap in Figure 21. 
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